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ABSTRACT 
One of the main problems in the field of multifunctional proteins 
such as ligandin is the possibility that multiple forms and iso-
proteins may exist. Two forms of liver ligandin [ GSH (reduced 
glutathione) S-transferase B] have been described, a heterodimeric 
form consisting of equal amounts of Ya (22000 daltons) and Ye 
(25000 daltons) subunits, and a homodimeric form containing only 
Ya. Because rat testis ligandin, prepared by the standard 
technique of anion-exchange and molecular exclusion chromatography, 
contains more Ye subunit than Ya, it has been claimed that testis 
and liver ligandin are different entities (Bhargava, Ohmi, Listow-
sky and Arias (1980) J. Biol. Chem. 255, 724-727). 
This thesis investigated the nature and character of ligandin in 
the steroid-producing tissues of the rat. A comparative study was 
undertaken to establish whether testis ligandin differed from liver 
ligandin. Different methods of purification were used to 
investigate testis ligandin and its relationship to other GSH 
S-transferases in steroidogenic tissues. 
Testis ligandin purified by immunoaffinity chromatography using 
anti-liver YaYa ligandin antiserum yielded a product identical with 
liver preparations (Y c=Ya). This suggests that the differences 
previously described may be due to contamination of testis ligandin 
by a closely related species. Testis ligandin prepared by the 
standard technique was similar to that previously reported, 
containing more Ye than Ya. Cross-linking studies of standard 
testis ligandin preparations with dimethylsuberimidate showed more 
than one band in the 50000 dalton region, further stengthening the 
view that these testis ligandin preparations may be contaminated. 
Since this contaminant was likely to be another GSH S-transferase, 
sodium dodecyl sulphate/ polyacrylamide-gel-electrophoretic analysis 
was performed on testis GSH S-transferases separated by CM-
cellulose chromatography. GSH S-transferase AA which was present 
in large amounts, was shown to migrate in the same region as Ye 
subunit. CM-cellulose chromatography of a 'pure' standard testis 
ligandin preparation revealed significant amounts of GSH 
S-transferase AA migrating as Ye subunit, in addition to ligandin 
consisting of equal amounts of Ya and Ye subunits, indicating that 
testis ligandin is identical with liver ligandin and that 
previously described differences are due to a contaminant 
identified as GSH S-transferase AA. 
Studies on ligandin in other steroid-synthesising tissues showed 
that ovary and adrenal ligandin prepared by standard techniques 
also contained more Ye than Ya. Separation of ovary GSH S-trans-
ferases on CM-cellulose showed that GSH S-transferase B, the peak 
reacting with anti-liver YaYa ligandin antisera contained equal 
amounts of Ya and Y c subunits, suggesting a situation similar to 
that in the testis exists. Glutathione peroxidase II activity of 
testis and ovary GSH S-transferases was investigated. Fractions 
corresponding to GSH S-transferase AA, A and B exhibited activity 
with cumene hydroperoxide. The considerable glutathione peroxidase 
activity of GSH S-transferases in testis and ovary suggest a 
protective function for the cells of gonadal tissue against 
oxidative damage to essential intracellular components. 
Further attempts to clarify the function of ligandin in the 
steroid-synthesising tissues were made. The pattern of gonadal 
ligandin development during early life, puberty and pregnancy 
determined by radioimmunoassay was found to parallel serum steroid 
hormone concentrations. This correlation was not observed in liver 
or kidney. Ligandin was localised to specific cells of the 
steroid synthesising tissues using immunocytochemical techniques. 
These findings suggest that there may be a functional link between 
steroidogenic cells, or products of their activity and certain GSH 
S-transf'erases. Phenobarbital pre-treatment did not have any 
effect on developing testis, ovary or adrenal ligand in 
concentrations. Immunocytochemical localisation of ligandin in rat 
steroid-producing tissues using a peroxidase anti-peroxidase (PAP) 
technique with anti-liver YaYa ligandin antiserum as the first 
antibody, showed staining in the testis to be limited to the 
interstitial (Leydig) cells. Stromal cells of the ovary and the 
fascicular, glomerular and reticular zones of the adrenal cortex 
also contained immunoreactive material. PAP staining with 
anti-testis ligandin antisera (testis ligandin prepared using the 
standard technique) showed far greater intensity of staining in 
these tissues, presumably due to reaction with both ligand in and 
GSH S-transferase AA. 
This study has clarified the structural aspects of testis ligandin 
and demonstrated identity with liver ligandin. Ontogeny of 
ligandin in the steroidogenic tissues and localisation to specific 
regions in these tissues suggests a functional link between 
ligandin, GSH S-transferases, GSH peroxidases and activity of 
steroidogenic tissue. 
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INTRODUCTION AND LITERATURE REVIEW 
1 
INTRODUCTION 
Ligandin, a multifunctional protein found in many organs and 
species, has been claimed to vary in structure and function, from 
organ to organ and from species to species. This study was 
designed to test the hypothesis that ligandin, found in the 
steroid-producing tissues of the rat, differs in structure and 
function from that found in liver, kidney and small intestine. In 
order to provide a background to the hypothesis, as well as a 
context in which relevance of the results may be judged, the 
literature review found in this chapter will cover briefly the 
historical aspects of the subject which include the discovery of Y 
protein, azocarcinogen-binding protein, cortisol metabolite-binding 
protein and glutathione S-transferase B (GSH S-transferase B). The 
distribution of this protein in various species, organs, tissues, 
cells and organelles will also be described. 
The different functions of ligandin and GSH S-transferases have 
received widespread attention in recent literature. Since many 
excellent and comprehensive reviews are available, only those 
functional aspects relevant to the hypothesis tested will be 
reviewed in detail. In contrast, the recently described function 
of ligandin and the GSH S-transferases as GSH peroxidase II, which 
has not been well covered in the literature, will be reviewed in 
detail here. 
2 
The maturation of enzyme systems and the effects of weaning, 
puberty, pregnancy and senescence on these systems will be 
examined. 
Further, several of the methods of purification of ligandin and the 
GSH S-transferases and studies concerning its structure and 
immunological properties will be included. 
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SECTION A 
LIGANDIN AND THE GLUTATHIONE S-TRANSFERASES 
HISTORICAL ASPECTS 
In 1967, Arias' group at the Albert Einstein College of Medicine, 
New York, were studying mechanisms responsible for rapid transfer 
of bilirubin from plasma into liver. In order to study the binding 
of bilirubin and sulphobromopthalein (BSP) (Fig. 1.1) to proteins 
present in liver cytosol they subjected a mixture of cytosol and 
labelled bilirubin to gel filtration on Sephadex G-75, a technique 
which would not disrupt the anion-protein bond. Their study 
demonstrated the presence of three protein fractions in liver 
cytosol which bound to bilirubin and BSP (Levi et al 1969a). 
These fractions were termed X, Y and Z in order of elution from the 
column. The small amount of bilirubin present in the void volume 
or X peak was thought to represent non-specific adsorbtion to high 
molecular weight proteins and as such was not pursued. Subsequent 
studies thus focused on the isolation and characterisation of · the 
organic anion-binding proteins responsible for the Y and Z peaks. 
Of the two proteins, Y was considered to be the major organic anion 
binding protein of hepatic cytosol since it was found to be present 
in greater abundance and to have a higher affinity for most organic 
anions than Z. 
At about the same time that the Y protein studies were being 
carried out, other workers in different centres were independently 
HOOC COOH 
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Fig. 1.1 Structural formulae of (top) bilirubin; (centre) 








pursuing the same species but in 
Ketterer et al (1967) identified 
different capacities. Thus 
a basic azodye carcinogen-
binding protein and Litwack's group a corticosteroid binding 
protein ( corticosteroid Binder I) (Morey and Litwack 1969). The 
realisation that these proteins had similar physical and chemical 
characteristics led to the exchange of antisera and to the 
establishment of identity. The term ligandin was suggested since 
none of the previous terms used described the many ligands bound by 
this protein (Litwack et al 1971). 
The possibility that ligandin may have catalytic activity was 
initially suggested by Kaplo\Vitz et al (1973) when it was found 
that much of the unconjugated BSP added to cytosol as a marker of 
the Y peak was converted to a GSH adduct. This finding led to the 
discovery by Jakoby's group that GSH S-transferase B, the major 
transferase of rat liver, was immunologically indistinguishable 
from ligandin (Habig et al 1974a). The GSH S-transferases 
first described by Boyland and Chasseaud (1969) catalyze the 
conjugation of GSH with a large number of compounds bearing an 
electrophilic carbon (Fig. 1. 2) to form the corresponding 
thioether, which is subsequently acted upon by other enzymes which 
remove glutamate and glycine, and which acetylate the amino group 
of the resultant thioether of cysteine. The N-acetyl cysteine 
thioether is the mercapturic acid of each of the substrates and is 
usually a non-toxic, soluble product which is readily excreted 
(Fig. 1.3). 
Ligandin has now emerged as a protein able to bind non-covalently 
to a vast number of ligands, including bilirubin, sulphobromo-
pthalein, heme, cortisol metabolites, oestrogens and bile acids 
Cl SG ¢re, ¢re, 
GSH + I + HCI 1 
N02 N~ 
Cl SG g•o, <Yo, 








I 01:CH, 0 
GSH + I I 4 
N02 N02 
o5·" o5 GSH + + H2S04 5 ~ / 
GSH + ICH3 GSCH3 • HI 6 
Fig. 1. 2 The reactions between GSH and (1) 1. 2-dichloro-4-
nitrobenzene; (2) l-chloro-2, 4-dinitrobenzene (both are aryl 
substrates); (3) trans-4-phenyl-3-buten-2-one (an alpha, beta-
unsaturated ketone); (4) 1, 2-epoxy-3-(p-nitrophenoxy) propane (an 
epoxide) (5) menapthyl sulphate (a sulphate ester) and (6) 
iodomethane (an alkyl substrate). All these reactions are 
catalysed by GSH S-transferase enzymes. 
Acetyl-CoA 
CONHCH2COOH 
R.X + HSCH2CH 
NHCOCH2CHCOOH (GLUTATHIONE) 
NH2 l GSH S-transferases 




1 Y-Glutamyl Transpeptidase 
CONHCN2COOH 
R.SCH2cH + Glutamate 








Fig. 1. 3 Metabolic pathway for the biosynthesis of the 
mercapturic acids. R.X represents an electrophilic compound. 









(eg. cholic acid and lithocholic acid, Fig. 1.4). Putative 
functions include that of a storage and transport protein within 
the cell analogous to that of albumin extracellularly. There is no 
direct evidence that these proteins are responsible for recognition 
and uptake of organic anions from the vascular space. However, 
they do influence net uptake by reducing the efflux into plasma by 
binding these substances within the cell (Wolkoff 1980). Ligandin 
is also able to bind covalently to reactive electrophiles such as 
azodye carcinogens (eg. 4-dimethylaminoazobenzene, Fig. 1.1) and 
their metabolites, and has been claimed to be responsible for 
eliminating 
activity as 
these harmful substances. Finally, its catalytic 
a GSH S-transferase, as a de1ta5, 3-keto steroid 
!:he: cJ ,sc.o'lrz':J, 
isomerase (Fig. 1. 5) (Benson et al 1977) and" more recent ,.. as a 
GSH peroxidase (Fig. 1.11) (Prohaska 1980), suggests that it may 



















(3a, 7a, 12a-trihydroxy cholanic 
',OH acid) 
Lithocholic acid 
(3a - monohydroxy cholanic acid) 
Fig. 1.4 Structural formulae of the bile acids; cholic acid and 
lithocholic acid. 
0 
A5 •ANDR0STENE•3, 17•D10NE A4 •ANDll0STENE•3, 17•D10NE 
Fig. 1. 5 Isomerisation of delta5-3-ketosteroid isomer to 
delta4-3-ketosteroid isomer Rat liver GSH S-transf erases 
are able to catalyse this reaction (Benson et al 1977). 
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DEFINITION OF LIGANDIN vs GSH S-TRANSFERASE B 
The multiple functions of ligandin have led to the use of a large 
number of synonyms and definitions which are often confusing. 
Ligandin, as purified from rat liver (Arias et al 1976, Listow-
sky et al 1976), is a basic, cytoplasmic protein existing in 
dimeric form, with a capacity for binding various electrophiles 
non-covalently and certain metabolites of carcinogens covalently. 
It is immunologically identical to GSH S-transferase B, but 
distinct from the other transf erases. 
Y protein was the original name of the ESP-binding fraction eluting 
from a molecular sieving column (Levi et al 1969a). This term, 
including the terms corticosteroid Binder I (Morey and Litwack 
1969) and azodye carcinogen-binding protein (Ketterer et al 
1967) have, as mentioned before, been replaced by ligandin (Litwack 
et al, 1971). 
The subunit composition of rat liver ligandin has led to further 
confusion and will be defined here. Discontinuous sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of 
the Y peak showed three major bands in the 25000 dalton molecular 
weight region. Bass et al (1977a) named these Ya (22000 
daltons), Yb (23500 daltons) and Ye (25000 daltons). Purified rat 
liver ligandin consists of Ya and Ye in two different dimeric 
forms, YaYa and YaYc (Yb is removed during purification) (Bass et 
al, 1977a). The dimers have been separated by Hayes et al 
(1979) who have named the YaYa species, Ligandin, and the YaYc 
species, GSH S-transferase B (see later). 
7 
Different groups of workers have their own preferred terminology. 
Those studying the enzymatic aspects of this protein appear to 
prefer GSH S-transferase B, while those dealing with its other 
functions, such as binding, use ligandin. 
Unless specifically stated, the terms ligandin or GSH S-transferase 
B will be used in this dissertation to denote either or both the 
YaYa and YaYc dimeric species. 
8 
SPECIES AND TISSUE DISTRIBUTION 
The distribution of ligandin and the GSH S-transferases in 
different species, in various tissues and in their cellular and 
sub cellular components has been widely studied. This chapter 
reviews the recent literature with particular emphasis on studies 
in man and in the rat. 
Ca) Phylogeny 
The appearance of ligandin in the liver coincides with the 
transition from aquatic to terrestial life. Teleosts, elasmo-
branchs and several species of amphibia have no ligandin detectable 
by BSP-binding to the Y peak. In contrast there is an abundance of 
ligandin (or Y protein) in post-metamorphosis amphibia, reptiles, 
birds and in mammals (Levine et al 1971). A similar phylo-
genetic pattern has been observed when GSH S-transferase activity 
was measured in these vertebrate species ( Grover and Sims, 1964). 
Insects, molluscs, Planaria (Clark and Smith, 1975), plants 
(Frear and Swanson, 1970), and peas (Frear and Swanson, 1973) have 
GSH conjugating activity. Yeast does not (Jakoby 1978). Recently, 
GSH S-transferase activity has been detected in bacteria. Several 
strains of Salmonella typhimurium contain GSH S-transferase 
activity in addition to high levels of glutathione (Summer et 
al 1980). 
(b) Invertebrate GSH S-Transferases 
Tables 1. 3 1. 7 illustrate the different forms, substrate 
specificities, enzyme kinetics and immunologic properties of GSH 
9 
S-transferases found in various species and tissues, some of which 
have been purified to homogeneity. Purification methods such as 
ion-exchange chromatography, isoelectric focusing and 
polyacrylamide-gel-electrophoresis (see Table 1.1 and Chapter l, 
Purification Methods) have all been used to isolate these proteins, 
while different substrates such as CDNB, DCNB, pNBC, SO, EA, IM and 
cumene. OOH (see Table 1. 2 for abbreviations) have been used to 
characterise the wide spectrum of catalytic activities. 
In the early 1960s GSH S-transferases were implicated in the 
metabolism of insecticides (Hodgson and Casida, 1962) and these 
enzymes were accordingly investigated in insects (Table 1. 3). 
Motoyama and Dauterman (1978) used CM-cellulose to isolate multiple 
forms of GSH S-transferase activity in an insecticide-resistant 
strain of the house-fly, Musca domestica, while Usui et al 
(1977) were able to separate and purify several of the transferases 
from fat bodies of the cockroach, Periplaneta. The catalytic 
properties of these enzymes differed from mammalian liver GSH 
S-transferases but were similar- in the regard that they also 
displayed a wide range of overlapping specificities with various 
substrates. GSH S-transferase activity has been demonstrated in 
abdominal homogenates as well as in fat body and gut preparations 
of several species of insects (Yang 1976). Insecticidal compounds 
that are substrates for transferase reactions include 
organophosphosphorus triesters, organothiocyanates and chlorinated 
hydrocarbons. The GSH S-transferases catalyse two main types of 
reaction with these insecticides, ie the formation of 0-alkyl or 
0-aryl conjugates, both of which result in detoxication. The 
former appears to be the major metabolic pathway in vivo 
(Motoyama and Dauterman 1980). 
TABLE 1.1. KEY TO TABLES 1.3 - 1.7 
Method Used: 
(1) Gel filtration (G-100 or G-75 Sephadex) 




(3) Affinity chromatography (a) GSH-BSP Sepharose 4B 
(b) hexyl-GSH Sepharose 6B 
(c) GSH-Sepharose 
(4) SDS-polyacrylamide gel electrophoresis 
(5) Isoelectric focusing 
(6) Hydroxyapatite chromatography 
ABBREVIATIONS USED IN TABLES 1.3 - 1.7 
sa = specific activity in umol/min/mg 
s/u = subunit 
pk = peak 
T/F = GSH S-transferase 
m. weights= molecular weights in daltons 














- reduced glutathione 
- l-chloro-2.4-dinitrobenzene 
- 2.4-dichloronitrobenzene 
- p-nitrobenzyl chloride 
- styrene oxide 
- ethacrynic acid 
- iodomethane 
- benzo(a)pyrene 4.5-oxide 
- 1-menapthyl sulphate 
- trans -4-phenylbut-3-en-2-one 
- sulphobromopthalein or disodium 
t phenolterabromophthalein sulphonate .. 
- cumene hydroperoxide 









1977), ie several 
enzymes may be active with a specific compound. Each enzyme may 
display also activity with several different types of compounds, as 
do the transferase enzymes of rat liver (Lu 1979). Insect drug-
metabolising enzyme activities may be more readily understood since 
the characteristics of the enzyme in rodents are well documented, 
allowing for comparisons of the biotransformation mechanisms 
between the different species. Investigations carried out by Baars 
et al (1979) with the fruit-fly, Drosophila melanogaster, 
an organism often used in genetic toxicology testing (Vogel and 
Sobels 1976) demonstrated comparable GSH S-transferase activity in 
this species, which indicated a xenobiotic metabolism function 
similar to that encountered in mammals. 
Contamination of estuarine and marine environments by organic 
xenobiotics prompted investigations of the toxicology of aquatic 
ecosystems. The presence of the GSH S-transferase enzymes were 
apparent in marine crustaceans such as the Blue Crab (Tate and Herf 
1978) and molluscs (Bend et al 1977). The hepatopancreas 
(analogue of vertebrate liver) generally contains the highest 
enzyme specific activity, although activity can be detected in 
other tissues as well (See Table 1.3). Earthworms which have been 
exposed to pollutants and pesticides, display effective GSH 
































































































































































































































































































































































































































































































































(c) Vertebrate GSH S-Transferases 
Identification of the GSH S-transferases in rat extracts can be 
carried out either by the use of specific antibodies or less 
specifically by measuring enzyme activity with certain substrates 
and interpreting these patterns. Studies on the GSH S-transferases 
in animals other than the rat (Table 1.4) are incomplete. Tables 
1. 5 and 1. 6 summarise details on the rat GSH S-transferases. 
Liver GSH S-transferases in various vertebrate species have 
differences in substrate specificity and catalytic properties 
as shown in Table 1. 4. Multiple forms of GSH S-transferase exist 
in some species, for example rat liver has seven isoenzymes. These 
vary in amino acid and isoelectric points but are similar in size 
and overlap in substrate specificity. They are thought to be the 
product of at least 6 genes. Guinea pig liver has 5 different 
forms (Irwin et al 1980). Chicken liver has 4 GSH 
S-transferase forms (Yeung and Gidari 1980), while hamster liver 
has 3 different forms, 2 of which cross-react with both rat liver 
ligandin and human liver GSH S-transferase epsilon. The five forms 
of monkey liver GSH S-transferases which can be separated by 
CM-cellulose are closely related to each other and are similar to 
the immunologically identical human GSH S-transferases, differing 
only in isoelectric point and are thought to represent post-
translational modifications of a single gene product (Asoaka et 
al 1977). Nimmo et al (1980) noted that trout liver 
contained a transferase similar to rat liver ligandin in molecular 
weight and isoelectric point, but not in ability to bind BSP or 

























































































































































































































































































































































































































































































































































































































































































































































The range in molecular weight of the GSH S-transferases is from 
40000 - 46000 daltons (enzyme); 23000 - 26000 daltons (subunits). 
The isoelectric points of hepatic GSH S-transferases (pl = 6. 5 to 
10.0) do not vary greatly from species to species. The GSH 
S-transferases discussed here represent mainly the cationic and in 
less detail the neutral groups of enzymes (Tables 1.4) 1.5 and 
1. 6). The GSH S-transferases isolated from rat tissues other than 
liver resemble the hepatic forms with regard to molecular weight 
and isoelectric point (as shown in Table 1. 5). 
Species of snakes with naturally higher hepatic GSH S-transferase 
activities than others appear to have survived in contaminated 
ecosystems, this success of species survival perhaps being due to 
the presence of an efficient detoxifying system (Stafford et al 
1976). 
(i) Immunological Studies 
Following isolation of homogenous preparations of rat and human 
hepatic ligandin, monospecific antibodies were used as a tool to 
study the antigenic relationship of these proteins with other 
hepatic GSH S-transferases and with similar proteins in other 
tissues and species. Development of a radioimmunoassay for rat 
ligandin facilitated the quantitation of this protein in different 
tissues (Bass et al 1977b). Immunodiffusion showed no cross-
reactivity with anti-rat ligandin antiserum and liver preparations 
from guinea pig, mice, rhesus monkey, Shetland ponies, chickens, 
rabbits, fish, amphibia or reptiles (Fleishner et al 1972). 
This antibody was used to establish identity between Y protein, 
cortisol metabolite binder I and azocarcinogen-binding protein. 
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The liver supernatants from different strains of rats (Long Evans, 
Gunn and Sprague-Dawley) all contained ligandin which cross-reacted 
with the antibody as did the ligandin from different rat tissues. 
Hamster tissue demonstrated partial immunologic identity ith the 
rat antibody (Fleishner et al 1977). Recently, Smith et al 
(1980) using a highly purified monospecific antibody to rat liver 
ligandin, were able to show cross-reactivity with both human and 
hamster liver preparations. 
The five basic human transferases react similarly with monospecific 
antibody prepared against each of the other four proteins 
(Fleishner et al 1976). Antisera against the human proteins 
showed cross-reactivity with rhesus monkey liver preparation but 
not with rat. 
(ii) Rat GSH S-Transferases Liver 
Table 1.6 lists the properties of the seven rat liver cytosol GSH 
S-transferases designated E, D, C, B, A and AA in order of their 
elution from carboxymethylcellulose ( CM-cellulose) cation exchange 
columns (Habig et al 1974b; Habig et al 1976). Gillham 
(1973) has described an additional transferase, GSH S-transferase 
M, which binds to diethylaminoethylcellulose (DEAE-cellulose) at pH 
8. 0 and conjugates the reaction of GSH to 1-menapthyl sulphate. 
All but transferase D have been purified to homogeneity. The GSH 
S-transferases represent approximately 10% of soluble rat liver 
proteins. The major transferase of rat liver is GSH S-transferase 
B which accounts for 5% of total cytosol protein (Fleishner et 
al 1972). 
14 
Earlier work with crude preparations led to enzymes being named on 
the basis of substrate reactive groups or carbon (skeleton) 
backbone, and resulted in terms such as glutathione aryl, alkyl, 
alkene and epoxide transferases (Boyland and Chasseaud 1969). 
These terms are no longer considered applicable since there is 
considerable overlapping of catalytic capabilities of isoenzymes 
and all are able to catalyse conjugation of GSH with several 
substrates (Jakoby 1978 and Chasseaud 1979). Rat GSH 
S-transferases A and C are structurally and immunologically similar 
and differ only in isoelectric point. None of the other rat liver 
GSH S-transferases appear to share immunological identity. The 
specific activity of GSH S-transferases B and AA with the substrate 
CDNB is several times greater than that with DCNB (Table 1.6), 
while GSH S-transferases A and C both have considerable activity 
with DCNB. However their specific activity for CDNB is 10 times 
greater. GSH S-transferase A and C differ in their ability to 
catalyse reactions with the substrate trans-4-phenyl-3-buten-2-
one, the specific activity of GSH S-transferase C is 20-fold higher 
than A (Guthenberg and Mannervik 1979). In addition to the broad 
specificity these proteins have for their substrates, Ketley et 
al (1975) have shown that they have overlapping binding of 
non-substrate ligands. The tightness of binding is dependent on 
both the nature of the ligand and the specific GSH S-transferase. 
The amino-acid composition of rat GSH S-transferases A and C are 
similar. The difference index is 2. 2 and can be interpreted as 
producing statistically significant proof of a close relationship 
between two proteins provided they are of similar length (Metzger 
et al 1968). A value of zero is equivalent to complete amino 
15 
acid homology, while 100 indicates absence of homology. Such 
comparisons of GSH S-transferase B with A, B with C, and B with AA 
yielded values of 9. 5, 8. 8 and 7. 4 respectively (Jakoby et al 
1976). Cornish-Bowden (1978) adopted an alternative approach, ie 
estimation of the number of sequence differences in the various GSH 
S-transferases. Rat liver GSH S-transferases A and C had an 
estimated sequence identity of about 95%, while the other 
transferases showed much less similarity. His finding that rat GSH 
S-transferases AA and B were far more similar than expected for 
unrelated proteins may be of particular importance as the results 
of our study become apparent. 
Each GSH S-transferase has a distinct isoelectric point ranging 
from pH 7 to 10. Using preparative isoelectrofocusing Hales et 
al (1978) have separated transferases AA, B, A and C (in order of 
decreasing basicity). They also identified an additional GSH 
S-transferase with a pl of 6. 6 which may be GSH S-transferase M, or 
may represent an as yet unidentified isoenzyme. 
(iii) Rat GSH S-Transferases Other Tissues 
The capacity of different tissues to metabolise foreign compounds 
is important, particularly if that tissue is the site of entry or 
exit of foreign compounds and their metabolites from the body eg 
liver, lungs, gastrointestinal tract, kidneys and skin. Generally, 
hepatic tissues have greater GSH S-transferase activity than 
extrahepatic tissues, although evidence has accumulated that these 
enzymes are present in significant amounts in the extrahepatic 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Kraus and Kloft (1980) demonstrated that the steroidogenic organs 
displayed very high specific activity with varying substrates 
compared to the other tissues analysed. Specific activity for 
1, 2-epoxy-3-(p-nitrophenoxy)-propane was high in the testis, while 
both testis and adrenal cytosol displayed high specific activity 
for CDNB. The adrenal gland and the ovaries were also able to 
catalyse the nucleophilic attack of GSH on methyl iodide. Compared 
to the liver, testis preparations had substantially higher specific 
activities for CDNB, 1,2-epoxy-3-(p-nitrophenoxy)-propane and 
methyl iodide. These workers were unable to explain why the 
steroidogenic organs should have such high GSH S-transferase 
activities with these substrates, since there was no apparent link 
between steroid synthesis and conjugation with glutathione. They 
postulated that the transferases functioned as binding or transport 
proteins, or by protecting nucleophilic tissue components from 
denaturation by electrophilic reactants. 
Bend and co-workers have demonstrated the ability of GSH S-trans-
f erases to metabolise reactive chemicals in the steroidogenic 
organs. In the rat, testicular GSH S-transferase activities with 
SO, CDNB, DCNB and tPBO as substrates vary from 40% to 90% of 
hepatic activity per mg of protein (Mukhtar et al 1978a), while 
ovarian GSH S-transferase specific activity towards SO is 67% of 
that seen in the liver (Mukhtar et al 1978b). 
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Rat and mouse sperm GSH S-transferase and de1ta5-3-ketosteroid 
isomerase specific activity varied from 0.4 to 4.1% values seen in 
liver cytosol (Mukhtar et al 1978c). The epididymis, the site 
of spermatozoa! maturation, was also shown to have GSH S-trans-
ferase conjugating activity (Hales et al 1980). lsoelectric 
focusing resolved cytosol from fractions of rat epididymis-vas 
deferens into six peaks of activity (pl 7. 0-8. 9) (Table 1. 5). Four 
peaks were similar to rat liver transf erases A, B and C and 
possibly M, while the other two peaks did not correspond to 
previously described transf erases. 
The epididymis, unlike the liver, is not thought to be involved in 
drug metabolism. However the GSH S-transferases may protect the 
epidymis and maturing spermatozoa from electrophiles or 
alternatively may catalyse some other reaction in this tissue. 
The intestine is another organ which comes into contact with 
toxins and is a route of entry for many carcinogens into the body. 
Consequently an adequate detoxifying enzyme system is necessary. 
Rat duodenum and jejunum display considerable GSH S-transferase 
activity with CDNB as substrate. A total of 3% of the extractable 
protein from these tissues cross-reacts with antibody to GSH 
S-transferases A, B and E (Pinkus et al 1977). The major 
fraction of total intestinal transferase activity has been shown to 
be GSH S-transferase B, contributing 2% of rat intestinal 
extractable protein (Fleishner et al 1972). The highest level 
of GSH S-transferase activity in the rat gastrointestinal tract is 
found in the proximal small intestine. Middle and distal small 
intestinal tissues also display activity ( Clifton and Kaplowitz, 
1977). 
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Another major route of entry for foreign compounds is through the 
lungs. Studies of pulmonary GSH S-transferase activity have been 
carried out with the emphasis on epoxide substrates (Mukhtar and 
Bresnick, 1976a, b, de Pierre and Moron, 1979). Grover (1974) found 
that rat lung preparations possessed greater GSH S-transferase 
activity towards the K-region epoxide of benz(a)anthracene than 
corresponding liver preparations. This is an exception to 
previously reported studies which stated that hepatic tissues 
contribute more activity per mg of soluble protein than do 
extrahepatic tissues (Bend et al 1976). However Chasseaud et 
al (1980) confirmed Grover's findings with studies carried out on 
monkey lung . and liver tissue. Guthenberg and Mannervik (1979) 
described 5 different forms of lung GSH S-transferases separable on 
hydroxyapatite following hexylglutathione affinity chromatography 
(Table 1. 5). 
Using immunodiffusion techniques ligandin was detected only in the 
liver, kidney and small intestinal mucosa of the rat (Fleischner 
et al 1976). However with the development of radioimmunoassay 
techniques (Bass et al 1977b) it became apparent that ligandin 
was widely distributed in the tissues of the adult rat, with the 
highest concentrations in liver, kidney, small intestinal mucosa, 
testis, ovary and adrenal gland. Lesser quantities were present in 
salivary gland, gastric mucosa of colon, pancreas, pituitary, lung, 
thyroid, bladder, heart and seminal vesicles. 
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Bannikov and Tchipyseva (1978) were the first to describe locali-
sation of ligandin in the rat gonadal tissue using immunofluores-
cent microscopy. Subsequent immunohistochemical and immunofluores-
cent studies have identified and localised ligandin in most tissues 
in which it has been detected by radioimmunoassay. Rat serum also 
contains GSH S-transferase activity. Using SO and BPO as 
substrates, Mukhtar and Bend (1977) found levels of less than 1% of 
hepatic enzyme activity. Serum enzyme specific activity was less 
than 1% of hepatic enzyme activity. 
(iv) Human GSH S-Transferases 
Five cationic or basic GSH S-transferases have been isolated from 
human liver (Table 1. 7). These are designated alpha, beta, gamma, 
delta and epsilon in order of increasing isoelectric point (pl 7 .8 
8.8) (Kamisaka et al 1975). These proteins have similar 
amino acid composition and molecular weight (48000 daltons) and 
consist of two identical subunits. The delta protein accounts for 
the major portion of the total purified hepatic transferases. The 
minor differences between the various cationic transf erases have 
been attributed to a variable number of amide groups giving rise to 
differing charge isomers. These enzymes are thought to be products 
of a single gene. All five cationic human transf erases react 
similarly with monospecific antibody prepared against each of the 
other four proteins and are termed ligandin(s) (Fleishner et al 
1976). 
In addition to the cationic transf erases, acidic or anionic 
transferases have been demonstrated in human liver (Table 1. 7). 
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Awasthi et al (1980b) were able to purify two such transferases 
the major form omega with a pl of 4.6, and a minor form psi (pl 
5.4). Koskela and Valmet (1980) have also described the presence 
of an acidic form (pl=4.63). Significant differences in catalytic 
properties of the cationic and anionic forms have been noted. 
Recently Warholm et al (1980) described the presence of another 
human liver GSH S-transferase which only occurs in some individ-
uals. This transferase, which has been purified, has an isolectric 
point of 6 - 6.5 and has been termed transferase mu (Warholm et 
al 1981). It is a "neutral" transferase which has a 20-fold 
higher activity with benzo(a)pyrene-4, 5-oxide and 100-fold 
higher activity with trans-4-phenyl-3-buten-2-one than the 
cationic transferases. 
Another anionic GSH S-transferase has been purified; this time from 
human erythrocytes (Marcus et al 1978). The enzyme (pl=4. 5), 
is named transf erase rho and has an amino acid composition 
different from liver anionic transferases. Its molecular weight is 
47500. GSH S-transferase activity has also been documented in 
human lymphocytes and peripheral leucocytes (Kaplowitz et al 
1978). Human placenta appears to have a single form of GSH 
S-transferase with isolectric point, amino acid composition and 
substrate specificity similar to red cell transferase ( Gu then berg 
et al 1979, Polidoro et al 1981a). Bilirubin and BSP 
competitively inhibit placental transferase activity (Polidoro et 
al 1981a), thus suggesting that this system may have a role in 
selective exchange of organic hydrophobic anions across the 















































































































































































































































































































































































































































































GSH S-transferase activity with epoxide substrates has been 
detected in human skin (Mukhtar and Bresnick 1976c), and in lung 
tissue (Greene and Jernstrom 1980, Moron et al 1979). 
Established cell cultures derived from different species display 
GSH S-transferase activity towards CDNB, DCNB and 1, 2-epoxy-3-(p-
nitrophenoxy)propane (Wiebel et al 1980), rodent cell lines 




Several groups involved in the study of azocarcinogen binding in 
rat tissues have investigated the tissue and cellular distribution 
of ligandin using histological methods. Employing a fluorescent 
antibody procedure, Bannikov et al (1972, 1973) demonstrated 
the presence of ligandin in normal rat liver, kidney, small 
intestine, ovary and testis . Fleishner et al (1977) using a 
similar technique, found ligandin to be present in the cytoplasm of 
hepatocytes, proximal renal tubular epithelium and epithelial cells 
of the proximal, mid and distal small intestine of rat, hamster and 
man. These investigators did not detect ligandin in ovary and 
testis. Carruthers and Baumler (1979), who also employed the 
fluorescent antibody procedure, detected ligandin uniformly 
distributed in the cytoplasm of normal and 3'-methyl-4-dimethyl-
aminoazobenzene-treated rat liver, but not in liver carcinomas. In 
highly differentiated hepatomas, ligandin was uniformly 
distributed, but was absent in poorly differentiated hepatomas, 
anaplastic carcinomas and in most adenocarcinomas (Bannikov et 
al 1973) . 
The effect of carcinogens on the ligandin content of normal and 
carcinogen treated rat liver, kidney and testis was investigated by 
Carruthers and Baumler (1980) . Using the fluorescent antibody 
technique, liver and kidney from carcinogen-treated rats contained 
lower amounts of ligandin compared to untreated tissues, while the 
amount of ligandin in the testis of barbital-3'-methyl-p -
dimethylaminoazobenzene-treated rats was significantly increased. 
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Ligandin was localised in the steroidogenically active cells using 
immunofluorescence and a monospecific anti-liver ligandin antibody. 
Testis of adult rats and rats at 1, 2, 7, 9, 11, 21 and 30 days 
after birth were examined and all typical Leydig cells were shown 
to contain ligandin, while the other cell types (seminiferous 
tubule cells, Sertoli cells and cells of blood vessel-like 
endothelium) did not (Bannikov and Tchipyseva 1979). The nuclei of 
the Leydig cells often showed very bright fluorescence indicating 
that ligandin could be present in these organelles. These workers 
localised ovarian ligandin to the theca interna cells, to thecal 
cells persisting in corpora lutea, to atretic follicles and to 
ovarian interstitial tissue. No ligandin-specific fluorescence was 
found in the primordial follicles, theca externa cells, granulosa 
cells, connective tissue of ovaries, or luteal cells of the corpus 
luteum. The same ligandin-specific fluorescence was found in 
pregnant ovaries and in the luteal cells of corpora lutea. Corpora 
lutea at the stage of involution, contained no ligandin. These 
studies demonstrated the presence of ligandin in gonadal cells in 
which active steroidogenesis occurs, ie Ley dig cells, interstitial 
cells of ovaries, cells of theca interna and luteal cells in 
pregnant rats. The presence of ligandin in these steroidogenically 
active cells may be explained by postulating a protective role 
whereby ligandin prevents possible damage caused by high concentra-
tions of steroids. 
Bannikov and Tchipyseva (1979) were unable to detect any ligandin-
containing cells in the adrenal gland or placenta of the rat. 
Using immunofluorescence and immunodiffusion Arias and co-workers 
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were similarly unable to detect any ligandin in the adrenal (Arias 
1981). 
With the application of the peroxidase-antiperoxidase procedure of 
Sternberger (1979) for light and electron microscopy, ligandin was 
localised to the cytosol and smooth endoplasmic reticulum of rat 
hepatocytes (Capron et al 1979) . Campbell et al (1980), 
using the peroxidase-an ti peroxidase method, demonstrated ligandin 
in human hepatocytes in renal proximal convoluted tubules and in 
the thick segment of Henle's loop of kidney. Ligandin was also 
present in oxyntic cells of human stomach, interstitial cells of 
testis, fully developed Graffian follicles of ovary and reticular-
type cortical cells of the adrenal gland. Foetal adrenal cortex 




The GSH S-transf erases are located mainly in the cytosol as is 
glutathione. The mitochondrial matrix space has also been shown to 
contain activity (Wahllander et al 1979) while GSH 
S-transferase activity has been associated with the membranes of 
the endoplasmic reticulum (microsomes) (Glatt and Oesch 1977, 
Morgenstern et al 1979) , a site particularly suited for GSH 
conjugation of reactive intermediates generated by the cytochrome 
P-450 system. Because this activity could be greatly stimulated by 
treatment of the microsomes with sulfhydryl reagents, while 
supernatant activities remained unaffected, and differences in 
substrate specificities and characteristics were observed, it was 
concluded that the microsomal GSH S-transferase activity was 
distinct from that of the cytoplasm (Morgenstern et al 1980) . 
Similarly Friedberg et al (1979) found differences in induction 
response in that phenobarbital treatment increased the specific 
activity of the soluble fraction two-fold, while microsomal 
specific activity remained unchanged. Three microsomal GSH 
S-transferases had similar isoelectric points to those of 
cytoplasmic GSH S-transferases A, B and C, also antiserum raised 
against transferase A (cross-reacting with transferase C) 
immunoprecipitated 50% of the microsomal activity . These findings 
suggested that the pattern of GSH S-transferases in the microsomal 
fraction is similar to that in the cytoplasm. 
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Three of the GSH S-transferases from rat liver mitochondria have 
been isolated. Two have similar molecular weights to that of the 
cytosolic forms, while the third has a molecular weight of 88000. 
The isoelectric points range from neutral to acidic for these 
mitochondrial forms (Kraus 1980). The physiological function of 
GSH S-transferases in these organelles remains obscure. GSH 
S-transferase activity in highly purified endomembranes and plasma 
membrane fractions was highest in rough endoplasmic reticulum, 
followed by microsomes and then smooth endoplasmic reticulum. 
Nuclei, nuclear envelope, plasma membrane, unbroken mitochondria 
and Golgi apparatus had much lower specific activities (Friedberg 
et al 1979). 
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STRUCTURAL AND SUBUNIT STUDIES 
The structure and composition of ligandin and GSH S-transferase 
subunits have been subjected to intensive 
attempt to understand some of the many 
attributed to this protein. 
investigation in an 
different functions 
(a) Subunits of Ligandin / GSH S-Transferase B 
Initial SDS-PAGE of pure rat liver ligandin, employing a continuous 
system revealed a single band of 23000 dalton molecular weight 
(Ketterer et al 1975, Listowsky et al 1976) . Using gel 
filtration chromatography ligandin had been shown to exist in 
solution as a 46000 dalton molecular weight protein. The protein 
was thus thought to exist as a dimer consisting of two identical 
subunits . However, with the introduction of discontinuous SDS-PAGE 
(2% Acrylamide spacer gel; 10 or 12% Acrylamide resolving gel), 
greater resolution was obtained, and rat liver ligandin was shown 
to consist of equal amounts of two non-identical subunits. The 
molecular weights of these two subunits are 25000 daltons and 22000 
daltons (Bass et al 1977a). 
The Y sulphobromopthalein-binding fraction of rat hepatic cytosol 
was shown by discontinuous SDS-PAGE to consist of three major 
bands, termed Ya (22000), Yb (23500) and Ye (25000) (Bass et al 
1977a) . Although the three bands were initially present in rat 
hepatic cytosol, the Yb subunit disappeared during the first anion 
exchange step of purification suggesting that Yb represents a 
relatively acidic species. Yb has recently been identified as a 
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subunit of GSR S-transferases A and C (Hayes et al 1980, Scully 
and Mantle 1980) . 
Phenobarbital pretreatment increased the concentration of Ya and Yb 
but had little effect on Ye (Bass et al 1977a) . Ligandin could 
be separated using non-denaturing techniques into two forms, YaYa 
and YaYc. These findings led Bass et al (1977a) to suggest 
that ligandin was a heterogeneous species existing as two non-
identical subunits which were the monomers of two distinct 
proteins. Bhargava et al (1978ab) disputed this hypothesis and 
presented results of electrofocusing and cross-linking experiments 
which indicated that the two subunits were part of a single 
heterodimeric protein rather than monomers of two different 
proteins. It is now accepted by most workers that there are two 
distinct species of ligandin, a homodimeric species, and a 
heterodimeric species. Carne et al (1979) and Hayes et al 
(1979) were able to separate the YaYa dimer from the YaYc dimer on 
CM-Sephadex. When compared with GSH S-transferase B (prepared by 
the method of Habig et al 1976) and ligandin (prepared as 
described by Bass et al 1977a) the CM-Sephadex elution volumes 
of ligandin and the Ya Ya dimer; and GSH S-transferases and the YaYc 
dimer were identical . This led Hayes et al (1979) to suggest 
distinct identities for ligandin (YaYa) and GSR S-transferase B 
(YaYc) . 
Antisera raised against either YaYa or YaYc both reacted 
monospecif'ically against purified YaYa and YaYc ligandin and also 
against liver supernatant fractions, suggesting that antigenic 
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similarity exists between the Ya and Ye subunits of ligandin (Bass 
et al 1977a). Amino acid analysis and limited proteolytic 
digests revealed a close 
(Bhargava et al 1980b) . 
relationship between the two species 
Although isolation of the YaYa dimer 
could be achieved, separation of the Ye subunit from the Ya could 
not be carried out in non-denaturing systems (Bass et al 
1977a). Bhargava et al (1980b) isolated Ye by extraction from 
SDS-polyacrylamide gels. This product did not retain catalytic 
activity . Urea (7M) denaturation of YaYc was able to dissociate 
the subunits (Hayes et al 1981) after which chromatography of 
the renatured products was carried out on CM-Sephadex. Sixty per 
cent of the original CDNB/GSH conjugating activity was recovered. 
Three peaks of enzyme activity eluted from CM-Sephadex, 
corresponded to the elution positions of ligandin (YaYa) GSH 
S-transferase B (YaYc) and GSH S-transferase AA (YcYc) (Hayes et 
al 1981). These experiments suggested that Ya Y c protein may be a 
hybrid of ligandin (Ya Ya) and GSH S-transferase AA (YcYc). 
However, this does not explain the antigenic cross-reactivity 
between Ya and Ye subunits (Bhargava et al 1980b), and their 
lack of immunologic identity to transf erase AA (Habig et al 
1976). 
Amino acid analysis of the Y c subunit showed that although it 
contained most of the cysteine present in the intact dimer, the 
overall amino acid composition of each of the subunits was similar. 
This has been confirmed by peptide mapping studies (Bhargava et 
al 1980b). SDS-PAGE of staphylococcus U8/V8 pronase-treated 
subunits revealed similar patterns for Ya and for Ye. It is 
thought that the Y c contains an extra peptide of about 25 to 30 
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amino acid residues at the COOR-terminal end (Bhargava et al 
1978a). 
The Ya and Ye subunits are not linked by disulfide bridges. This 
was shown by demonstrating similarity of the subunits on SDS-PAGE 
in the presence and in the absence of beta-mercaptoethanol (Bass 
et al 1977a, Bhargava et al 1978a). 
(b) Subunits of Other GSH S-Transferases 
The molecular weight of rat liver GSH S-transf erases is 
approximately 46000. All have been shown to exist as dimers of 
three possible subunits Ya (22000), Yb (23500) and Ye (25000). 
Hayes et al (1980) and Scully and Mantle (1980) have determined 
the monomer composition of the different GSH S-transferases by 
means of SDS-PAGE. Transferase AA exists as YcYc, while 
transferases A and C exist as YbYb. GSH S-transferase B and 
ligandin, as defined by Hayes et al (1979), exist as Ya Ye and 
YaYa dimers respectively. 
The subunit and amino acid composition of GSH S-transferases AA and 
B suggest that they may be the product of a single gene. 
Tran sf erases A and C may also be coded for by a separate single 
gene, especially since they cross-react with antisera raised 
against each other. Scully and Mantle (1981) have proposed that 
all the transferases are generated by proteolysis of the YcYc 
protein 
artifact. 
and suggest that the YaYa species is a purification 
This suggestion has been disputed by Hayes et al 
(1981), and although no spontaneous inter-conversion between Ya Ya 
and YaYc was observed on storage, their hybridisation studies 
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suggested that GSH S-transferase B (YaYc) is a hybrid of ligandin 
(Ya Ya) and GSH S-transferase AA (YcYc) . Transferases D and E 
appear to contain both Ye and Yb bands on SDS-PAGE (Hayes et al 
1980). 
(c) Isoelectric Points of GSH S-Transferases 
The isoelectric points for each of the rat GSH S-transferases is 
shown in Table 1. 6. Gel isoelectric focusing yielded two bands of 
active enzyme for GSH S-transferases A (Pabst et al 1974) and E 
(Fjellstedt et al 1973). Two bands were also observed for 
transferases B and C (Habig et al 1974b). The multiple forms, 
or 'microheterogeneity' exhibited by ligandin, described by 
Ketterer et al (1976) and by Bass et al (1977a), have been 
attributed by Hayes et al (1979) to be due to the distinct YaYa 
and Ya Ye dimeric forms. The heterodimer Ya Ye described by Bhargava 
et al (1978a) showed a single band on electrofocusing. GSH 
S-transferase AA, which has a single band on isoelectric focusing, 
has an isoelectric point identical to one of the bands of GSH 
S-transferase B, ie a band which focuses at a pH of 10 (Habig et 
al 1976). In order to prove that GSH S-transferase AA was unique 
from the other GSH S-transferases, Habig et al (1976) compared 
enzyme activities of eluted sectioned gels and demonstrated 
distinct differences in behaviour between the bands of transferases 
AA and B. 
(d) Subunit Binding Studies 
The binding activity of ligandin has been extensively studied. 
Ligandin binds a variety of endogenous and exogenous hydrophobic 
compounds at a single site (Ketterer et al 1975, Tipping et 
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al 1976a,b, 1978). GSH binds at an adjacent site (Jakoby 
1978). Thus in the case of GSH S-transferase activity, the 
hydrophobic ligands compete with the electrophilic substrates 
(Ketterer et al 1976). Although specific subunit binding of 
non-substrate ligands to the GSH S-transferases has not been 
investigated, Ketley et al (1975) have shown that bilirubin 
binds strongly to transf erases B, C and A and poorly to AA. 
Several studies of the binding and catalytic activities of the 
ligandin subunits have been carried out by Arias and co-workers. 
Their evidence indicates that primary high affinity binding of 
bilirubin to ligandin and GSH S-transferase activity are 
independent and occur at different domains in the protein (Bhargava 
et al 1978b). Several reports have described the presence of 
cysteine residues on the Ye subunit (Bhargava et al 1980b). 
Since binding occurs to cysteine residues (Ketterer et al 1976) 
it has been suggested that thiol groups are involved in the binding 
and catalytic sites of ligandin. Carne et al (1979) detected 
four thiol residues in ligandin. One of these residues appears to 
be associated with the hydrophobic binding site of ligandin. 
Bhargava et al (1978b) reported two binding sites for 
bilirubin to rat liver ligandin; a high affinity primary site: 
7 -1 
CKassoc=5 x 10 M ) , 
which may be present on the homodimer YaYa, and a secondary, lower 
affinity site: 
5 -1 
CKassoc=3 x 10 M ) • 
Their findings suggest that the high affinity site at which 
bilirubin is bound to ligandin is independent from the site at 
which catalytically reactive substrates bind. 
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Following photoactivation, BSP was shown to bind covalently .to the 
Ya subunit only (Bhargava et al 1980b) suggesting that 
non-covalent binding of BSP, which preceded photolabelling, was 
probably mediated by Ya. Other reports (Arias 1979, Arias et 
al 1979, 1980) have suggested that the 25000 molecular weight 
subunit (Y c) was able to bind photolabelled BSP or activated 
carcinogen metabolites covalently . Y c binding to the labelled 
carcinogen exceeded that of Ya by 600-800%. The cysteine residues 
contained on the Y c polypeptide are thought to be responsible for 
this binding function. However, a more recent report suggests that 
the metabolites of 3'-methyl-N , N-dimethyl-4-aminoazobenzene 
bind exclusively to the Ya peptide (Ohmi et al 1981a) . 
The Ya monomer has been implicated in lithocholic acid (Fig. 1.4) 
binding and under non-equilibrium conditions the Ye monomer does 
not bind this bile acid (Hayes et al 1981). Under equilibrium 
conditions only the Ya subunit contains a high affinity binding 
site for cholic acid (Fig. 1. 4) while both Ya and Y c subunits 
possess low affinity cholic acid binding sites (Hayes et al 
1980). 
(e) Translational Studies on the Subunits 
Poly(A)-containing rat liver mRNA was isolated and translated into 
ligandin in a wheat-germ cell-free system (Daniel et al 1977). 
Ligandin synthesised in vitro dissociated into two 
polypeptides, the Y c subunit predominated immediately after 
synthesis converting into Ya upon ageing. These results suggest 
that Y c is the primary translational product of ligandin mRNA. 
Pickett et al (1981) found the primary translation product of 
rat liver GSH S-transferase B mRNA to be two distinct polypeptides. 
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The mRNA's coding for the two subunits were present in unequal 
concentration with the mRNA coding for Ya exceeding that for Ye. 
The amount of translationally active mRNA encoding for GSH 
S-transferase B is induced 3 to 4-fold by phenobarbital 
administration; in contrast to the findings by Daniel et al 
(1977) and, interestingly in view of Bass et al's earlier work 
(1977a), only the mRNA for Ya is induced. 
35 
PURIFICATION METHODS 
Purification procedures for the isolation of ligandin and GSH 
S-transf erases have been numerous and varied. Most have made use 
of ion-exchange and molecular sieving chromatography, isoelectric 
focusing, polyacrylamide gel electrophoresis and affinity 
chromatography. Because of the importance of obtaining pure 
preparations before any conclusive studies can be carried out, this 
section will consider the merits and shortcomings of various 
methods of purification. 
(a) Ligandin: Standard Purification Method 
The standard purification procedure for rat liver ligandin was 
first described by Fleischner et al (1971). This method was 
used to purify rat renal ligandin and described in detail by Kirsch 
et al (1975). The technique makes use of the finding that 
ligandin has a higher pl than most cytoplasmic proteins. Fig. 1. 6 
details the procedure. A 100000 g supernatant fraction is passed 
over either a triethylaminoethyl (TEAE)- or a diethylaminoethyl 
(DEAE)-cellulose column equilibrated with a high pH, low ionic 
strength buffer. Gel-filtration of the unbound ligandin-
containing fraction is then carried out (Sephadex G-100 at pH 7. 4). 
Measurement of the binding activity of BSP, bilirubin, or GSH 
S-transferase catalytic activity with specific substrates enables 
the identification of the ligandin-containing peak. The final 
stage utilises QAE-Sephadex A. 50 which combines both gel filtration 
and anion-exchange steps. Purity of the protein can be determined 
by SDS-polyacrylamide gel electrophoresis or gel isoelectric 
focusing. 
Rat tissues dissected, rinsed and perfused where possible with 
ice-cold saline and homogenised in O.OlM sodium phosphate buffer pH 
7.4 / 0.25M sucrose. 
I 
!Homogenate centrifuged at 27000 g for 30 minutes 
I 
upernatant decanted, and ultracentrifuged at 100000 g for 120 
inutes. 
I 
Supernatant concentrated to 15ml and dialysed against O.OlM Tris. 
HCl buffer oH 8.8 (buffer A) 
I 
~ialysed material applied to DEAE- or TEAE-cellulose column, equi-
brated with buffer A. 
I 
The eluted peak pooled, concentrated to 10ml and dialysed against 
O.OlM sodium phosphate buffer pH 7.4 / O.lM NaCl (buffer B) and 
applied to Sephadex G-100 column equilibrated with buffer B. 
I 
ractions contaming GSH-CDNB conJugating activity pooled, concen-
trated to approximately 7ml, and dialysed against buffer A. 
I 
The dialysed material applied to QAE-S ephadex column equilibrated 
with buffer A. 
I 
The eluted peak assessed 
by means of SDS - PAGE, 
for purity. 
Pooled and stored or, recnromal.ograpny 
in sterile tubes of purified ligandin 
at 4°c. performed on QAE-
Sephadex with buffer 
C (0. OlM Tris.HCl, 
pH 9.1). 
Fig. 1.6 - Standard Purification Procedure for Ligandin (Fleischner 
et al 1971 and Kirsch et al 1975) 
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This method has been used to prepare pure ligandin for many 
detailed structural and functional studies from rat liver (Bass 
et al 1977a, Bhargava et al (1978a, b, 1980a, b, 1980b) and 
from rat testis (Bhargava et al 1980a). 
(b) GSH S-Transferases: Standard Purification Method 
Rat GSH S-transferases have been purified to homogeneity by the use 
of entirely conventional procedures as is shown in Fig. 1. 7 (Habig 
et al 1974a, 1976, Pabst et al 1974). This method makes 
use of the alkaline isoelectric point of these proteins and absorbs 
them to CM-cellulose. This is followed by their sequential elution 
with a salt gradient. The substrate CDNB is usually used to follow 
the course of purification. CM-cellulose chromatography is 
followed by repeated chromatography with hydroxyapatite. An 
independently derived but very similar purification technique for 
rat GSH S-transferases A and C has been reported which also takes 
advantage of this basic nature of the enzymes (Askelof et al 
1975). Human liver GSH S-transferase purifications follow along 
similar lines to that described for rat except that gel filtration 
and preparative isoelectric focusing were used in the final steps 
(Kamisaka et al 1975). Purification of GSH S-transferases from 
guinea pig liver (Hayakawa et al 1977) and from monkey liver 
(Asoaka et al 1977) have been achieved with this standard 
technique. 
Others have substituted the final hydroxyapatite steps of the 
procedure with isoelectric focusing, ie Awasthi et al (1980a) 
when isolating bovine lens GSH S-transferase, and Yeung and Gidari 

























































































































































































































































isoelectric focusing has been used for obtaining preparations from 
rat liver and kidney (Hales et al 1978). 
(c) GSH S-Transferases: Affinity Methods 
More recently, another approach has been described which speeds the 
process of protein purification and holds much promise. This is 
affinity chromatography, where a number of compounds having 
affinity for the transferases can be coupled to a matrix and the 
GSH S-transferases selectively isolated from other contaminating 
proteins. 
GSH S-transferases from rat liver have been successfully isolated 
by means of a thioether of BSP and GSH coupled to cyanogen-bromide 
activated agarose gel (Wolkof'f et al 1979), this separates the 
proteins on the basis of their organic anion binding rather than 
their charge or size characteristics. The GSH S-transferases bound 
to BSP coupled matrix was eluted by increasing the buffer pH and 
ionic strength. This technique has been used to purify ligandin 
which binds BSP with high affinity. The final product on SDS-PAGE 
consists of two subunits (the smaller subunit present in relatively 
higher concentrations). GSH S-transferases from the larvae of the 
Greater Wax Moth has also been isolated by this technique (Clark 
et al 1977). 
BSP coupled directly by cyanogen bromide to agarose was effective 
in isolating GSH S-transferases from porcine liver (Grahnen and 
Sjoholm 1977) while GSH coupled directly to epoxide activated 
agarose was used to isolate the GSH S-transferases from human liver 
(Simons and vander Jagt 1977). A combination of affinity 
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chromatography, anion exchange and molecular sieving chromatography 
and isolectric focusing has been used to purify the cationic forms 
of human liver GSH S-transferases (Awasthi et al 1980b), as 
well as the transferases from rat liver mitochondria (Kraus 1980) 
and from guinea pig liver (Irwin et al 1980). 
The usual column matrix is either agarose or sepharose to which the 
affinity ligand is covalently bound via primary amino groups or 
similar nucleophilic groups in an irreversible manner by methods 
involving the use of cyanogen halides (Axen et al 1967). 
Use of Spacer Molecules 
The inter-position of a spacer group between ligands and the 
supporting matrix is important for the isolation of small ligands. 
for protein-ligand complexes of low affinity and for multi-subunit 
proteins. Successful separations using adsorbants which have 
groups varying in length from two to ten carbon-long aliphatic 
chains placed between the ligand and supporting matrix, have been 
described (O'Carra et al 1973). The purification of GSH 
S-transferases was facilitated by the use of an affinity support 
column with 1, 6-diaminohexane as a spacer between the coupled GSH 
and the agarose matrix. 
of the rat liver GSH 
This system was able to separate several 
S-transferases (Lawrence et al 1978a). 
GSH S-transferase B appeared in the void volume, transferase AA was 
eluted after applying a 0-0. 75M KCl gradient, while transferases A 
and C were eluted with an 0-20mM GSH gradient. 
A major disadvantage of any affinity column is detaching the 
protein once it has been specifically interacted with the ligand on 
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the column. These difficulties encountered in elution of the 
adsorbed transferases from a matrix coupled to BSP-GSH were 
described by Guthenberg and Mannervik (1979). These workers have 
prepared pure GSH S-transferases from rat lung and liver using 
S-hexylglutathione as the ligand coupled to Sepharose 6B 
(Guthenberg and Mannervik 1979). This ligand provided a better 
compromise between good binding and elution properties. Following 
elution from the S-hexylglutathione Sepharose affinity column, the 
GSH S-transferases could be separated by means of hydroxyapatite 
chromatography. Although this technique is very useful for 
isolation of GSH S-transf'erases from sources in which they are less 
abundant than liver, not all the transferases have been recovered. 
Thus only GSH S-transferases A, B and C have been recovered while 
the other transferases, namely AA, D and E, are apparently 
unaccounted for. It is not known whether these forms are lost 
during affinity or hydroxyapatite chromatography . 
A combination of affinity chromatography and ion exchange 
chromatography was used to prepare GSH S-transferases from human 
placenta (Guthenberg et al 1979) and liver (Warholm et al 
1981), while S-carbamidomethyl glutathione linked to Sepharose 
CL-4B via lysyl spacers was used to isolate 6 forms of hepatic rat 
GSH S-transferases (Inoue et al 1981). These workers used 
several adsorbants but found those with a free carboxyl group 
within the spacer moiety to have a high specificity as well as a 
high capacity for GSH S-transferases. An affinity matrix coupled 
to cholic acid was used to isolate a bile acid binding protein with 
GSH S-transferase activity from rat liver cytosol (Pattinson 1981). 
This protein has been identified as GSH S-transferase C, and 
migrates as Yb on SDS-PAGE. 
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Binding of the transf erases to the adsorbent can be used to study 
enzyme-ligand interactions. Therefore affinity chromatography may 
be employed to characterise ligand-binding sites (Lowe and Dean 




LIGANDIN IN RELATION TO DEVELOPMENT OF THE RAT 
The inability of neonatal mammals to handle drugs normally 
metabolised by adults of the same species is well documented. Thus 
neonates are sensitive to harmful effects of many drugs and 
xenobiotics, which are relatively safe in adults (Horning et al 
1975). Deficiency of enzymes responsible for drug biotransfor-
mation is partly responsible for the increased toxicity of these 
substances seen in the neonate. The extent and type of biotrans-
formation depends on the stage of development. While there has 
been much interest in the development of enzyme systems in 
utero and in the early neonatal period, most of the reported data 
concerns enzyme changes in the liver. In the adult organism, the 
liver is a major site of xenobiotic detoxication. However, many of 
the enzymes responsible for this process are widely distributed and 
are present in practically all other organs and tissues. 
The purpose here is to review the knowledge of changes in ligandin 
and the GSH S-transferases during development in relation to some 
other xenobiotic metabolising enzyme systems. Factors which may 
affect these enzyme systems, with particular reference to the rat, 
will also be considered. 
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(a) Changes in Ligandin During Development 
In the early 1960s various workers found hepatic uptake and 
conjugation of BSP and bilirubin to be significantly reduced in 
newborn rats and man (Combes and Stakelum 1962, Vest 1962). Low 
concentrations of hepatic carrier proteins for BSP and bilirubin 
were found in foetal and neonatal tissue and rapid increases with 
maturity were observed (Grodsky et al 1970). 
Developmental studies of the bilirubin and BSP-binding proteins, Y 
and Z, in guinea pig liver showed that Y developed much more slowly 
than Z. Y concentration at birth was between 5% and 20% of adult 
concentrations and matured at about 15 days postpartum, while Z 
reached adult concentrations immediately prior to birth (Levi et 
al 1969b). Deficiency of ligandin in neonatal primates was 
claimed to be causally related to associated "physiologic" jaundice 
(Levi et al 1970, Grodsky et al 1970) of the newborn. 
Klaassen (1973, 1975) demonstrated that liver of five-day-old rats 
possessed only 10% of adult values of Y protein. 
increased slowly during the first 15 days of life, 
This amount 
after which 
there was a rapid increase between 15 and 35 days, and a second, 
slower rise to adult levels at about nine-weeks. 
Although the development of Y protein and hepatic organic anion 
uptake appear to correlate, Klaassen (1975) disputed a major role 
for ligandin in hepatic handling of organic anions. In the kidney 
Pegg and Hook (1977) studied GSH S-transferase activity and renal 
organic anion transport capacity in developing rats and rabbits, 
and suggested that these enzymes were not rate-limiting in renal 
organic anion transport. 
43 
Recently, an ontogenic study of rat liver ligandin (Karavanova et 
al 1980) using immunohistochemical measurements of ligandin 
(immunofluorescent technique), reported that between 16-17 days of 
gestation foetal liver contained ligandin and noted an increase 
during the two days prior to birth. This consisted of an increase 
in both the number of fluorescent cells as well as the intensity of 
fluorescence in each cell. At birth practically all hepatocytes 
fluoresced intensely, but on the 4th-6th day of extra-uterine life 
ligandin fluorescence diminished prior to increasing again to reach 
adult levels at 15-18 days postpartum. These results contrasted 
with all previous studies which showed that the liver of foetal and 
newborn rats contained less of ligandin than at any time post 
partum (Hales and Neims 1976a, Foliot et al 1973). Karavanova 
et al (1980) observed an even distribution of ligandin 
throughout the liver lobule in the period immediately before and 
after birth, contrasting with the normal adult pattern where 
ligandin is predominantly centrilobular. 
(b) Changes in the GSH S-Transferases During Development 
(i) In the Liver 
Rat liver GSH S-transferase activity towards epoxide substrates was 
shown to be less than 10% of adult values at birth, and to increase 
gradually reaching maturity at 40 days of age (Figs. 1. 8 and 1. 9) 
(James and Pheasant 1978, Mukhtar and Bresnick 1976b). However, 
excretion of the corresponding mercapturic acid was not influenced 
by this maturation of enzyme activity. In fact Reed and Beatty 
(1980) have suggested that the availability of GSH in foetal and 
newborn animals may be rate-limiting in determining activity of 
GSH-dependent enzymes. 
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The different patterns observed in maturation of GSH S-transferase 
activity towards styrene oxide and towards CDNB suggest that the 
development of various hepatic GSH S-transferases is probably not 
homogenous (Baars et al 1980). The results of Hales and Neims 
(1976a) are in accordance with this suggestion. It is now known 
that there is preferential development of GSH S-transferase B 
during the first postnatal week, resulting in higher levels of GSH 
S-transferase B relative to the other GSH S-transferases. Weaning 
may result in further variation in maturation of GSH S-transferase 
species (Baars et al 1980). 
(ii) In the Steroidogenic Tissues 
Studies of xenobiotic-metabolising systems have been directed at 
liver and to a lesser degree kidney, intestine and lung. Little 
attention has focused on the ability of steroidogenic tissues to 
metabolise reactive chemicals in spite of the importance of 
potential interactions between reactive electrophiles and germinal 
cells. 
However it is known that testis, ovary and adrenal glands have the 
ability to metabolise toxic chemicals, such as alkene or arene 
oxides (Mukhtar et al 1978a, b). The developmental patterns of 
GSH S-transferases in endocrine tissues has been described by these 
workers. The specific activity of GSH S-transf erase in testes of 
6-day-old rats was three times greater than the corresponding 
specific activity in the liver of the same rats (Mukhtar et al 
1978a). Testicular GSH S-transferase activity (measured with 
styrene oxide as substrate) increased slowly with age (Fig. 1. 8). 
The specific activity of adult rat testis GSH S-transferase was 
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Fig. 1. 8 Postnatal development of 100000 g supernatant fractions 
of GSH S-transferase activities in rat testis and liver with 
styrene oxide as substrate. Left top panel represents testicular 
specific activities (nmolproduct/min/mg · protein, mean+ SD.). Left 
bottom panel represents total testicular enzyme activities (nmol 
product/min/organ, mean + range). Right top and bottom panels 
represent corresponding hepatic specific activity and total organ 
activity respectively. From: Mukhtar et al (1978a). 
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high (about 50-60% of corresponding hepatic values) when compared 
to the specific activities of testicular microsomal epoxide 
metabolising enzymes (epoxide hydrase, cytochrome P. 450, aryl 
hydrocarbon hydroxylase). In fact, the GSH S-transferase specific 
activity was 100 times greater than the specific activity of the 
other enzymes mentioned. A similar study of epoxide metabolising 
enzymes in rat ovary (Mukhtar et al 1978b) revealed significant 
GSH S-transferase activity at the earliest time point studied (12 
days postpartum) (Fig. 1. 9). Ovarian GSH S-tansferase specific 
activity (substrates SO and 4, 5-BPO) increased to reach adult 
levels at about 35 days of age. 
Relatively high specific GSH S-transferase activity was present in 
the adrenal glands of 1-day-old rats (95% of adult values), this 
specific activity remained relatively constant for the first 64 
days of extrauterine life (Fig. 1.9). 
(iii) In Other Tissues 
The developmental pattern of GSH S-transferase activity in serum is 
identical to that found in rat liver. Rat serum transferase 
activity using either styrene oxide or benzo(a)pyrene 4. 5-oxide 
as substrates is higher than that of rabbit and guinea pig (Mukhtar 
and Bend 1977). 
GSH S-transferase activity towards styrene oxide or 3-methyl-
cholanthrene-11, 12-oxide in rat foetal lungs is reduced. Lung 
enzyme activity reaches maximum levels 20-30 days after birth Fig. 
1.9) (Mukhtar and Bresnick 1976a). 
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Fig. 1. 9 Postnatal development of rat GSH S-transferase 
supernatant fractions of (A) liver <•> and lung (o) with styrene 
oxide and (B) with 3-methyl cholanthrene-11, 12-oxide as 
substrates, from: Mukhtar and Bresnick (1976). ( C) represents the 
postanatal development of rat ovary GSH S-transferase activity 
measured with styrene 9.8-oxide (e) and benzo(a)pyrene 
4, 5-oxide (o) as substrates. (D) represents GSH S-transferase 
activity measured in adrenals with the same substrates as above, 
from: Mukhtar et al (1978b). 
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(iv) In the Foetus 
Pelkonen (1980) found oxidative enzyme systems to be deficient in 
guinea pig and rat foetal liver with activity appearing soon after 
birth. Adult levels were attained within a few days in the guinea 
pig and within a few weeks in the rat. These observations are in 
contrast with data from GSH S-transferase enzyme systems which 
suggests that these enzymes in human foetal and adult liver have 
similar activity ( Grover and Sims 1964, Boyland and Chasseaud 
1969), although the concentration of immunoreactive hepatic 
ligandin in the human foetus near term was lower than that in adult 
liver (Fleishner et al 1976). It may be possible to explain 
these apparently conflicting data by invoking differences in foetal 
and adult enzyme phenotypes thus allowing a lower concentration of 
an enzyme with a high specific activity to have the same total 
activity for a particular substrate than a greater amount of enzyme 
with a lower specific activity. An alternative explanation is that 
GSH and not the GSH S-transferase may be rate-limiting. 
The presence of inter-species and inter-organ differences in the 
maturation of GSH S-transferases was suggested by the studies of 
Juchau and Namkung (1974) who observed that GSH S-transferase 
activity with napthalene-1, 2-oxide as substrate was higher in 
soluble fractions from primate foetal tissue than in the soluble 
adult rat liver fractions. This activity was notably higher in 
foetal adrenal glands of humans (72 days gestation) and pigtail 
monkeys (60 days gestation) than in simultaneously studied liver. 
Foetal adrenal gland is known to be more efficient than its adult 
counterpart in metabolising of xenobiotics and possesses 
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considerable sulphate (Namkung et al 1977) and GSH conjugating 
activity (Jachau and Namkung 1974). Similarly, considerable 
xenobiotic metabolising activity has been detected in foetal gonads 
and sex organs. Mukhtar et al (1981) recently reported that 
GSH S-transferase activity ( with CDNB as substrate) of foetal 
liver, kidney, lung, muscle, heart, adrenal gland, pancreas and 
stomach is higher than the corresponding activity of each organ in 
the adult. 
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FACTORS AFFECTING THE DEVELOPMENT OF THE GSH S-TRANS-
FERASES AND OTHER XENOBIOTIC METABOLISING SYSTEMS 
Several factors may influence the maturation of xenobiotic-
metabolising enzyme systems. These include maternal influences, 
premature or normal birth, weaning, puberty, pregnancy and 
senescence. The actual mechanisms responsible for the development 
of these enzyme systems are not known. 
(a) Birth. 
At birth there is a pronounced increase in the activity of many 
hepatic enzymes (eg enzymes of the monooxygenase system of 
mammalian liver (Neims et al 1976). Prior to birth maternal 
enzymes metabolise and detoxify foreign compounds for both mother 
and foetus. Although demonstration of metabolites of diazepam 
(Erkkola et al 1974) and chlorpromazine (Pelkonen et al 
1973) in the foetus suggests detoxication enzyme activity in 
vivo, the possibility of placental transfer of these metabolites 
has not been excluded. The increase in enzyme activity, usually 
initiated at birth, is not affected by premature delivery nor 
prolongation of the gestation period (Dauterman 1980). While it is 
thought that separation of maternal-foetal connections trigger and 
activate maturation responses in the cell, the mechanism by which 
these changes occur is not known. 
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(b) Weaning 
Feuer and Liscio (1969) found that early weaning in rats increased 
enzymes such as 4-methylcoumarin hydroxy lase. It has been proposed 
by Henderson (1978) that this increase was due to withdrawal of 
enzyme inhibitors present in milk. This effect has not been found 
for GSH S-transferase activity which, if anything, is suppressed by 
early weaning (Baars et al 1980). 
(c) Puberty 
Conney (1967) found that a number of xenobiotic metabolising 
systems which were barely detectable before puberty, increased 
dramatically with the onset of sexual maturity. Several testicular 
enzymes follow a similar ontogenetic pattern including epoxide 
hydrase (Mukhtar et al 1978a), gamma-glutamyltranspeptidase 
(Hodgen and Sherins 1973), S-adenosyl-L-methionine decarboxylase 
(Macindoe and Turkington 1973), uridine diphosphatase (Xuma and 
Turkington 1972), sorbitol dehydrogenase and hyaluronidase (Lee and 
Shen 1975) which have all been reported to increase at puberty. 
Some enzymes, eg lactic dehydrogenase are present in high 
concentrations in neonatal testes, decline to a nadir during the 
second or third week of life and increase dramatically at puberty 
to reach adult levels (Hodgen and Sherins 1973). 
Greengard (1969, 1971) first provided information suggesting that 
endocrine events could trigger the changes in formation of 
enzymes. Initiation of pubertal onset is dependent on a complex 
process of neuroendocrinological events which involve maturation of 
the hypothalamic-pituitary-gonadal axis. The onset of puberty has 
been presumed to be associated with increased follicle stimulating 
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hormone (FSH) and luteinising hormone (LH) release from the 
pituitary (Donovan and van der Werff ten Bosch 1965). These 
gonadotropins are present at low levels during the prepubertal 
period of female rats, after which there is an increase and change 
in relative production before the first ovulation. This surge of 
gonadotropin is accompanied by an increase of plasma prolactin 
levels (Ojeda et al 1976, Ojeda et al 1980). Puberty in 
the female rat may be defined as vaginal opening and the first 
ovulation. These events occur from 36-39 days of age. Vaginal 
opening and the initial ovulation are preceded by increases in 
blood concentrations of estradiol, progesterone and testosterone 
(Parker and Mahesh 1976). The biosynthetic precursors of these 
hormones also increase at the time of puberty. Puberty in the male 
rat is more difficult to define·. When relative weight of body, 
testes, seminal vesicles and prostates as well as amount of serum 
testosterone have reached a certain level, sexual maturation 
usually occurs (Glass and Swerdloff 1980). FSH induction of 
gonadal sensitivity to LH may be a cause of sexual maturation in 
the male rat (Odell et al 1973). 
Changes in Circulating Hormonal Levels 
In a study of serum LH, FSH and prolactin levels of male and female 
rats from birth to puberty, Dohler and Wuttke (1974) found that 
neonates of both sexes had high FSH and LH levels. These levels 
fell after the first week of life, then sporadically rose and fell 
until about day 37 when a preovulatory surge was noted in females. 
Following this the rats displayed normal cyclic activity. 
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For the first three weeks of life prolactin levels are low in both 
male and female rats, after which they increase gradually in both 
sexes and attain peak values between days 37 and 45. Cyclic 
fluctuations were observed in the females after day 37 had been 
reached. 
Meijs-Roelofs et al (1975) and Parker and Mahesh (1976) showed 
that serum estradiol levels increase before the preovulatory surge 
of gonadotropins and prolactin. It has been suggested that 
enhanced estradiol secretion of the ovary may be responsible for 
triggering secretion of prolactin and gonadotropins. Serum 
progesterone levels are low in both newborn males and females, 
remain low for the first 10 days of life, increase slowly for the 
next 10 days after which they rise rapidly during the 3rd and 4th 
week of life to reach adult levels. 
Prolactin has also been implicated in the maturational process 
which leads to puberty and is said to have a dual effect, part of 
which is exerted by increasing the LH receptor content of granulosa 
cells, and part mediated through the hypothalamus where it results 
in decreased prolactin and increased pituitary FSH secretion 
( Clemens et al 1969). Prolactin administration has been shown 
to advance the onset of puberty by about six days when given at 20 
days of age, and by two days when given at 25 days of age. 
Administration of other anterior pituitary hormones (FSH, LH, TSH 
and GH) had no effect. The effect of prolactin administration was 
abolished in hypophysectomised rats (Wuttke et al 1976, Ad vis 
and Ojeda 1978). Precocious puberty may also be produced by 
electrical stimulation of the hypothalamus. This increases plasma 
FSH levels (Meijs-Roelofs 1972). Adrenalectomy has been found to 
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delay vaginal opening and ovulation by 4-5 days (Ramaley and 
Campbell 1977). 
(d) Pregnancy 
The activity of a large number of enzymes is decreased during 
pregnancy. For example glucuronide conjugation of xenobiotics is 
reduced during late pregnancy as a result of increases of 
progesterone and pregnanediol, which are known inhibitors of 
glucuronyl transferase in vitro. Similar inhibition of 
glucuronide conjugation has led to high levels of unconjugated 
bilirubin in the blood of breast-fed infants. This jaundice has 
been claimed to be associated with the presence of 
pregnane-3-alpha-20beta-diol in the mother's milk (Dauterman 1980). 
The activities of liver microsomal metabolising enzymes are also 
reduced during pregnancy. Rat hepatic cytochrome P. 450 is 
decreased by 25% and is uninducible by pre-treatment of the 
pregnant rats with phenobarbital (Dauterman 1980). Although 
activity of glucuronyl transferase is reduced in pregnant rabbits, 
cytochrome P-450 concentration remains unchanged. 
In contrast to these findings, GSH S-transferase specific activity 
towards epoxide substrates has been reported to occur in the 
ovaries of pregnant rats at mid-pregnancy (Mukhtar et al 
1978d). The different rat GSH S-transferases appear to be induced 
at various stages of the gestation period (Polidoro et al 
1981b). At mid-pregnancy (10-11 days) only hepatic GSH 
S-transferase activity towards 1,2-epoxy-3-(p-nitrophenoxy)propane 
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was increased (82% of control values). However, in late pregnancy 
(19-20 days) hepatic GSH S-transferase activity with CDNB is 
significantly increased (57%) while those for DCNB are decreased. 
(e) Senescence 
Senescent animals are less responsive to changes in their environ-
ment than younger animals. A slower rate of enzyme induction has 
been observed in old versus young animals (Adelman et al 
1972). Significant decreases in hepatic drug-metabolising capacity 
occur with senescence (Schmucker and Wang 1980). A significant 
decrease in BSP uptake by isolated hepatocytes with advanced age 
has been observed (Knook 1980). This has been attributed to an 
age-related decrease in the BSP-storage capacity of the liver. 
Although studies in ageing tissues have generally indicated a 
decreased ability to metabolise drugs, hepatic cytosol from 
senescent rodents do not appear to have altered GSH S-transferase 
activity when metabolising epoxides (Birnbaum and Baird 1979). 
The testis, ovaries and adrenals show an apparent reduction in GSH 
S-transferase activities (measured with SO, 4, 5-BPO) after the rats 
had reached about 140 days of age (Mukhtar et al 1978a, b). In 
addition these workers were able to show a decline in hepatic GSH 
S-transferase specific activities measured with these substrates. 
Plasma testosterone levels of mammals decrease markedly during 
senescence (Ghanadien et al 1975), while ageing Leydig cells 
appear to have impaired steroidogenic capacity (Lin et al 
1980). 
INDUCTION OF LIGANDIN AND GSH S-TRANSFERASES 
IN DEVELOPING ANIMALS 
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Rat liver ligandin content can be increased by up to 100% after 
administration of microsomal enzyme inducers such as phenobarbitone 
(Fleischner et al 1976) . Similar changes in GSH S-transferase 
activity can be induced in developing rats by phenobarbitone 
treatment (Hales and Neims 1976a). The increase in GSH 
S-transferase activity following induction in neonatal rats results 
in adult levels which then persist. Male and female rats exposed 
perinatally to polychlorinated biphenyls had higher levels of GSH 
S-transferase activity (mainly towards CDNB) than controls at all 
ages examined (Lamartiniere et al 1979). Administration of the 
glucocorticoids, dexamethasone acetate or corticosterone acetate to 
neonatal rats stimulated the development of adult levels of hepatic 
GSH S-transferase activity (assayed with SO, CDNB, or 4. 5-BPO as 
substrates). Glucagon administration did not affect GSH 
S-transferase activity (Mukhtar et al 1979). 
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SEX DIFFERENCES OF LIGANDIN AND THE GSH S-TRANSFERASES 
Sex differences in mammalian liver xenobiotic metabolism appear 
with the onset of puberty and are maintained throughout life 
(Dauterman 1980). Sex differences in enzyme activity are also 
dependent upon which substrates are used and which species are 
investigated. Although activity of hepatic GSH S-transferase 
levels continue to rise in animals of both sexes after weaning, 
DCNB conjugation to GSH is two to three-fold higher in adult males 
than in adult females (Darby and Grundy 1972). Activity towards 
CDNB in rat liver did not exhibit sexual differentiation (Hales and 
Neims 1976a, b). 
Ligandin levels in male rat liver supernatants were significantly 
lower (3.3% of male liver supernatant protein) than those from 
female rat liver (4. 5% of female liver supernatant protein). 
Hypophysectomy of the females abolished this sex difference (Hales 
and Neims 1976b). Male mammals (rat and mouse) exhibited 
relatively lower GSH S-transferase activity (measured with CDNB) in 
the brain than did female mammals, while several species of male 
birds exhibited comparatively higher activity of brain GSH 
S-transferases than did the correspoinding females (Das et al 
1981). No significant sex differences in GSH S-transferase 
activity towards CDNB specimens was detected in human liver (Darby 
1973). 
Recent work by Lamartiniere (1981) suggests that the sexual 
differentiation of hepatic GSH S-transferases is due to a 
hypothalamic inhibiting factor present in the male, but not in the 
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female. This factor acts on the pituitary, postpubertally, 
preventing the secretion of a pituitary inhibiting factor, 
resulting in higher GSH S-transferase activities in adult males 
than in females. Adult females autonomously secrete this pituitary 
inhibiting factor. Thus, hepatic GSH S-transferases may be under 




Another quite unexpected role for ligandin and certain GSH 
S-transferases was discovered in the late 1970s. This activity, ie 
glutathione peroxidase, is present in many tissues of the rat in 
varying amounts. The role of the GSH S-transferases/GSH 
peroxidases as multi-funtional proteins involved in hydroperoxide 
metabolism as well as their relationship with selenium-dependent 
GSH peroxidases is considered in this chapter. 
HISTORICAL ASPECTS 
Glutathione peroxidase (GSH peroxidase) (Hydrogen peroxide: GSH 
oxidoreductase EC 1.11.1. 9), was first detected in erythrocyte 
lysates where it protects haemoglobin from oxidative breakdown 
(Mills 1957). In 1959 (Mills 1959) GSH peroxidase was isolated 
from bovine erythrocytes and shown to be distinct from both 
catalase and haemoglobin. Cohen and Hochstein (1963) initially 
showed that GSH peroxidase, and not catalase, protects haemoglobin 
in intact erythrocytes from being oxidised to methaemoglobin by 
hydrogen peroxide. As a result of these experiments with red cells 
the detoxification of H202 has generally been ascribed to GSH 
peroxidase. More recent work with the isolated perfused rat liver 
(Oshino and Chance 1977) indicates that within the peroxisome 
catalase does function as the primary H202 scavenger, while GSH 
peroxidase plays an important role in other subcellular fractions 
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such as mitochondria and cytosol. In addition GSH peroxidase has 
been shown to have added importance in protecting isolated 
hepatocytes from H202 produced as a result of microsomal 
oxidative demethylation in which the formate produced can inhibit 
catalase and significantly reduce its contribution to H20 2 
removal (Jones et al 1978). 
GSH peroxidase activity is sustained by that of another glutathione 
dependent enzyme, namely glutathione reductase. This enzyme main-
tains the continuous reduction of oxidised glutathione (GSSG) in a 
NADPH2-dependent reaction. In erythrocytes the major source of 
NADPH2 is from hexose shunt activity, while in other tissues an 
alternative source could be from isocitric or malic dehydrogenase 
activity. Erythrocytes are unable to maintain this activity due to 
an incomplete Krebs cycle. 
59 
SELENIUM DEPENDENT GLUTATHIONE PEROXIDASE / GLUTATHIONE 
PEROXIDASE I 
Several groups have studied GSH peroxidase I and purified it to 
homogeneity. This protein is unusual in that it contains a 
selenium moeity which has been shown to participate in the 
catalytic cycle of the enzyme. The protein is made up of four 
0 
identical spherical (r=19A) monomers each containing a selenium 
atom (Ladenstein et al 1979). Selenoproteins are apparently 
very rare and interesting studies have been carried out in order to 
ascertain how the selenium is incorporated into GSH peroxidase I 
(Sunde and Hoekstra 1980a). The Se moiety in the reduced form . of 
GSH peroxidase I is thought to be a selenocysteine. The 
selenocysteine moiety was identified as the catalytic site in GSH 
peroxidase I (Forstrom et al 1978) which was shown to fit into 
the electron density of residue 35 of the 180 amino acid residue 
subunit. The molecular weight of each subunit purified from rat 
liver was determined to be approximately 19000 (Nakamura et al 
1974, Tappel 1978). 
Rat liver GSH peroxidase I was found to be very stable under de-
naturing conditions. In the presence of other proteins it exists 
in an aggregated form becoming dissociated upon isolation and 
storage, thus suggesting a strongly hydrophobic nature which would 
support the enzyme's ability to interact with hydroperoxides at the 
hydrophobic membrane surface (Tappe! 1978, Stults et al 1977). 
There also appears to be a charge phenomenon in that the protein 
initially isolated is neutrally charged but becomes negatively 
charged on storage. A disulfide interchange could be responsible 
for this. Of all sulfhydryl compounds tested only GSH was able to 
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serve as a substrate for this enzyme (Flohe et al 1971). 
Cyanide inhibits GSH peroxidase I resulting in severe loss of 
enzyme activity and release of selenium from the enzyme (Prohaska 
et al 1977a). Cadmium and other heavy metals were also shown 
to have an inhibitive effect on GSH peroxidase I (Splittgerber and 
Tappel 1979). At physiological concentrations of GSH and 
peroxides, GSH peroxidase I is in a reduced form (Flohe et al 
1973) and cyanide has no effect. After purification the enzyme 
presumably exists in a more oxidised form and cyanide is able to 
inhibit catalytic activity. An explanation for this observation 
could be that the active centre of the enzyme alternates between 
oxidised and reduced forms, this steady-state mechanism having been 
well established as a UNI UNI BI UNI PING-PONG mechanism. 
Immunohistologic studies suggest that GSH peroxidase I is located 
in cytoplasm of hepatocytes. More intense staining was seen in the 
periportal areas than the central zone of the lobule (Yoshimura 
et al 1980). 
DISCOVERY OF THE NON-SELENIUM DEPENDENT GLUTATHIONE 
PEROXIDASE I GLUTATHIONE PEROXIDASE II 
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In 1970 Little et al carried out kinetic analysis of partially 
purified GSH peroxidase preparations from pig's blood. Using the 
organic hydroperoxide, cumene hydroperoxide (see structural formula 
below) as substrate, nonlinear Lineweaver-Burk plots were obtained, 
and as high levels of substrate were able to enhance enzyme 
activity the possibility that there were two enzymes with different 
Vmax and Km values was considered. 
It was not until 1976 that the first evidence for the existence of 
a second GSH peroxidase species was obtained by Lawrence and Burk 
using cumene hydroperoxide as substrate. These workers observed 
that GSH peroxidase activities were 42% of control values in liver 
supernatant of rats fed a Se-deficient diet for two weeks, while 
activity measured with H202 was only 8% of control values. 
Fractionation of liver cytosol on Sephadex G-150 columns revealed 
two peaks of activity. The first peak (absent in Se-deficient rat 
liver supernatants) could be detected with H20 2, while the 
second peak, eluting at a molecular weight corresponding to 39000 
daltons, could only be detected with cumene hydroperoxide. This 
peak persists in severe selenium deficiency. Heating experiments 
demonstrated that peak 2 was heat labile while peak 1 was more heat 
resistant. Dissociation experiments subsequently proved that the 
second peak was not due to subunits of peak 1 dimers. 
62 
Comparison of the two distinct GSH peroxidase species (Prohaska and 
Ganther 1977b) showed that the second species was not active with 
H20 2 and was not a selenoenzyme (there was no incorporation of 
75se in vivo). This non-selenoenzyme showed zero order 
dependence on GSH concentration and was not inhibited by cyanide, 
while the selenoenzyme showed 1st order dependence on GSH and was 
inhibited by cyanide. The non Se-dependent GSH peroxidase (GSH 
peroxidase II) activity of testis cytosol accounted for more than 
half of the total GSH peroxidase activity when chromatographed on 
Sepadex G-75 columns (Fig 1.10). 
The question arose as to what the nature of this second species of 
GSH peroxidase activity was. Prohaska and Ganther (1977b) 
suggested that the GSH S-transferases, known for their affinity for 
hydrophobic substrates and their ability to catalyse GSH to 
electrophilic centres, might be responsible. They believed the 
GSH S-transferases could bind organic hydroperoxides and GSH in 
close proximity, thus promoting a nucleophilic attack on 
electrophilic oxygen. Partial purification of rat liver GSH 
peroxidase II on CM-cellulose yielded 5 peaks of GSH S-transferase 
activity when assayed with CDNB. When these peaks were assayed for 
peroxidase activity with cumene hydroperoxide as substrate, GSH 
S-transferase AA was found to have the highest specific activity 
when compared to the other transferases. Transferase B also 
exhibited considerable activity while activity of transferases A 
and C was much lower (Prohaska and Ganther 1977b, Irwin et al 
1980). Transferases D and E which do not bind to the column had 
measurable GSH peroxidase II activity but was contaminated by large 































Fig. 1.10 Sephadex G-75 chromatograptiy and GSH peroxidase 
activity of the 100000 g supernatant fractions from rat (A) testis, 
(B) liver, (C) kidney and (D) brain. Column fractions were 
assayed for GSH peroxidase activity with O. lmM cumene hydro-
peroxide. From: Prohaska and Ganther (1977b). 
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Guinea pig liver transf erases separated by CM-cellulose and assayed 
for peroxidase activity showed a different elution profile to that 
of rat liver transferases (Irwin et al 1980). The final peak 
of guinea pig liver transferase activity eluting from CM-cellulose 
exhibited the majority of peroxidase activity. In fact this 
represented the primary functional GSH peroxidase since there is 
very little of GSH peroxidase I in guinea pig liver (Lawrence and 
Burk 1978). Similarities between this CM-cellulose peak and rat 
liver GSH S-transferase AA have been noted. 
All five human liver cationic GSH S-transferases (alpha, beta, 
gamma, delta and epsilon) display GSH peroxidase II activity. 
Anionic species (psi and omega) do not exhibit peroxidase activity 
(Awasthi et al 1980). The GSH peroxidase II activity of the 
cationic GSH S-transferases from human liver is limited to cumene 
hydroperoxide. H202 and tert-butylhydroperoxide 
C [ CH3] 3 COOH) are unsuitable substrates for these enzymes. 
Lawrence et al (1978b) purified rat liver GSH S-transferase B 
and demonstrated GSH peroxidase II activity towards cumene 
hydroperoxide and tert-butylhydroperoxide. This peroxidase 
activity was shown to be competitively inhibited by BSP. Induction 
in rats with phenobarbital increased GSH peroxidase II activity but 
had no effect on GSH peroxidase I. 
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OCCURRENCE AND DISTRIBUTION 
(a) Species Distribution 
There is a great deal of inter-species variation with regard to the 
relative proportions of GSH peroxidases I and II. GSH peroxidase 
II is the predominant form in liver soluble fractions of guinea 
pigs, humans and sheep while GSH peroxidase I predominates in 
hamsters and rats (Lawrence and Burk 1978) (see Table 1.8A): 
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(b) Tissue Distribution 
GSH peroxidase enzyme activity has been found in most tissues of 
mammals including liver, kidney, stomach, spleen, erythrocyte, 
heart, lung, lens, brain, adrenal and testis (Flohe and Gunzler 
1976). Variable amounts of GSH peroxidase II are present in 
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tissues of higher animals (Lawrence and Burk 1978). Thus spleen, 
heart, lung, thymus and intestinal mucosa had very little GSH 
peroxidase II, adrenals, liver and kidney had more than one-third 
of total activity attributed to GSH peroxidase II, while brain and 
fat tissue had less than one-third. In testis GSH peroxidase II 
accounted for 91% of total activity (see Table 1. 8B). No data is 
available demonstrating the organ distribution of GSH peroxidase in 
man. 
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(c) Subcellular Distribution 
Subcellular distribution of GSH peroxidase differs from that of 
catalase. GSH peroxidase is absent in peroxisomes but present in 
the supernatant fraction and in matrix space of mitochondria (Flohe 
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and Schlegel 1971). Mitochondrial extracts from rats fed a 
selenium-deficient diet have virtually no measurable GSH peroxidase 
activity (Sies and Moss 1978) indicating that the non Se-dependent 
species is not important in these organelles. Cardiac mitochondria 
lack selenium-dependent GSH peroxidase activity which is present in 
the mitochondrial matrix of liver (Katki and Myers 1980). This 
membrane bound activity of cardiac mitochondria differs from GSH 
S-transferases which exhibit peroxidase activity in that it is 
capable of utilising both cumene hydroperoxide and H202 as 
substrates. 
A non-selenium dependent enzyme species exhibiting GSH 
S-transferase activity has been demonstrated in rat liver 
microsomal fractions (Reddy et al 1981). 
MECHANISM OF THE GLUTATHIONE PEROXIDASE ACTIVITY OF 
THE GLUTATHIONE S-TRANSFERASES 
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The kinetic properties of purified preparations of rat liver GSH S-
transferases AA and B were compared using both cumene hydroperoxide 
and tertbutylhydroperoxide substrates (Prohaska 1980). The 
peroxidase activity of transferase AA with either substrate was 
shown to be similar to that of B. Transf erase AA has high maximum 
velocity with both hydroperoxides when compared to that of other 
substrates. 
Keen et al (1976) suggested that the mechanism of GSH trans-
ferases involves nucleophilic attack by GS- on some electrophilic 
atom (C, S or N) in the substrate. A similar mechanism could be 
suggested for the transferases when they act upon organic 
hydroperoxides (ROOH) in which GS- attacks an electrophilic 
oxygen, resulting in the formation of the unstable sulfenic acid of 
glutathione (Prohaska 1980). 
ROOH + GSH -:. [ GSOH] + ROH 
[GSOH] + GSH -:. GSSG + H20 
This intermediate [ GSOH] could be formed during the oxidation of 
GSH by cumene hydroperoxide, catalysed by the transferases (AA or 
B). 
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ROLE OF THE GLUTATHIONE PEROXIDASE ENZYME SYSTEM IN: 
(a) Oxygen Toxicity 
Molecular oxygen is toxic to virtually all forms of life. Exposure 
to concentrations greater than the ambient fifth of an atmosphere 
causes toxicity, thus the margin of safety is narrow. In addition 
normal products of aerobic life such as reactive oxygen 
intermediates (02-), singlet oxygen (02*) and hydrogen 
peroxide (H202) are able to initiate free radical chain 
reactions that lead to organic and lipid peroxide formation. GSH 
peroxidases in conjunction with superoxide dismutases and catalase, 
function in the detoxification of hydroperoxides. These defences 
against oxygen toxicity although sufficient to meet ordinary 
demands are easily overwhelmed. There are several ways in which to 
achieve this. One is to apply hyperbaric oxygen (Deneke and 
Fanburg 1980), and another is to use compounds which increase the 
extent of the monovalent pathway of oxygen reduction, eg paraquat 
(Bus et al 1975, Smith et al 1979). 
This defense system against oxygen toxicity operates as follows: 
the first in the line of defence is superoxide dismutase which con-
verts superoxide radicals into H202 and molecular oxygen 
(Fig. 1.11); second is catalase and selenium (Se)-dependent GSH 
peroxidase / GSH peroxidase I which share the task of reducing 
H202 to H20. Catalase has the advantage of not consuming any 
reductant other than H202, while GSH peroxidase uses GSH as a 
reductant and H202 or alkyl hydroperoxides as oxidant. 
Third and last in the line of defence, and required only if a 
polyunsaturated membrane fatty acid has been peroxidised, are the 









Fig. 1.11 General illustration of the involvement of selenium-
dependent (GSH peroxidase I) and non-selenium dependent (GSH 
peroxidase 11) glutathione peroxidases in the detoxication of 
hydroperoxides. Adapted from Wendel (1980). 
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capable of preventing further propagation of a radical chain 
reaction that leads to lipid peroxidation, deterioration of 
membrane lipids and severe impairment of energy-related membrane 
functions. Loss of membrane integrity leads to cell death. 
GSH peroxidase was thought to catalyse the following reaction: 
2GSH + H202 = GSSG + H20. 
In the late 1960s this enzyme was also shown to catalyse the 
reduction of organic hydroperoxides formed from unsaturated fatty 
acids (Christopherson 1968). Hence the above reaction may be 
generalised to: 
2GSH + ROOH = GSSG + .ROH + H20. 
Catalase was found to have no effect on the lipid peroxides 
(Little and O'Brien 1968). The lipid products produced by the 
decomposition of lipid peroxides by GSH peroxidase were identified 
(Christophersen 1968) and the possibility that this enzyme 
functioned as an anti-oxidant in breaking the autocatalytic chain 
reaction of lipid peroxidation was considered. 
(b) Lipid Peroxidation 
Lipid peroxidation is a unique form of cellular injury implicated 
in the genesis of liver necrosis and evoked by hepatotoxins such as 
carbon tetrachloride, alpha-amanitin and yellow phosphorus. It is 
a multiphasic process involving initiation, propagation and 
termination reactions. The initiation step, the mechanism of which 
is not yet understood, is represented by the abstraction of 
hydrogen from unsaturated fatty acids during free radical attack 
yielding free radicals of lipids (Fig. 1.12). The hydrogen atoms 
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Fig. 1.12 Initiation, propagation and termination reactions in 
lipid peroxidation. From: Bus and Gibson (1979). 
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acids are highly susceptible to this free radical attack. Oxygen, 
singlet oxygen, superoxide anion and/ or hydroxyl radical have all 
been proposed as the initiators of lipid peroxidation. 
The free radicals generated from fatty acids during initiation are 
unstable and undergo a series of transformations reacting rapidly 
with molecular oxygen to form peroxy-free radicals. These species 
then abstract from one fatty acid chain the methylene hydrogen of a 
neighbouring unsaturated fatty acid yielding a hydroperoxide and a 
new radical. Thus the propagation step is represented by an 
autocatalytic chain reaction where lipid peroxidation spreads 
linearly. Unstable hydroperoxides decompose to form additional 
free radicals. Termination of lipid peroxidation occurs when the 
substrate is depleted yielding non-radical products that stop the 
reaction. The obvious targets for lipid peroxidation are the 
subcellular membranes rich in unsaturated fatty acids, resulting in 
loss of both structural integrity and function in the affected 
organelles. In addition to this localised damage the breakdown 
products of lipid peroxides, such as aldehydes, migrate far from 
their site of production causing damage at distant loci. Several 
of these lipid peroxides are known for their extremely high 
toxicity including carbon tetrachloride, chloroform, 1, 1- dichlo-
roethylene and thioacetamide, all of which produce liver necrosis 
in vivo or in vitro. Oxidation of membrane lipids and 
proteins may result inter alia in membrane dysfunction and 
altered membrane permeability. 
Methods of measuring lipid peroxidation include determination of 
the levels of malondialdehyde an end-product of oxidative chain 
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cleavage of polyunsaturated fatty acids formed during peroxide 
breakdown. The microsomal NADPH oxidase system promotes lipid 
peroxidation in microsomes during catalytic activity forming stable 
malondialdehyde which can thus be used as a measurement of lipid 
peroxidation. 
The GSH peroxidase enzyme system has been claimed by several 
workers to be responsible for inhibition of lipid peroxidation. 
Flohe and Zimmerman (1970) originally considered that GSH peroxi-
dase exerted its inhibition by converting the lipid hydroperoxide 
precursors of malondialdehyde to hydroxy fatty acids. Christopher-
sen (1968) proved that GSH peroxidase could catalyse this reduction 
reaction in vitro. It was generally assumed that the same 
phenomenon accounts for in vivo GSH peroxidase protection 
against lipid peroxidation in biological membranes. The picture 
was complicated when McCay et al (1976) presented results 
showing that membrane lipid peroxides are not reduced to lipid 
alcohols, and that GSH peroxidase activity exerts its effect by 
preventing free radical attack on polyunsaturated membrane lipids. 
Thus in vivo GSH peroxidase may inhibit initiation of lipid 
peroxide formation rather than catalysing their reduction. 
Although the in vivo mechanism is still under debate it can be 
concluded that GSH peroxidase serves a critical function in 
inhibiting the lipid peroxidative process in biological membranes. 
Following Mccay et al's (1976) observation that dialysed, 
unfractionated liver cytosol (105000 g supernatant) and GSH 
combined could block malondialdehyde production by the NADPH 
microsomal lipid peroxidation system, Burk et al (1980) set out 
to ascertain which of the two peroxidase species, was responsible 
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for this function. Partially purified GSH peroxidase I, free of 
GSH S-transferase activity, but very active with H202 or cumene 
hydroperoxide, was completely inactive in inhibiting lipid 
peroxidation. In contrast a broad peak of protective activity was 
present following Sephadex G-100 gel filtration coinciding with the 
GSH S-transferases. 
15 
A possible explanation for this observation.,.. that GSH peroxidase I 
metabolises much of the H202 produced by metabolic processes in 
the cells. Selenium deficiency may allow sufficient H202 to 
accumulate in cells to initiate reactions which attack membrane 
lipids. The capacity of GSH peroxidase I may, therefore, lie in 
its ability to prevent significant levels of H202 from 
occurring. GSH peroxidase I does not appear to prevent the 
peroxidative damage to lipids in membranes initiated by either 
microsomal NADPH oxidase activity or by ascorbate. The 
glutathione-dependent cytosolic factor which inhibits lipid 
peroxidation may be due to one or more of the GSH S-transferases. 
Chapter 2 
THE AIMS OF THIS STUDY 
AND EXPERIMENT AL DETAILS 
73 
THE A IMS 0 F TH IS STUDY AND 
EXPERIMENTAL D E T A I L S. 
This thesis investigated the nature and character of ligandin in 
the steroidogenically active tissues of the rat. A comparative 
study was undertaken to establish whether ligandin in the testis 
did in fact differ from ligandin in the liver. Different methods 
of purification were used to investigate the multiple forms of 
ligandin and its relationship with the GSH S-transferases in 
steroidogenic tissue (Section A). 
The development of ligandin in the testis, ovary and adrenal was 
studied and compared with that of liver and kidney. The effect of 
puberty, pregnancy and induction on ligandin concentrations were 
also studied. A quantitative relationship between steroid hormone 
~~ 
secretion ,)igandin in steroidogenic tissues was considered (Section 
B). 
The peroxidase antiperoxidase (PAP) immunocytochemical technique 
was used to localise ligandin in the liver, testis, ovary and 
adrenal of developing rat, and the ovary and placenta during 
pregancy (Section C). 
SECTION A 
IDENTITY OF LIGANDIN IN RAT TESTIS AND LIVER AND 
STUDIES ON THE DIFFERENT GSH S-TRANSFERASE FORMS 
IN STEROIDOGENIC TISSUES 
(a) Introduction 
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The main aim of this work was to determine whether ligandin in the 
steroidogenic tissues of rat testis, ovary and adrenal gland was in 
fact different in structure and function from that found in the 
non-steroidogenic tissues such as liver and kidney. Comparative 
studies were carried out with ligandin obtained from both testis 
and liver of rat. 
This section deals with the purification of testis ligandin and its 
subsequent characterisation. In order to perform these studies, 
various techniques had to be developed and applied. Cross-linking 
studies were employed in order to study the subunit structure of 
testis ligandin. The application of dimethylsuberimidate (DMS), a 
bifunctional imidoester highly specific for the epsilon-amino group 
of lysine residues (Davies and Stark 1970), followed by SDS-PAGE, 
was carried out in an attempt to resolve the arrangement and 
stoichiometry (homodimer vs heterodimer) of the subunits. The 
rationale being that where two polypeptides are in close contact, 
the reactive groups of each protomer may approach each other 
closely enough for the bifunctional reagent to "cross-link" the two 
chains. SDS-PAGE analysis would then reveal a single band 
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migrating with the combined molecular weights of the two poly-
peptides. 
The production of antisera to ligandin was necessary for immuno- a-
ffinity chromatographic studies of ligandin from liver and testis. 
The techniques applied and the results obtained are presented in 
this section. In addition, antisera was required for 
radioimmunoassay and immunohistochemistry, which will be detailed 
in this Chapter, Sections B and C. 
Following the standard purification procedure for liver ligandin 
(Bass et al 1977a) (Fig. 1.6) the preparation obtained from 
testis material will be referred to here (unless specified 
otherwise) as testis ligandin. 
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(b) Materials 
All reagents used were of analytical grade and were purchased as 
detailed below: 
NADPH, agarose, bovine serum albumin (Fraction V) and human serum 
albumin (crystalline) from Miles Laboratories (Pty) Ltd, Goodwood, 
South Africa. 
Glutathione reductase (Type IV) prepared from yeast, Coomassie 
Brilliant Blue R, Dansyl chloride and N-ethylmorpholine were 
obtained from Sigma Chemical Co., Saint Louis, Missouri, USA. 
Amido Black, Sodium azide and Tris-(hydroxy-methyl)-aminomethane 
(Tris) and 1-Iodohexane from E. Merck, Darmstadt, Germany. 
Cumene hydroperoxide (70% in cumene) was from Fluka AG, Buchs, 
Switzerland. 
Complete Freund's Adjuvant and Agar Noble from Difeo Laboratories 
Detroit, Michigan USA. 
Acrylamide, N, N'-methylene-bisacrylamide and sodium dodecyl 
sulphate (were specially purified for electrophoresis); ammonium 
persulphate, N, N, N', N'-tetramethylethylene diamine (TEMED), 
bilirubin, reduced glutathione (GSH) and Hydriodic Acid (55% HI), 
from BDH (British Drug Houses) Chemicals Ltd, Poole, Dorset, 
England. 
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Cyanogen bromide-activated Sepharose 4B, epoxy-activated Sepharose 
6B, Thiol-Sepharose, QAE-Sephadex A-50 and molecular weight 
standards for electrophoresis from Pharmacia, Uppsala, Sweden. 
Dimethylsuberimidate from Pierce Chemical Co. Rockford, Illinois, 
USA. 
Spectrapor membrane tubing 2 (molecular weight cut off 12000-14 
000) from Spectrum Medical Industries INC, Terminal Annex, Los 
Angeles, USA. 
Undistilled anaesthetic ether from Natal Cane By-Products Ltd., 
Merebank, Natal, South Africa. 
TLC-micropolyamide sheets from Schleicher and Schull, D-3354 
Dassel, Postfach 4, Germany. 
Buffer Compositions 
Composition 
O.OlM Sodium phosphate 
containing 0.25M sucrose 
O.OlM Sodium phosphate 
c_ontaining O. lM NaCl 
0.05M sodium sulphate 
containing 0.5M NaCl and 
O.OOM EDTA 
O.OlM Potassium phosphate 
O.lM Potassium phosphate 




containing 0.001M EDTA 
0.05M Triethanolamine 



























Preparation of Tissue The livers, testes and adrenals of adult 
male Long-Evans rats (250-300g) fed ad libitum or the testes 
from male cadavers as soon after death as possible (less than 12 
hours) were used. Ovaries from adult female Long-Evans rats 
(200-250g), also fed ad libitum, were used. 
Male Long-Evans rats (250-300g) housed under controlled conditions 
of temperature and humidity were used as organ donors. Rats were 
allowed free access to food and water unless otherwise stated. 
Ovaries were obtained from Long-Evans rats (200-250g). Human 
testis was obtained within 12 hours of death from subjects who died 
as a result of trauma. 
Preparation of Cytosol Rats were anaesthetised with ether. Liver 
and kidney were rapidly removed and immediately perfused via the 
hilar vessels with ice cold 0.14M NaCl. Following excision of all 
surrounding tissue and other adherent tissue, the testes, ovaries 
and adrenals were immersed in saline at 0°C prior to being blotted, 
weighed and homogenised. Following initial fragmentation with 
scissors, homogenisation was carried out in O.OlM sodium phosphate 
buffer pH 7 .4 / 0.25M sucrose, with sufficient buffer added to 
yield a 25% (w/v) homogenate, except for the adrenals and ovaries 
where 2ml of buffer was routinely added. All steps were carried 
out at 4°C. 
NOTE; read ug, ul and uM as µg , µ/ and µM 
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The initial centrifugation was at 27000 g for 30 minutes in a 
Sorvall RC-5 superspeed centrifuge. The supernatant fraction was 
carefully removed without disturbing the floating lipid layer and 
re-centrifuged at 100000 g for 120 minutes in a Beckman model L5.35 
ultracentrifuge. The supernatant was removed as before and stored 
on ice. 
Ultrafiltration and Dialysis Cytosol (prepared as previously 
described) was concentrated using an Amicon model 202 ultrafil-
tration cell with a PM-10 membrane. Dialysis was carried out 
either in the Amicon cell, where buffer change was achieved by 
flushing through dialysing buffer until the correct pH was 
obtained, or by using dialysis tubing (Spectrapor molecular weight 
cut off 12000-14000) presoaked in distilled H2o. 
Standard Purification Procedure of Ligandin (Fig. 1. 6) Ligandin 
was purified from the liver, testes, ovaries and adrenals of Long 
Evans rats (250-300g) as described by Kirsch et al (1975) and 
Bhargava et al (1980a). Cytosol prepared by centrifugation at 
100000 g was obtained from 100g of rat tissue (only 10g of ovaries 
or adrenals were obtained) and was dialysed against O.OlM Tris.HCl 
pH 8. 8 (buffer A) and chromatographed on a column of either TEAE-
or DEAE-cellulose in buffer A. The single protein peak eluted was 
pooled, concentrated (Amicon cell, PM-10 membrane) and chromato-
graphed on a column of Sephadex G-100 in O.OlM sodium phosphate 
buffer, pH 7. 4 / 0. lM NaCl. Fractions exhibiting enzyme activity 
with CDNB were pooled, concentrated, dialysed against buffer A and 
chromatographed on a column of QAE-Sephadex A-50 in buffer A. 
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The single protein peak eluted was pooled and stored in sterile 
tubes at 4°C. In certain studies the purified ligandin was 
subjected to a further chromatographic step with QAE-Sephadex using 
buffer C (O.OlM Tris. HCl pH 9.1). 
Polyacrylamide gel electrophoresis Polyacrylamide gel 
electrophoresis in O .1 % SDS was performed on vertical slab gels 
(Laemmli 1970). The system comprised a 3% (w /v) stacking gel (3 x 
14 x 0,2cm) in 0.14M Tris.HCl buffer pH 6.8, and a 5% - 25% (w/v) 
gradient gel (20 x 14 x 0.2cm) in 0.56M Tris.HCl buffer, pH 8.8. 
Samples were prepared as described by Maizel (1971). Gels were 
fixed and stained for 2. 5 hours in 10% trichloroacetic acid, 1. 0% 
Coomassie Brilliant Blue R in methanol/water (1:2 v/v) and 
destained in a solution of 5% methanol/7% acetic acid (v /v) 
molecular weight estimation. Molecular weights of ligandin 
preparations, the aggregates and dimethylsuberimidate cross-linked 
material were determined by comparison with standards of known 
molecular size (phosphorylase b 94000; albumin 67000; ovalbumin 
43000; carbonic anhydrase 30000; trypsin inhibitor 20100; 
alpha-lactalbumin 14400). The relative mobility of each protein 
was calculated from the distance migrated of each protein compared 
with that of the bromophenol blue "tracking-dye". These values 
were plotted against the log standard protein molecular weight 
(Fig. 2 .1). Linear graphs were obtained and the unknowns read from 
this plot. 
Coelectrophoresis To compare the subunits of purified rat liver 
and testis ligandin, dilute samples were coelectrophoresed on 
SDS-polyacrylamide gels with rat testis and rat liver ligandin 
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Fig. 2 .1 Determination of the comparative molecular weights of 
rat testis ligandin Ya and Y c subunits and dimethylsuberimidate 
cross-linked testis ligandin material by discontinuous gradient 
PAGE in SDS. Details of these procedures as well as the assumed 
molecular weights of the standard proteins are given in Chapter 2. 
Section A. 
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Dansylation of Proteins: N-terminal analysis Protein labelling 
was achieved using the method of Gray (1972) modified as described 
below. Test tubes (6 x 50mm) were acid cleaned and heated in 100°C 
oven overnight before use. 50-250ug protein was dissolved in 50ul 
1% SDS by heating in a boiling water bath for 2-5 minutes. When 
the solution had cooled, 50ul of distilled N-ethylmorpholine was 
added and mixed. Immediately before use 50mg dansyl-chloride was 
dissolved in 1ml water-free acetone, 50ul dansyl-chloride solution 
was added to the protein solution and mixed. The reaction test 
tube was covered with tin foil and incubated for 30 minutes at 
45°C. The protein was precipated with acetone. Following 
centrifugation the supernatant was carefully decanted and discarded 
while the pellet was washed with 80% acetone and recentrifuged. 
After the supernatant was discarded the pellet was dried under 
vacuum. 20ul of 5.7M HCl was added and the tubes were sealed in a 
gas flame and incubated at 105°C for 6-15 hours. The shorter 
hydrolysis time gives a better recovery of praline but less 
complete protein hydrolysis. Following hydrolysis the mixture was 
was freeze-dried, the residue re-dissolved in 5ul of 95% ethanol 
and spotted onto a 5 x 5 cm micropolyamide sheet. One spot of a 
mixture of standard amino acids was spotted onto the reverse side 
of the polyamide sheet. Development was carried out sequentially 
in four solvent systems; solvent 1, 1. 5% formic acid in water 
(v/v); solvent 2, Benzene:acetic acid (9:1 v/v); solvent 3, ethyl 
acetate: acetic acid: methanol (20: 1: 1 v /v); solvent 4, 50mM 
Na3P04 in 25% aqueous ethanol. After drying the sheet was . 
examined under an ultraviolet lamp. A blue dansyl-OH spot was seen 
on all chromatograms. Dansyl-derivatives of tyrosine fluoresced an 
intense yellow-brown 
amino acids yielded 
colour, while dansyl derivatives of other 
a yellowish-white colour. Blocked NH 2 
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terminals failed to produce fluorescence corresponding to any of 
the standard amino acids. 
Amino Acid Analysis (Moore and Stein 1963) The protein was 
dialysed into distilled H20. After determination of protein 
concentration 3 measured aliquots were transferred into chromic 
acid-washed pyrex hydrolysis tubes and freeze-dried. 1ml of 6N 
HCl was added to each tube and the contents frozen in liquid N2. 
Excess HCl was evacuated from the tube on an oil-vacuum pump to 
less than 50 microns after which the tubes were flushed with N 2 
and vacuum-sealed. Hydrolysis was carried out in a 110°C oven for 
24 hours. 
Analysis of amino acids was carried out on a Beckman (121 MB) 
amino-acid analyser. Chromatographic peaks were identified and 
integrated by an on-line computer and results expressed as residues 
per mole. 
Cross-Linking Studies To prevent the aggregation of ligandin 
which may occur under low salt conditions, cross-linking reactions 
were carried out at a salt concentration of 0.4M NaCl / 0.05M KCl, 
and to favour cross-linking within the protomers over that between 
the protomers (Davies and Stark 1970), low protein concentrations 
were used (0.3mg/ml). A reaction buffer of 0.05M triethanolamine 
containing 0.4M NaCl / 0.05M KCl adjusted to a pH of 8 was used. 
Immediately before use a 30mg / ml solution of dimethylsuberimidate 
(DMS) (see structural formula below) was prepared in 0.05M 
triethanolamine / 0.4M NaCl / 0.05M KCl, pH 8.0 and immediately 
readjusted to pH 8 with 0.5M NaOH. Aliquots of this solution were 
added to liver and testis ligandin (200ul) in O.OlM Tris HCl 
buff er, pH 8. 0. After standing on ice for various time periods 
84 
the reaction was quenched by addition of an equal volume of 0.3M 
ethanolamine. Thereafter the SDS-PAGE sample application buffer 
containing 3% beta-mercaptoethanol was added in equal volume to the 
cross-linked solution, incubated for 6 minutes at 100°C and 
electrophoresed in SDS on polyacrylamide gradient gels. 
Difference Spectroscopy of Bilirubin and Ligandin Stock solutions 
of bilirubin were prepared (lOuM) in lOmM NaOH and adjusted to a pH 
of 8.8 with 0.02M Tris. HCl buffer pH 7 .o. The concentration of 
the stock solution was determined spectrophotometrically by using 
an ( 400 value of 52000 litre.mol-!cm-1. An Aminco 
(DW 2) dual wavelength ultra-violet/visible spectrophotometer or a 
Varian 635 spectrophotometer was used to compare difference spectra 
of bilirubin with liver ligandin and of bilirubin with testis 
ligandin. 
(1976a). 
The methods used were described by Tipping et al 
The temperature of the cell compartment was 24°C. 1 ml 
of a lOuM solution of bilirubin was added to one compartment of 
both reference and sample cells, while an equal volume of protein 
was added to the other compartment of both cells. A base line was 
obtained and, after mixing the solutions in the sample cells, 
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measurements were obtained immediately and after 5, 10 and 15 
minutes. 
Separation of Glutathione S-transferases Rat liver and testis 
supernatants were chromatographed on a DEAE-cellulose column (2.6 x 
35cm), equilibrated with O.OlM Tris.HCl buffer, pH 8.0. Fractions 
exhibiting absorbance at 280 nm were pooled and concentrated to a 
volume of 10 ml (Amicon cell, PM-10 membrane). After dialysis into 
O.OlM potassium phosphate buffer pH 6.7 (buffer C), the preparation 
was applied to a CM-cellulose column (2.6 x 30 cm) previously 
equilibrated with buffer C (Habig et al 1974b). A 600 ml 
linear gradient, 0-120mM KCl in buffer C was applied to the column 
and 3ml fractions were collected and stored at 4°C prior to assay. 
In a separate experiment, testis ligandin prepared according to 
Bhargava et al (1980a) was chromatographed on a CM-cellulose 
column (1.6 x 10cm) as described above. 
Assays Glutathione S-transferase activity was measured by 
following the conjugation of GSH with either 1-chloro-2, 4-dinitro-
benzene ( CDNB) at 340nm or 2, 4-dinitrochlorobenzene (DCNB) at 345nm. 
(Habig et al 1974b). Reaction rates were corrected for the small 
amount of non-enzyme catalysed conjugation of GSH with either CDNB 
(( =9600) or DCNB (( =8500). Specific activities (umol/min/mg 
protein) were calculated from the equation: 
OD/min x final assay vol x 103 
( £) sample vol protein cone. 
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Glutathione peroxidase activity was assayed, as described by 
Prohaska and Ganther (1977). 50ul of sample was added to a mixture 
in a cuvette of 0.55ml O.lM potassium phosphate buffer pH 7.0 / 
O.lM KCl; 0.1ml 10.03M EDTA; 0.1ml O.OlM GSH; 0.1ml 0.0011M NADPH 
and 0.1ml GSH reductase (4ug GSH reductase). A blank cuvette 
contaiµed all the above solutions excepting for the sample. The 
cuvettes were incubated at room temperature for 10 minutes. A 
stock solution of 0.2g (w/v) cumeric hydroperoxide (70% in cumene) 
in 10% (v /v) ethanol was made up and lOul of this stock added to 
both blank and sample cuvettes. The change in absorbance was read 
at 340nm which measured the disappearance of NADPH (( =6000). 





One enzyme unit is defined as 1 umol of NADPH oxidised per minute. 
Protein Determinations Protein concentrations were determined by 
the method of Lowry et al (1951), using bovine serum albumin as 
standard. 
Sulphobromopthalein Assay Sulphobromopthalein (BSP) concentra-
tions were measured by adding lOOul 2M NaOH to 250ul aliquots of 
column fractions and reading absorbance at 580nm (Levi et al 
1969a). 
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Immunological studies Antisera to liver and testis ligandin were 
raised by injecting 50ug of purified proteins in Freund's complete 
adjuvant into popliteal lymph nodes of male albino rabbits. 
Thereafter, 50ug of ligandin in adjuvant was injected into multiple 
subcutaneous sites at three-week intervals. Animals were bled 10 
days after booster inoculations. The separated sera were tested 
for specific antibody production by immunodiffusion and 
immunoelectrophoresis (Bass et al 1977a). Radial 
immunodiffusion used 1. 2% agar gels (Ouchterlony 1958) and 
immunoelectrophoresis 1% agar gels (Bass et al 1977a). 
(i) Immunodiffusion 
1.2g Agar-Noble, O.lg sodium azide and 100ml of 0.05M sodium 
phosphate buffer pH 7 .4 / 0 .15M NaCl were heated in a conical flask 
until the solution clarified. The mixture was not allowed to boil. 
After clarification the flask was placed in a 60°C water bath. 
10ml of molten agar solution was poured onto warmed glass plates 
(9.2cm x 8.2cm) positioned on a horizontal platform. The plates 
were allowed to cool for 1 hour. 4mm diameter wells were cut using 
an LKB 2117 Multiphor templat~ and bores. lOul antiserum was 
placed into the central well and lOul of antigens into the 
peripheral wells. The plates were kept horizontal in an air-tight 
moisture box at room temperature for 48 hours after which they were 
washed for 3 days with several changes of O. 9% saline / 0 .1 % sodium 
azide solution. The plates were stained in 1.0% Amido Black (made 
up in de staining solution) for 3 hours, and de stained in 5% Acetic 
' 
Acid. An alternative method which avoided this delay due to 
washing was also employed. After immunodiffusion the plates were 
covered with six layers of blotting paper soaked in distilled 
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H20, eight layers of dry blotting paper and placed in between 2 
glass sheets. A 1kg weight was placed evenly on top of the glass 
plates and left for 1 hour. The blotting paper was replaced after 
30 minutes. The weights were removed and the gel dried down to a 
fine film with a hair dryer. Staining and destaining were carried 
out as before. 
(ii) Immunoelectrophoresis 
100ml of O. 05M veronal buffer pH 8. 7 / 0. 2% sodium azide was added 
to lg of Agar-Noble. A similar procedure as that described for 
immunodiffusion was followed until the agar was set and cooled on 
the glass plates. Using the LKB 2117 Multiphor template for 
immunoelectrophoresis 4mm diameter wells were cut. A sharp scalpel 
blade was used to cut the outline of troughs without removal of the 
agar. Gel plates were placed onto LKB Multiphor apparatus, the 
tanks filled with 0.05M veronal buffer, and moistened filter paper 
wicks placed in contact with ends of gel plate and the buffer 
tanks. lOul of sample was placed into the wells and a current of 
12mA/plate was applied for 1~-2 hours. The agar was carefully 
removed from the troughs and 30-50ul of antiserum added. Immuno-
diffusion was then carried out as described before. 
(iii) Preparation of IgG 
IgG was prepared by ammonium sulphate precipitation according to 
the method of Hebert et al (1973). A volume of serum was 
gently stirred whilst an equal volume of a 70% ammonium sulphate 
solution was slowly added. The reaction mixture was set aside at 
room temperature for 4 hours and then centrifuged. The supernatant 
j 
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was discarded and the pellet resuspended in 0.9% NaCl, pH 8.0 to a 
final volume equal to the original volume of serum. This procedure 
was repeated twice, after which the resuspended precipitate was 
dialysed into 0.9% Nacl, pH 8.0 with frequent changes of the 
buffer. To test for the presence of residual sulphate, a small 
volume of saturated barium chloride was added to an equal volume of 
the saline-dialysate. If no cloudiness resulted, the dialysed 
fraction was considered to be substantially free of sulphate. The 
IgG fraction was checked for albumin contamination by means of 
cellulose acetate electrophoresis (Kohn 1960). 
Affinity Chromatography Techniques 
(i) Immunoaffinity Chromatography 
The procedure for immunoaffinity chromatography of proteins as 
described by Livingston (1974) formed the basis of these studies. 
Affinity reagents consisting of the gamma globulin fractions of 
either anti-rat liver ligandin antiserum, or anti-rat testis 
;,., #tis c.1t11p1-er 
ligandin antiserum were prepared as previously described. 3g of 
/\ 
cyanogen bromide (CNBr)-activated Sepharose 4B was swelled and 
washed in 600ml O.OlM HCl on a sintered glass filter in order to 
remove dextran and lactose additives. Approximately 100mg of 
anti-rat liver YaYa ligandin IgG or anti-rat testis ligandin IgG 
was dissolved in 10 ml of coupling buffer (0. OlM potassium 
phosphate buffer pH 6.8 / 0.5M NaCl) and mixed with the swollen gel 
in a glass-stoppered test tube and rotated end-over-end overnight 
at 4°C. An aliquot was immediately removed, centrifuged and 
absorbance at 280nm recorded. The remaining active groups were 
reacted with lM ethanolamine at pH 8 for 2 hours, after which 
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several washing cycles (O.lM acetate buffer / lM NaCl pH 8.0 and 
O.lM borate buffer / lM NaCl pH 4.0) were carried out to remove 
non-covalently adsorbed protein. A second aliquot was removed and 
the absorbance at 280nm recorded. 
% coupling = 1st A28o reading x 100 
2nd A280 reading 
98. 4% of liver antibody and 94. 2% of testis antibody was coupled. 
Partially purified rat tissue ligandin (TEAE eluate, Fig. 2.2) was 
applied to a 10 x 0.9 cm column of affinity material. After 
unbound protein had been washed from the column, immunoreactive 
material was eluted with O. lM glycine pH 3. 0. The pH of all 
fractions was immediately adjusted to pH 7 .4 with lM Tris buffer. 
(ii) Activated Thiol-Sepharose 
Ligandin YaYc was dialysed into 0.05M sodium phosphate buffer pH 
8.0 / 0.5M NaCl/ 0.001M EDTA. 0.05M L-cysteine was made up in the 
same buffer. Buffers were deaerated before use in order to avoid 
oxidation of free thiol groups. 4g of activated Thiol-Sepharose 4B 
was swollen and washed with 0.3M NaCl pH 7.0. The swollen gel was 
packed into a column (10cm x 15cm) and equilibrated with starting 
buffer (0.05M sodium phosphate buffer pH 8.0 / 0.5M NaCl / 0.001M 
EDTA) at a flow-rate of 5ml/hour. The ligandin sample was applied 
to the column and the unbound material washed off with the starting 
buffer. Bound fractions were eluted after application of 
L-cysteine buffer to the column. Fractions containing enzyme 
activity were pooled and desalted on a Sephadex G-25 (Fine) column 
(2.6cm x 60cm). 
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(iii) Hexylglutathione Affinity Chromatography 
The method described by Guthenberg and Mannervik ( 1979) was used. 
Supernatant fractions of liver, testis, ovary and adrenal were 
passed through a Sephadex G-25 column (bed volume; 5 times sample 
volume) in O.OlM Tris HCl buffer pH 7.8. The enzyme active peak 
was pooled, concentrated in an Amicon ultrafiltration chamber 
(PM .10 membrane) and applied to the hexylglutathione affinity 
column (1cm x 10cm) (see below for method) equilibrated in the Tris 
buffer. The column was washed with O.OlM Tris.HCl buffer pH 7.8 / 
0.2M NaCl until no more protein eluted from the matrix. GSH 
S-transferases were eluted from the affinity column with 0.005M 
S-hexylgluthione in O.OlM Tris.HCl buffer pH 7.8 / 0.2M NaCl. All 
fractions displaying GSH-CDNB conjugating activity were pooled and 
desalted on the Sephadex G-25 column equilibrated in O.OlM 
potassium phosphate buffer pH 6.8 / 0.001M EDTA. 
S-hexylglutathione was synthesised according to method A of Vince 
et al (1971). 2mmoles of GSH were dissolved in 2ml H20. 4 
mmoles of 2N NaOH (freshly made up) was added with stirring at room 
temperature. 12-15ml of absolute ethanol was added "dropwise", 
with stirring to the 'cloud point', after which equimolar (2mmoles) 
1-lodohexane was added "dropwise" over a period of 30 minutes, with 
stirring. The mixture was stirred vigorously at room temperature 
for 3 hours. If any precipitation occurred, a few drops of ethanol 
were added. The pH was then reduced to 3.5 by "dropwise" addition 
of 47% hydrogen iodide (approximately 15 drops) and the mixture 
chilled to 4°C. The crystals formed were separated by filtration 
and washed with 20ml H20. Recrystallisation steps were carried 
out. The sample was dried and stored in a dessicator at -20°C. 
The yield obtained was approximately 65%. 
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A O. 005M solution of S-hexylglutathione for eluting bound material 
was prepared by homogenising crystals in O.OlM Tris.HCl buffer pH 
7 .8 / O. 2M NaCl. lM Tris. stock was added "dropwise" until the 
crystals were dissolved. The solution was then made up to volume 
with O.OlM Tris.HCl buffer pH 7.8 / 0.2M NaCl. 
For preparation of the hexylglutathione affinity column, 6g of 
epoxy-activated Sepharose 6B was washed in a sintered glass funnel 
with 800ml of H20 for 1 hour. 94mg of S-hexylglutathione was 
then dissolved into 12 ml of O.lM NaHC0 3 / NaOH buffer pH 10.6, 
with stirring. Approximately 7 drops of 1 M NaOH was required to 
readjust pH back to 10. 6. The ligand solution was added to the gel 
suspension and shaken gently for 30 hours at 30° C. 
The gel suspension was then washed on a sintered glass funnel with 
each of the following: 
(a) 200ml O.lM NaHC03 / NaOH buffer pH 10.6, 
(b) 200ml O.lM sodium borate buffer pH 8.0 / 0.5M NaCl, 
Cc) 200ml O.lM sodium acetate buffer pH 4.0 / 0.5M NaCl, and 
(d) 400ml H2o. 
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Chromatofocusing (Sluyterman and Elgersma 1978) Following 
concentration of material which bound to the hexylglutathione 
affinity column, the sample was applied to a chromatofocusing 
column (0.9cm x 20cm) of PBE 94 gel equilibrated with 15 column 
volumes of 0.025M ethanolamine.HCl pH 9.4. The GSH S-transferases 
were eluted with 250 ml of Polybuffer 96, (diluted 1:10), pH 8.0. 
Following SDS-polyacrylamide electrophoresis of fractions eluting 
from the chromatofocusing column, the gels were washed in 11% 
Trichloroacetic acid for 24 hours, before staining with Coomassie 
Blue. 
(d) Results 
PURIFICATION AND CHARACTERISATION OF RAT TESTIS 
LIGANDIN 
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Standard Purification Procedure Table 2. 2 shows the details of 
purification of testis ligandin following the standard purification 
procedure described by Kirsch et al (1975) and Bhargava et 
al (1980a). Specific activity using CDNB and GSH as substrates 
was determined at each stage. The mean specific activity of the 
final product of four separate testis preparations was 15. 6 
umol/min/mg. The elution profile from TEAE-cellulose, Sephadex 
G-100 and QAE-Sephadex chromatography steps of the purification are 
shown in Fig. 2. 2. The patterns correspond with those obtained for 
the purification of rat liver ligandin (Bass et al 1977a) and 
for rat renal ligandin (Kirsch et al 1975). A single peak 
comprising the basic cytosol proteins eluted from DEAE-cellulose. 
Several purifications were carried out using either TEAE- or 
DEAE-cellulose in the first step and no difference was apparent 
when either of these cellulosic-anion exchangers were used. 
Following concentration and chromatography on Sephadex G-100, three 
peaks were obtained, the CDNB-GSH conjugating activity was confined 
to the second peak. QAE-Sephadex chromatography of the enzyme 
active peak resulted in a single peak being eluted. 
Subunit Composition SDS-PAGE of each stage of testis ligandin 
purification is shown in Fig 2.3. The final preparation of testis 
ligandin has more Y c than Ya (lanes 6, 7 and 8) . Ligand in prepared 
from rat liver using the same purification method had equal amounts 
Total 
Activity * 
Protein Volume Specific 
Activity* 
(umol/min/ml) (mg/ml) (ml) (umol/min/mg) 
Testis 50 46.3 23.5 
cytosol 
TEAE- 10.3 2.6 9.4 
cellulose 
Sephadex 2.1 0.2 25.0 
G-100 
QAE- 1. 7 0.1 31.0 
Sephadex 
A50 
Table 2.2 - Summary of Purification of Rat Testis Ligandin 
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Fig. 2. 2 Purification of ligandin from the 100000 g supernatant 
of rat testes. (A) Elution of protein from DEAE-cellulose in 
O.OlM Tris.HCl buffer pH 8.8. (B) Elution of protein from Sephadex 
G-100 in O.OlM sodium phosphate buffer pH 7 .4 / O. lM NaCl. (C) 
Purification of the CDNB-enzyme active peak on QAE-Sephadex A.50 in 
O.OlM Tris.HCl buffer pH 8.8. Fractions pooled at each stage of 
the purification are indicated by the horizontal bars (see Chapter 
2, Section A, Methods and Results, for details). 
+ 
Fig. 2. 3 SDS/Polyacrylamide 5 - 25% (w/v) gradient gel electro-
phoresis at each stage of rat testis ligandin purification. 
(1) molecular weight markers 94000; 67000; 43000; 30000; 20100; 
14400. (2), (3) testis cytosol (100000 g supernatant), (4) protein 
peak after TEAE-cellulose chromatography, (5) peak exhibiting 
GSH-CDNB conjugating activity after Sephadex G-100 chromatography, 
(6) fraction 30 from QAE Sephadex A-50 eluate, (7) fraction 35, (8) 
fraction 38 • Between 10 and 30 ug of protein were loaded per 
sample. Samples were prepared as described by Maizel (1971). 
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of Ya and Ye subunits, similar to that described by Bhargava et 
al (1978a), while livers from rats pre-treated with pheno-
barbital contained more Ya than Ye. The estimated molecular 
weight of Ye was 25000 daltons and of Ya, 22000 daltons (Fig. 
2.1). Coelectrophoresis of purified liver and testis ligandin 
revealed that the Ye and Ya subunits of the two preparations 
migrated identically on SDS-PAGE. 
N-Terminal Analysis Dansyl-chloride labelling of testis ligandin, 
liver YaYc ligandin and liver YaYa ligandin was carried out 
according to the method previously described. No NH2-terminal 
residues were detected for freshly isolated preparations of 
ligandin suggesting that the NH2-terminus is blocked. All three 
ligandin preparations (testis YaYc, liver YaYc and YaYa) gave a 
similar result. Dansyl derivatives of tyrosine and lysine were 
noted, indicating the presence of large amounts of internal 
tyrosine and lysine residues. Samples stored at 4°C for a period 
of three months showed proline to be the NH2-terminal amino acid 
in all three ligandin preparations. This was possibly due to 
degradation of the proteins. Bhargava et al (1978a) presented 
similar findings for liver ligandin preparations. 
Amino Acid Analysis The amino acid composition of testis ligandin 
prepared according to the standard purification procedure is 
presented in Table 2. 3. In addition, the amino acid composition of 
liver YaYa ligandin, the range of values quoted by several workers 
for liver YaYc ligandin and the amino acid composition of liver GSH 
S-transferase AA are shown. 
AMINO ACID aTESTIS 
b GSH S-TRANS- GSH S-TRANS-
b LIVER YaYa LIVER YaYc 
LIGANDIN FERASE AA FERASE B LIGANDIN LIGANDIN 
(ex Habig (ex Jakoby (ex Bass (ex Ketterer 
et al (1976) 1978) 1977) et al (1976) 
Lysine 34 34 36 35 34 
Histidine 7 7 6 4 
Arginine 26 26 22 20 22 
Aspartate 32 41 37 31 34 
Threonine 7 8 11 12 12 
Serine 15 12 12 14 14 
Glutamate 40 47 46 40 40 
Praline 24 25 20 17 16 
Glycine 30 23 21 16 18 
Alanine 42 33 31 26 26 
\-Cystine 1 2 4 nd 6 
Valine 14 31 25 17 18 
Methionine 14 10 8 12 14 
Isoleucine 7 14 18 18 46 
Leucine 45 49 50 46 20 
Tyrosine 17 19 13 12 12 
Phenylalanine 16 15 17 15 18 
Tryptophan nd 2 9 1 2 
Table 2.3 Amino Acid Analysis of Testis ligandin; Liver GSH S-transferases 
AA and B; YaYa and YaYc Liver Ligandin. 
nd = not determined 
aResidues per mole (47000g) 
bResidues per mole (45500g) 
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Testis ligandin had similar amino acid composition to GSH S-
transf erase AA. 
Covalent Cross-linking of Testis Ligandin SDS-PAGE analysis of 
material after cross-linking had been allowed to proceed for 2. 5 
hours at 4°C showed 2 distinct bands migrating in the 50000 
molecular weight region (Fig. 2. 4). DMS cross-linked liver Ya Ya or 
Ya Y c ligandin could not be resolved into more than 1 band, agreeing 
with the findings of Bhargava et al (1978a). 
Degradation of Ligandin and Appearance of Aggregates after Storage 
at 4°C Although ligandin preparations (liver and testis) contained 
0.1% sodium azide and were stored at 4°C under identical 
conditions, it appeared on SDS-PAGE that the testis Ya subunit 
degraded more readily (3 weeks after preparation) than was observed 
for the Ya subunit of liver ligandin. Testis ligandin preparations 
also revealed the presence of aggregates between 62000 and 66000 
daltons on SDS-PAGE following storage at 4°C for approximately 2-3 
weeks. Similar patterns of aggregates were observed with stored 
liver YaYc and YaYa ligandin and ovary and adrenal ligandin 
preparations. Incubation at 100°C for 10 minutes following 
reduction with beta-mercaptoethanol appeared to remove these 
aggregate forms, suggesting that the highly charged proteins may 
form disulfide bridges during ageing and subsequent denaturation. 
Bilirubin Binding Earlier studies of bilirubin binding using 
difference spectra with liver ligandin and bilirubin, and testis 
ligandin and bilirubin showed liver ligandin to have binding 










Fig. 2.4 SDS-PAGE of "pure" testis ligandin cross-linked with 
dimethylsuberimidate. The 1st lane contains testis ligandin 
purified by standard procedures, no DMS added; the 2nd lane, testis 
ligandin after addit ion of DMS and cross-linking reaction allowed 
to proceed for L 2 h under conditions described in Methods section; 
the 3rd lane, after cross-linking for 2. 5 h , and the 4th lane, 
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Fig. 2. 5 Difference spectra resulting from the binding of 
bilirubin by liver ligandin (----:-) and bilirubin by testis 
ligandin (-----) (A) The sample cell compartments contained 
1.0ml of a 50uM protein solution. The reference cell compartments 
contained 1.0ml lOuM bilirubin. The following spectra were 
obtained after m1xmg the solutions of sample cell cuvette. 
Details are described in Methods and Results. (E) refers to total 
bilirubin. (B) Difference spectra resulting from the binding 
of 1:10 dilutions of bilirubin with liver ligandin and 1:10 
dilutions of bilirubin with testis ligandin. 
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characteristics similar to those previously reported (Tipping et 
al 1976a) while testis ligandin appeared to have a lower affinity 
for bilirubin. This suggested that the primary high affinity 
binding site present on liver ligandin was lacking in testis 
ligandin preparations. More recently however, experiments carried 
out using concentrated ( 1. 8mg / ml) , freshly isolated testis ligandin 
demonstrated binding characteristics more reminiscent of liver 
ligandin than the earlier testis preparations (Fig 2. 5A). 1 in 10 
dilutions of bilirubin incubated with these ligandin preparations 
gave rise to a red shift in the absorption maximum, accompanied by 
a smaller difference-spectra result (Fig 2. 5B) • 
Immunological Properties Testis ligandin and liver cytosol 
revealed a single line of identity when placed in adjacent wells 
and subjected to immunodiffusion against anti-liver YaYa ligandin 
serum. Antiserum to liver YaY c ligandin gave a similar result. 
Anti-liver YaYa ligandin IgG (prepared as described in the Methods 
section) gave single precipitin lines as well. These results were 
in accord with those published by Bhargava et al (1980a). 
Antisera raised against testis ligandin (prepared using the 
standard technique) revealed a single line of identity when 
immunoelectrophoresed against testis cytosol and adrenal cytosol. 
However, a faint second line was noticed on immunoelectrophoresis 






Fig. 2. 6 Immunoelectrophoresis of testis ligandin antibody 
against liver, testis and adrenal cytosols in 1 % agar gel . The 
wells contain liver cytosol, testis cytosol and adrenal cytosol 
(1 ug in lOul) . The troughs each contain lOul of rabbit antiserum 
to testis ligandin. Electrophoresis was performed in O. 07M veronal 
buffer, pH 8. 7, at 12 mA for 2 h. The precipitates were stained 
with Amido Black. 
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Affinity Chromatography Purification Procedures 
(i) Anti-liver Ligandin Immunoaffinity Chromatography 
The profile obtained when the testis protein peak (TEAE-cellulose 
eluate) was applied to an anti-liver YaYa ligandin affinity column 
is shown in Fig. 2. 7. Fractions were analysed by SDS-PAGE (Fig. 
2.8). The starting material and TEAE-cellulose eluate had more Ye 
subunit than Ya. In contrast, the material recognised by the 
matrix-coupled anti-liver ligandin IgG (elution volume 85ml) had 
equal quantities of Ya and Ye. Unbound fractions (elution volume 
15 ml) contained no Ya subunit, while later fractions (elution 
volume 30ml) contained only traces of this species. 
(ii) Anti-Testis Ligandin Immunoaffinity Chromatography 
An affinity column of anti-testis ligandin antibody was prepared in 
a similar manner to the anti-liver ligandin affinity column, and 
the same testis starting preparation was applied to the column. 
SDS-PAGE (Fig. 2.9) revealed more Ye than Ya in the immunoreactive 
peak (elution volume 85ml) suggesting that the anti-testis ligandin 
antibody recognised more of the Y c subunit than the anti-liver 
ligandin antibody. 
(iii) Thiol-Sepharose Affinity Chromatography 
Liver ligandin prepared according to the standard procedure from 
phenobarbital pre-treated rats was applied to a Thiol-Sepharose 
column. Unbound material consisted of the YaYa dimer on SDS-PAGE 
(Fig. 2.10 - lane 1) while bound fractions obtained after elution 
Anti-ligandin affinity chromatography 
0•5 
0 50 100 
Elution Volume ( m 1 ) 
Fig. 2. 7 Chromatography of partially purified (TEAE-eluate) rat 
testis ligandin on anti-ligandin Sepharose 4B affinity columns. 
The elution profiles for anti-liver ligandin and anti-testis 
ligandin affinity · columns are identical. Unbound material eluted 
in the first peak (elution volume 10 - 40ml). Bound material was 
eluted with O. lM glycine pH 3, O (elution volume 80 - 95ml). 
e 
SDS-PAGE of ANT I - LI VER 
Ligand in Sepharose 48 
1 2 3 4 
- - Ye Ya 
Fig. 2. 8 SOS-PAGE of peaks eluted after anti-liver ligandin 
Sepharose 4B affinity chromatography. (1) testis TEAE-eluate 
(starting material), (2) material at elution volume 15ml, (3) 
material at elution volume 30 ml, (4) material after elution with 
0. lM glycine pH 3. 0. See Fig. 2. 7 for details. 
SDS - PAGE of ANTI-TESTIS 
Ligand in Sepharose 48 





Fig . 2. 9 SDS-PAGE of eluate from anti-testis ligandin Sepharose 
4B affinity column . (1) testis TEAE-eluate (starting material), 
(2) material eluting at 15 ml, (3) material eluting at 25 ml, (4) 
material eluted after application of O. lM glycine buffer pH 3. 0 
(elution volume 80 - 95 ml). See Fig. 2.7 for details. 
Fig. 2 .10. SDS-PAGE of eluate from a Thiol-Sepharose affinity 
column. Lanes, (2) liver YaYc ligandin from phenobarbital pretreated 
rats (starting material), (1) liver Ya Ya ligandin homodimer, material 
which did not bind to the column, (3) liver YaYc ligandin heterodimer, 
eluted after application of L-cysteine buffer, (4) Molecular weight 
markers (see Chapter 2, Section A, Methods and Results for details). 
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with L-cysteine contained equal amounts of Ya and Ye (lane 3). 
The starting material contained more Ya than Y c (lane 2). 
Appearance of aggregrates, molecular weight between 62000 and 
66000, was noted. Separation of testis ligandin subunits could not 
be achieved in this way (see Discussion). 
(iv) Hexylglutathione Affinity Chromatography 
Fig. 2.11 shows the elution profile of testis cytosol on an 
hexylglutathione affinity column. The first peak (unbound 
material) dfplayed relatively little enzyme activity with CDNB as 
" substrate, while the second peak which bound to the column, 
contained much higher levels of GSH S-transferase activity. SDS-
PAGE analysis of this material revealed the presence of Ya, Yb and 
Ye (Fig. 2.21). 
COMPARISON OF RAT TESTIS LIGANDIN WITH OVARY AND 
ADRENAL LIGANDIN 
The subunit composition of ligandin purified from rat ovary and 
adrenal tissue was investigated and comparisons made on SDS-PAGE 
with testis ligandin subunits. The same procedure described for 
testis ligandin was used to isolate ligandin from rat ovaries and 
r 
adrenals. The protein preparations obtained were compared on 
SDS-PAGE with testis ligandin preparations (Fig. 2.12). The Ye 
subunit species of both ovary and adrenal preparations were 
predominant. Aggregates between 62000 and 66000 daltons were 
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Fig. 2. 11 Chromatography of rat testis cytosol (Sephadex G-25 
eluate) on hexylglutathione affinity columns. Unbound material eluted 
in the first peak (elution volume 10-50ml). Bound material was eluted 
with 0.005M hexylglutathione (elution volume 96-llSml). 
+ 
Fig. 2.12 SDS- PAGE of rat adrenal and ovary ligandin, purified 
according to the standard procedure. Lanes (1) molecular weight 
markers, (2) testis ligandin, (3), (4) and (5) adrenal ligandin (6), 
(7) and (8) ovarian ligandin. See Chapter 2, Section A, Methods and 
Results, for details. 8, 5 and 3 ug of protein were loaded in lanes (3), 
(4) and (5) respectively, as well as in lanes (6), (7) and (8). 
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Both ovary and adrenal ligandin exhibited GSH S-transferase 
activity with CDNB as a substrate. Due to the low concentration of 
ligandin in these tissues, the amount of protein recovered from 
these tissues was usually less than O. lmg I ml. 
COMPARISON OF HUMAN TESTIS LIGANDIN WITH 
HUMAN LIVER LIGANDIN 
In order to determine whether the subunit composition of human 
testis ligandin differed from that found in human liver. Ligandin 
was isolated from the testis and liver of a 40 year-old cadaver, 
following the standard purification procedure. The elution 
profiles from the chromatographic steps are shown in Fig. 2 .14. 
The purification technique used was similar to that for the rat 
except that the pH of the O.OlM Tris.HCl buffer was 8.67 instead of 
8.8. DEAE-cellulose chromatography of the cytosol resulted in a 
broad peak of enzyme activity. After chromatography on Sephadex 
G-100, the CDNB-GSH conjugating fractions were applied to a 
QAE-Sephadex A. 50 column which yielded a single peak of enzyme 
activity. Comparison of purified human testis and human liver 
ligandin by means of SDS-PAGE showed that both consisted of 
identical subunits with molecular weights of 23500 (Fig. 2.15). 
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Fig. 2 .14 Purification of ligandin from the 100000 g supernatant 
of human testis. (A) Elution of protein from DEAE-cellulose in 
O.OlM Tris.HCl buffer pH 8.67. (B) Elution of protein from 
Sephadex G-100 in O.OlM sodium phosphate buffer pH 7.4 / O.lM NaCl. 
(C) Purification of the CDNB-enzyme active peak on QAE-Sephadex 
A-50 in O.OlM Tris.HCl buffer pH 8.67. Fractions pooled at each 
stage of purification are indicated by the horizontal bars ( see 
Methods and Results for details). 
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Fig. 2.15 SOS-PAGE at each stage of human testis ligandin purifi-
cation. (1) Rat liver ligandin, (2) rat testis ligandin, (3) human 
testis cytosol (10000 g supernatant), (4) protein peak after DEAE-
cellulose chromatography, (5) peak exhibiting GSH-CDNB conjugating 
activity after Sephadex G-100 chromatography, (6) and (8) testis 
protein peak after QAE-Sephadex A-50 chromatography, (7) human liver 
ligandin. Samples were loaded and prepared as described in Fig. 2.3. 
THE DIFFERENT GSH S-TRANSFERASE FORMS OF RAT LIVER, 
TESTIS AND OVARY 
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The finding that ligandin from the steroid-producing tissues 
consists predominantly of the Y c subunit remains unexplained. The 
possibility that a substance other than ligandin may contribute to 
this electrophoretic finding and to the differences in function 
attributed to testis ligandin was investigated. The other GSH 
S-transferases are closely related to ligandin in the rat liver, 
with similar molecular weights and overlapping substrate speci-
ficities. Therefore, these proteins were the most likely to 
provide a contaminating factor during purification. Prior to this 
study, the different GSH S-transferase forms which might be present 
in the testis, ovary and adrenal gland had not been investigated. 
The different GSH S-transferase and GSH peroxidase II forms found 
in testis and ovary will be detailed in this section. In order to 
compare the different testis and ovary GSH S-transferases with the 
GSH S-transferase forms found in liver, a similar procedure, 
described by Habig et al (1974b) was adhered to. 
Evidence is presented here which suggests that testis ligandin may 
be contaminated with another GSH S-transferase, namely GSH 
S-transferase AA. 
Elution of Rat Liver GSH S-transferases from CM-cellulose 
CM-cellulose chromatography resolved liver DEAE-cellulose eluate 
into five peaks of GSH S-transferase activity (GSH-CDNB conjugating 
activity) similar to those described by Habig et al (1976). 
Fig. 2. 16 shows the peaks obtained. Peak 1 (elution volume 
Fig. 2 .16 Elution pattern from CM-cellulose of liver DEAE-
cellulose eluate at pH 6. 7. GSH S-transferase activity was 
assayed with 1-chloro-2. 4-dinitrobenzene ( CDNB, 0) and L 2-dichloro-
4-nitrobenzene (DCNB, e). Enzyme activity is expressed as umol/min 
per ml. GSH peroxidase II activity was assayed with curnene hydro-
peroxide (curnene.OOH, • ) as substrate. Results were expressed as 
umol of cumene.OOH/rnin, by using the absorbtion coefficient (£) for 
NADPH of 6 x 103 litre.mo1-l.cm-l. Ligandin as measured 
by anti(liver ligandin) radioimmunoassay is expressed as ng of 
ligandin/tube (.6.). The KCl gradient was started after peak 1 had 














































































































































































































































































































































































32-70ml) represents material that did not bind to the column at pH 
6.7. Following initiation of the salt gradient (0-120mM KCl) a 
further four peaks were obtained; peak 2 (elution volume 
465-530ml), peak 3 (530-600ml), peak 4 (600-660ml) and peak 5 
(680-735ml). Only peaks 2 and 4 had GSH-DCNB conjugating activity. 
GSH peroxidase II activity with cumene.OOH as substrate was present 
in peak 5 and to a lesser extent in peaks 3 and 4. GSH peroxidase 
I activities were not measured in these experiments. Immuno-
reactivity determined by radioimmunoassay with antibody raised 
against liver ligandin was limited to peak 3. Details of the 
radioimmunoassay procedure will be presented in Section B of 
Chapter 2. 
Using the terminology of Jakoby et al (1976) based on elution 
volume from CM-cellulose and substrate specificities, peaks 1, 2, 
3, 4 and 5 are believed to be GSH S-transferase D and E, C, B, A 
and AA respectively. Hayes et al (1980) have determined the 
monomer composition of rat liver GSH S-transferases eluted from 
CM-Sephadex by means of SOS-PAGE. Transferases D and E contain 
proteins migrating as Y c and Yb, transferases A and C subunits 
migrated as Yb, transferase B as both Ya and Ye, while transferase 
AA migrate as Ye only. SOS-PAGE analysis of the peaks eluting from 
CM-cellulose revealed similar subunit compositions (results not 
shown). 
Elution of Rat Testis GSH S-transferases from CM-cellulose Fig. 
2 .17 shows the results of a similar experiment with testis DEAE-
cellulose eluate. Peak 1 (elution volume 40-50ml) represents 
GSH-CDNB conjugating activity that does not bind to the column at 
pH 6. 7. Four peaks of GSH-CDNB conjugating activity were obtained 
Fig. 2. 17 Elution pattern from CM-cellulose of testis DEAE-
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after initiation of the salt gradient; peak 2 (elution volume 
460-530ml), peak 3 (530-600ml), peak 4 (600-660ml) and peak 5 
(690-780ml). DCNB activity was limited to peaks 2 and 4. GSH 
peroxidase II activity (cumene.OOH as substrate) was present 
largely in peak 5, with additional activity measured in peaks 3 and 
4. Immunoreactivity determined by radioimmunoassay using 
anti-liver YaYa ligandin was present in fractions eluted between 
480 and 600ml. No significant immunoreactivity was detected in 
peak 5. SDS-PAGE of the immunoreactive peak revealed equal amounts 
of the Ya and Ye subunits. Peak 5 contained a major band in the Ye 
region. 
Chromatography of 'Purified' Testis Ligandin on CM-cellulose 
Chromatography of 'purified' testis ligandin yielded two peaks of 
GSH-CDNB conjugating activity. Only peak 1 contained immuno-
reactive material as determined by radioimmunoassay by using 
antiserum raised against liver YaYa ligandin. SDS-PAGE of peak 1 
material revealed equal amounts of Ya and Ye subunits; peak 2 
consisted entirely of Ye subunit (Fig. 2.18). 
Elution of Hat Ovary GSH S-transferases from CM-cellulose 
CM-cellulose chromatography of 100000 g supernatant fraction of rat 
ovary could be resolved into 4 peaks and a shoulder of GSH-CDNB 
conjugating activity (Fig. 2 .19). Peak 1 (elution volume 8-25ml) 
had considerable GSH-CDNB conjugating activity and represents 
material that does not bind to the column at pH 6. 7. Following 
initiation of the salt gradient (0-120mM KCl) peak 2 eluted as a 
shoulder of peak 3 (total elution volumes 122-142ml), peak 4 eluted 
between 142 and 165ml, and peak 5 eluted between 165 and 190ml. 
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Fig. 2 .18 CM-cellulose chromatography of "pure" testis ligandin 
at pH 6. 7. The KCl gradient (0 - 120 mM) was started at the 
beginning of the column run. GSH S-transferase activity was 
assayed with CDNB (0----0) and expressed as umoles/min/ml. GSH 
peroxidase II activity was assayed with cumene hydroperoxide 
(cumene.OOH) and expressed as umoles/min ( a---a ). Radioimmuno-
assay with anti-liver ligandin measured ng ligandin/tube ( ~). 
Comparisons of the standard preparation of testis ligandin ( 1), and 
fractions from each peak (2), (3), on SDS-PAGE is shown. 
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Fig. 2. 19 Elution pattern from CM-cellulose of rat ovary cytosol 










































































































































































































































































































































































between 127 and 140ml and between 145 and 165ml. 
GSH peroxidase II activity (cumene.OOH as substrate) was measured 
in peaks 4 and 5 and to a lesser extent in fractions eluting 
between 126 and 140ml. Immunoreactive material (measured with 
anti-liver YaYa ligandin radioimmunoassay) was present in peak 3 
(elution volume 130-145ml). SDS-PAGE analysis of the immunoreac-
tive peak revealed 2 bands consisting of equal amounts of Ya and Ye 
subunits. SDS-PAGE of peak 5 revealed a band in the Ye region. 
Chromatofocusing of Testis Hexylglutathione Material 
Re-chromatography of testis hexylglutathione material (Fig. 2 .11, 
peak 2) on a chromatofocusing column resulted in the elution of 
several peaks exhibiting CDNB-GSH conjugating activity as shown in 
Fig. 2.20. The first peak (eluting between fractions 15 and 22) 
had an isoelectric point of approximately 8. 5 and consisted of both 
Ya and Ye subunits on SDS-PAGE, with Ye present in greater 
quantities (Fig. 2. 21). This peak ehibited GSH peroxidase activity 
with cumene.OOH as substrate. The Ya and Ye subunits on SDS-PAGE 
diminished as the isoelectric point of the fractions decreased. A 
band with molecular weight corresponding to that of Yb was present 
in these fractions. 
The chromatofocusing polybuffer used here stains with Coommassie 
Blue on the SDS-polyacrylamide gels. Several washes with 10% TCA 
before staining will remove most of the polybuffer, except for 
areas at the front of the gel where the acrylamide concentration is 
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Fig. 2.20 Separation of the basic testis GSH S-transferases by 
chromatofocusing. Hexylglutathione-bound material from testis 
cytosol was eluted with a pH gradient, pH 9.4-8.0. GSH S-trans-
ferase activity was assayed with CDNB as substrate (0) and was 
expressed as umol/min/ml. GSH peroxidase II activity was assayed 
with cumene.OOH as substrate ( •), with the results expressed as 
umol/min. 
+ 
Fig. 2. 21 SDS- PAGE of the basic testis GSH S- transferases 
isolated by means of chromatofocusing. Lanes; (2), testis 
cytosol before hexylglutathione affinity chromatography (Fig 2 .11, 
peak 2), (4) to (14), fractions 19, 21, 23, 25, 28, 30, 32, 34 and 
38 eluting from the chromatofocusing column (Fig. 2.20). (1) and 
(15) are the molecular weight markers. 
105 
(e) Discussion 
Liver ligandin, as defined by Bass et al (1977a), consists of 
equal amounts of Ya and Ye. In contrast the Ye subunit accounts 
for as much as 90% of testis ligandin (Bhargava et al 1980a, 
Bass et al 1977a). Using the standard purification procedure, 
a protein with subunit structure, amino acid composition, binding 
characteristics and GSH S-transferase activity similar to that 
described by Bhargava et al (1980a) was purified. These 
workers found testis ligandin to have a lower affinity for 
bilirubin and BSP than liver. Circular dichroism spectra revealed 
absence of the primary binding site for bilirubin (Bhargava et 
al 1980a). 
When testis ligandin was prepared using affinity chromatography 
with anti-liver YaYa antiserum, it consisted of equal amounts of Ya 
and Ye. This was clearly different to testis preparations obtained 
by the standard purification procedure. The testis starting 
material contained more Ye than Ya (Fig. 2.8, lane 1). A 
considerable amount of Ye was eluted in the wash (lanes 2 and 3), 
suggesting that this may not have been recognised by the antibody. 
The immunoreactive material eluted using glycine buffer pH 3.0 
consisted of equal amounts of Ye and Ya (lane 4) resembling the 
proportions of these subunits found in liver ligandin. In addition 
antibodies raised against testis ligandin prepared by standard 
methods did not meet immunodiffusion and immunoelectrophoretic 
criteria for purity when tested against liver cytosol. Further-
more, SDS-P AGE of covalently cross-linked testis ligandin showed 
more than one band in the 50000 dalton region. 
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This finding differed from that reported by Bhargava et al 
(1978a) who noted only one band on SDS-PAGE for DMS cross-linked 
liver ligandin. Therefore another subunit combination in DMS 
cross-linked testis ligandin preparations exists, differing from 
that obtained with liver ligandin. This may be due to the presence 
of an additional protein in standard testis preparations. 
The view that standard preparations of testis ligandin could be 
contaminated by a closely related protein was strengthened by the 
findings of Hayes et al (1980) and Scully and Mantle (1980) who 
studied the subunit composition of liver GSH S-transferases. The 
GSH S-transferases of rat liver (AA, A, B, C, D and E) have been 
classified according to their reverse order of elution from 
CM-cellulose (Habig et al 1976). Transferases D and E elute 
before the salt gradient is applied after which transferase C, B, 
A, and AA elute sequentially . Whilst there is overlap of substrate 
specificity the various tradferases may be identified by their 
" order of elution from CM-cellulose and their ability to conjugate 
GSH to various substrates, they all conjugate CDNB. Only A and C 
conjugate GSH to DCNB (Habig et al 1974b), while GSH 
S-transferase B, A and AA have GSH peroxidase activity (Prohaska 
and Ganther 1977b, Lawrence et al 1978, Irwin et al 1980). 
On SDS-PAGE liver GSH S-transferase AA migrated as Ye, liver 
transferase B migrated as YaYc, while transferases A and C, which 
show immunological identity (Habig et al 1974b), migrated as 
Yb. This finding led Hayes et al (1979) to differentiate 
between GSH S-transferase B (Ya Ye) and ligandin (YaYa). Since this 
study has been aimed at determining the subunit composition of a 
protein in testis which reacts immunologically with anti-liver 
ligandin, the term ligandin has been used throughout, although in 
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the light of these findings the term GSH S-transferase B may be 
more appropriate. 
Purified ligandin (following the standard procedure, Fig.1.6) from 
rat ovaries and adrenals consisted of more Ye than Ya on SDS-PAGE, 
similar to testis ligandin preparations. To determine whether 
testis and ovary GSH S-transferase AA migrated as Ye, the testis 
and ovary GSH S-transferases were separated by CM-cellulose 
chromatography and the order of elution, SDS-PAGE, radioimmunoassay 
and catalytic activity with different substrates were used to 
characterise the various fractions. CDNB and DCNB activity 
resembled that seen in liver. GSH peroxidase activity was found in 
peaks corresponding to liver GSH S-transferases B, A and AA. Of 
interest is the fact that transferase AA acounts for most of the 
GSH peroxidase II activity in testis cytosol. SOS-PAGE of the 
testis and ovary CM-cellulose peak with the elution characteristics 
of transferase AA revealed a major band in the Ye region, similar 
to that reported by Scully and Mantle (1981) for testis 
preparations. This peak was not recognised by antibody raised 
against liver Ya Ya ligandin. Immunoreactivity was confined to 
fractions eluting in the GSH S-transferase B region of the 
CM-cellulose profile. On SDS-PAGE this peak consisted of equal 
amounts of Ya and Ye. GSH S-transferases from adrenal cytosol 
exhibited very low activities with all the substrates tested. Thus 
similar CM-cellulose profiles from this tissues could not be 
obtained. 
It was apparent that if GSH S-transferase AA was present in 
standard preparations of ligandin it would not be detected on 
SOS-PAGE. CM-cellulose chromatography was therefore used to study 
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"pure" testis ligandin and it was found to consist of GSH 
S-transf'erase B (equal amounts of Ya and Ye, recognised by antibody 
raised against liver YaYa) and GSH S-transferase AA (which 
resembles Ye on SDS-PAGE). The finding that standard preparations 
of testis ligandin are contaminated by GSH S-transferase AA offers 
a new explanation for studies previously reported and interpreted 
differently. 
Difference spectroscopy data showed bilirubin binding with standard 
testis preparations. This may be due to the Ya subunit. High 
affinity binding for bilirubin (Bhargava et al 1978b) and for 
cholic acid (Hayes et al 1981) has been associated with Ya. 
GSH S-transferase AA (YcYc) has a very low affinity for bilirubin 
(Ketley et al 1975) and its presence in these testis prepara-
tions would not contribute to binding. 
S-hexylglutathione affinity chromatography, a technique described 
by Guthenberg and Mannervik (1979) for preparing GSH S-transferases 
of rat liver and lung, was used to investigate the different enzyme 
forms of the testis GSH S-transferases. Material from testis 
cytosol which bound to this column was shown to consist of several 
bands on SDS-PAGE migrating between 25000 and 22000 daltons 
mole~ular weight. As very little enzyme activity eluted with the 
unbound material, most of the testis GSH S-transferase forms should 
be present in the bound peak (Fig. 2.11). Separation of these 
enzyme forms can be achieved by hydroxyapatite chromatography, or 
by isoelectric focusing. These methods do not provide satisfactory 
separation of the different enzyme forms. Application of a newly 
described technique, chromatofocusing (a combination of ion-
exchange chromatography and isoelectric focusing) (Sluyterman and 
Elgersma 1978), resulted in several peaks of CDNB-GSH conjugating 
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activity. The first, most basic peak eluting from the chromato-
focusing column displayed GSH peroxidase activity with cumene 
hydroperoxide as substrate. SDS-PAGE analysis of the peaks eluting 
from the chromatofocusing column showed a combination of the 3 
subunits Ya, Yb and Ye in differing amounts. The Ye subunit 
predominated in fractions which displayed the highest isoelectric 
point, with Yb present at lower isoelectric points. It is 
interesting to note that the Ya Y c composition of the first peak 
resembled that obtained by standard purification procedures (Ye 
greater than Ya) previously defined as 'testis ligandin'. 
Further characterisation of these peaks would be required in order 
to establish identity with respect to Habig's classification of the 
GSH S-transferases eluting from CM-cellulose (Habig et al 
1976). Hayes et al (1979) used CM-Sephadex to separate the 
liver GSH S-transferase forms and found that order of elution 
differed. This new approach of chromatofocusing may reveal the 
presence of other previously undescribed forms of GSH 
S-transf erases. 
Thiol-Sepharose affinity chromatography achieved separation of the 
YaYa liver ligandin homodimer from the YaYc heterodimer. These 
species are separable by means of the cysteine residues which are 
present on the Ye subunit. Bhargava et al (1980b) reported 
similar findings. Testis ligandin (more Ye than Ya) could not be 
separated in this way as all the material bound to the column. 
There does not appear to be any evidence of a YaYa species in 
testis preparations. 
During the course of this study other workers in the field have 
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made contributions which may have altered original ideas and 
concepts. It is now possible that homodimeric ligandin is another 
GSH S-transferase present in the liver in addition to heterodimeric 
GSH S-transferase B. The presence of this Ya Ya species in other 
tissues has not yet been demonstrated. Although Hayes et al 
(1981) using tryptic-digest peptide 'maps', have suggested that the 
Ya subunits of the homodimer (YaYa) and the heterodimer (YaYc) in 
liver are identical, it is possible that differences between the Ya 
subunits of other tissues exist. A similar argument can be used 
for the Y c subunits of GSH S-transferases AA and B. Differences 
occurring during preparation of liver ligandin using the standard 
purification procedure may well result in the co-purification of 
GSH S-transferase AA, as is the case in the testis. 
Very recently Kitahara and Sato (1981) have shown that an 
immunological relationship exists between GSH S-transferase AA 
(YcYc) and GSH S-transferase B (YaYc). The anti-YaYc antiserum 
used by these workers recognised antigenic determinants on both 
YaYa and YcYc homodimers, while the anti-YaYa antiserum showed 
identity with only YaYa and YaYc. This finding would explain why 
immunoaffinity experiments (Chapter 2, Section A) using anti-YaYa 
ligandin only reacted with the YaYc species while YcYc washed 
through the column, and why the GSH S-transferase AA peak, eluting 
from CM-cellulose, showed no significant reaction with anti-YaYa 
ligandin antiserum used in the radioimmunoassay. 
The question arose as to whether liver and testis ligandin from 
human tissues differed on SDS-PAGE following their purification 
according to the standard procedure. SDS-PAGE of material eluting 
from the final QAE-Sephadex chromatography step resulted in a 
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single band of molecular weight 23500, identical to that obtained 
with human liver ligandin (Fig. 2.15). Even though the amino acid 
composition, immunological characteristics and subunit molecular 
weights of the 5 cationic human liver ligandin species have been 
shown to be identical (Kamisaka et al 1975), they each exhibit 
differing substrate specificities (Table 1. 7). Human liver and 
testis ligandin may differ in this way and it would be necessary to 
carry out further studies in order to completely characterise and 
compare these two preparations from differing sources. 
Chromatography of testis cytosol on Sephadex G-75 results in an 
additional second large peak of GSH peroxidase II activity (Fig. 
1.10). Although Prohaska and Ganther (1977b) suggested that the 
GSH S-transferases exhibit peroxidase activity, they did not 
identify which testis GSH S-transferases might be responsible. The 
results presented in Chapter 2, Section A indicate that GSH 
S-transferases AA, A and B have GSH peroxidase II activity (cumene 
hydroperoxide as substrate) in the testis with transferase AA 
contributing to the majority of this activity. 
Although GSH peroxidase II activity is relatively high in both the 
ovaries and testis, the functional significance of these proteins 
in the gonads is unknown. It has been suggested that the GSH 
S-transferases play an important protective role in preventing 
damage to germ cells by xenobiotic compounds (Mukhtar et al 
1978c), alternatively the enzyme may prevent damage caused by high 
concentrations of endogenous steroids (Bannikov and Tchipyseva 
1978). The rat epididymis, site of spermatozoa! maturation, as 
well as the vas deferens, display GSH S-transferase activity 
towards CDNB (Hales et al 1980) (see Table 1. 5). The relative 
I 
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activity of GSH S-transferase B was highest at the site of the 
epididymis-vas deferens where most spermatozoa gain their 
fertilizing capacity. Significant GSH S-transferase activity with 
CDNB, BPO and SO was also found in rat, mouse and human semen 
(Mukhtar et al 1978c). The hormonal regulation of these 
enzymes may thus be of key significance in understanding the 




DEVELOPMENTAL AND INDUCTION STUDIES OF LIGANDIN IN THE 
STEROIDOGENIC TISSUES OF THE RAT 
{a) Introduction 
Ligandin is present in high concentrations in the steroid 
synthesising tissues of the rat where it has been claimed to 
influence intracellular accumulation and efflux of steroid hormones 
and their metabolites (Smith and Litwack 1980). The developmental 
pattern of ligandin in these steroid producing tissues is therefore 
of interest, particularly during the neonatal and pubertal period. 
In this study the emphasis has been placed on ligandin rather than 
the other GSH-transferases because of the availability of a sensi-
tive and specific radioimmunoassay developed in our unit, and 
because we believed that a comparative study of the ontogeny of 
ligandin in steroidogenically active and non-steroidogenically 
active tissues might shed light on the role of this multifunctional 
protein in these tissues. 
The maturation of the GSH S-transferases in the liver and kidney 
has previously been investigated by several workers and GSH 
S-transferase activity towards CDNB, immunoprecipitable by 
anti-GSH S-transferase B antiserum, has been examined by Hales and 
Neims (1976a). The developmental pattern of epoxide metabolising 
enzymes in rat testis, ovary and adrenal have been described 
(Mukhtar et al 1978a, b) but these measurements represent the 
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total activity of several GSH S-transferases and thus may not have 
bearing on the development of ligandin in the newborn and pubertal 
rat. 
This study provides the specific developmental pattern of immuno-
reactive ligandin in the steroidogenic tissues of the rat, in 
correlation with the corresponding circulating levels of serum 
steroid hormones (testosterone and progesterone, Fig 2.22) in these 
animals. Attempts to stimulate gonadal and adrenal ligandin 
concentrations with phenobarbital and testis ligandin with various 
hormones were carried out. 
The radioimmunoassay which was used for quantitating ligandin 





















The reagents were purchased as follows: 
125-Iodine and 1,2,6,7,[N]-3H Testosterone, used without 
further purification, were obtained from the Radiochemical Centre, 
Amersham, Buckinghamshire, England. 
Donkey anti-rabbit serum from Wellcome Reagents, Ltd., Beckenham, 
England. 
Testosterone, progesterone, Norit A Charcoal (purified) and 
Dextran T-70 were obtained from Sigma. 
Gelatin and Chloramine T was supplied by BDH. 
Toyo 514 Chromatography paper was from Toyo Kagaka Sangyo Co. 
Ltd., Tokyo, Japan. 
Rabbit anti-progesterone, 11-alpha-bovine serum albumin was 
obtained from Miles Laboratories (Pty) Ltd., Goodwood, South 
Africa. 
Falcon Plastic Tubes No. 2052 was from Div. Bee ton, Dickenson -and Co. Cockeysville, MD, 21030, USA. 
Human chorionic gonadotrophin (HCG), Human menopausal gonado-
trophin (HMG) were from Propan Ethicals (Pty) Ltd., Goldbree, 
334 Bree St. Johannesburg. 
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Dexamethasone sodium phospate from Merck Sharp and Dohme Park, Old 
Pretoria Main Rd, Halfway House 1685, South Africa. 
Phenobarbitone sodium from Maybaker (S.A.) (Pty) Ltd., 21 McHardy 
Ave, Port Elizabeth, South Africa. 
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(c) Methods 
Animals and Treatments For the developmental study Long-Evans 
rats aged 4, 9, 21, 36, 48 and 60 days were used. Liver, kidney, 
testis and adrenals were removed from male rats and ovaries from 
female rats. Serum was obtained from male and female rats aged 4, 
9, 21, 24, 37, 44, 49, 57 and 75 days. Animals aged 21 days and 
over were bled by means of cardiac puncture, while younger animals 
were bled by decapitation. All serum specimens were stored at 
-20°C, until assayed for steroid hormones. 
Ovaries, placenta and serum of pregnant female rats were collected 
at 4, 12, 16 and 20 days gestation. 
Preparation of Cytosol The procedure for preparation of cytosol 
has been detailed in Section A of this chapter. The adrenals, 
ovaries and tissues from newborn animals were homogenised in 2 ml 
of buffer. Details of the dilutions used are found in legends to 
the figures. 
Phenobarbital Induction Rats aged 4, 20 and 60 days were injected 
with 8mg/ 100g of phenobarbitone subcutaneously at approximately 
0900hrs each day for 5 days. Control rats were injected with 
saline. 
Hormone Induction Immature male rats (26 days) were injected with 
0,4 mg Dexamethasone sodium phosphate, lOOIU HCG and lOIU human 
menopausal gonadotrophin (HCG, 5IU FSH and 5IU LH) in 50ul saline 
( 0 .15M) per testis with a 26 gauge, short bevel needle. Control 
animals were injected with 50ul saline ( 0 .15M). Injections were 




(i) Preparation of Radio-labelled Ligandin 
Rat liver ligandin was purified as described in Section A of 
Chapter 2. High specific activity 1251-ligandin was prepared 
according to the method of Greenwood et al (1963) as modified 
by Bass et al (1977b). Using a small glass tube (2 x O. 5cm) 
the following reactants were mixed at room temperature in the 
following order using E-mil constriction pipettes: 
lOul (lmCi) carrier free 1251, 
25ul O. 5M sodium phosphate buffer pH 7 .4. 
The following reactants were then added (in the same phosphate 
buffer, diluted 1:10) with mixing: 
25ul (10-15ug) of ligandin, 
25ul (25ug) of chloramine-T and after reaction had proceeded for 
30 seconds, 
lOOul (50ug) sodium metabisulphite was added to terminate the 
reaction. 
After addition of 200ul (2mg) of cold carrier iodine in the form of 
potassium iodide, the entire contents of the reaction vessel were 
mixed with 500ul of 0.3M Tris HCl buffer, pH 8.67 / 0.1% bovine 
serum albumin and applied to a combined gel filtration ion exchange 
chromatography column. The column (0.5cm diameter) was packed to a 
height of 4-5cm with TEAE-cellulose and overlaid with 25cm of 
Sephadex G-25, equilibrated with 0.03M Tris HCl buffer pH 6.67 and 
adjusted to a flow-rate of 18-20ml/hour. Fractions of 0.6ml were 
collected. 
Assessment of the iodination was necessary in order to establish 
the extent of the dama 
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In order to accomplish this the following two procedures were 
carried out : 
Cl) Trichloroacetic acid (TCA) precipitation: 
5ul of the reaction mixture, or 20ul of purification column 
fractions (peak fractions 10, 19 and 35, from Fig. 2.23) were added 
to 1ml of 0.05M sodium phosphate buffer pH 7 .4 I 0.1% BSA, followed 
by addition of 1ml of 10% TCA with mixing. The mixture was 
incubated for 30 minutes at 4°C and was centrifuged. Radioactivity 
of the supernatant (500ul) and the precipitates were separately 
counted. The results of the procedure were expressed as the 
percentage of total counts present in the precipitate. 
(2) Chromatoelectrophoresis (Berson et al 1956). 
The various purification fractions were subjected to chromato-
electrophoresis performed on 3, 5 x 50cm strips of Toyo 514 paper 
using 5ul bovine serum albumin as carrier and Bromophenol Blue as a 
marker of damaged protein (Bass et al 1977b). Intact or 
undamaged 1251-ligandin remained at the origin, while the 
damaged labelled protein migrated with the bromophenol blue and 
free 1251 migrated ahead of the damaged protein. Sections of 
the chromatoelectrophoresis strips were cut, placed in Falcon tubes 
and counted. The intact protein was expressed as a percentage of 
the total radioactivity present. 
The 1251-ligandin was diluted with diluent buffer to give 
approximately 20000 cpm / 200ul before use in the assay. The 
labelled protein was stored for not longer than 2 weeks at 4°C. 
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(ii) Ligandin Radioimmunoassay Procedure 
Radioimmunoassay of ligandin from rat tissues was performed 
according to the method of Bass et al (1977b) using mono-
specific rat liver ligandin antisera. 
Preparation of antisera was described in Section A of this chapter. 
The radioimmunoassay procedure was carried out using a double 
antibody method (Morgan and Lazarow 1963) which separated the 
antibody-bound from free labelled antigen. High specific activity 
1251 rat liver ligandin was prepared as previously described. 
Falcon plastic tubes (12 x 75mm) were used in the assay. 
In order to determine the optimal anti-ligandin dilutions for the 
assay, incubation of serial dilutions of rabbit anti-liver ligandin 
antiserum with constant amounts of 1251 liver ligandin 
according to standard assay protocol were carried out. Bleeds 10 
days after each booster were tested. The dilution which demon-
strated 50% of maximum binding of the traces in the absence of 
unlabelled ligandin, ie the antibody titre, was used in the assay. 
In addition, optimisation of the non-immune rabbit serum and donkey 
anti-rabbit globulin dilutions was carried out by using constant 
concentrations of one reagent and varying the other. This was 
determined for each new batch of donkey anti-rabbit serum, as 
inter-batch variations were noted. Non-immune rabbit serum was 
used in a dilution of 1:400 and donkey anti-rabbit serum in a 1:20 
dilution for all assays carried out. 
lmmunochemical displacement curves were constructed by means of 
serial dilutions of liver and testis ligandin assayed using 
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labelled liver ligandin and anti-liver ligandin antiserum. These 
dose response curves were linearised by logit/log transform using 
the relationship: 
logit (Y)=a + b loge(X), [where Y=B/Bo, the ratio of bound 
counts (B) to counts bound in the absence of unlabelled antigen 
(B 0 ), with both B and B0 corrected for non-specifically bound 
(NSB) counts], 
logit (Y)=loge (Y/1-Y) 
a is the intercept and b is the slope of the linearised curve, 
while X is the dose of unlabelled antigen. 
All determinations were performed in duplicate. Dilutions were 
made using a diluent buffer comprising 0.5M sodium phosphate buffer 
pH 7.4 / 0.15MNaC1 / O.OlMEDTA I 0.5% bovine serum albumin/ 0.1% 
sodium azide. 
The assay procedure consisted of the consecutive addition of the 
following: 
(1) 200ul diluent buffer 
(2) 200ul sample or standard 
(3) 200ul ligandin antisera 
(4) lOOul non-immune rabbit sera 
(5) 200ul labelled ligandin 
The reagents were mixed and incubated for 24 hours at 4°C after 
which lOOul donkey anti-rabbit serum was added with mixing. 
Following a further 24 hour incubation period at 4°C, the tubes 
were centrifuged at 2000 g for 30 minutes at 4°C in a Sorvall RC-3B 
refrigerated centrifuge. Supernatants were decanted and tubes 
drained for 10 minutes care being taken to ensure that the opaque 
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pellet was not dislodged. Counting was performed as previously 
described and the data recorded on paper tape for transfer to a 
computer file. 
After determination of radioactivity the data were processed on a 
Univac series 1100 system computer using the Rodbard-Faden RIA-RUN 
programme (Rod bard 197 4). This programme fits the standard curve 
of the assay to a linear function from which "potency estimates" of 
the unknowns can be derived. Statistical analysis of several 
criteria of assay performance, provided by this programme, was 
carried out. Assays with criteria falling more than two standard 
deviations from the mean were discarded and repeated. 
Each assay incorporated the following protocol: 
Total counts - 4 tubes containing labelled protein only. 
Bo (maximum binding) 4 tubes with no standards or 
unknowns added. 
NSB (non specific binding) 4 tubes with no 
anti-ligandin antibody added. 
Standards 22 tubes (11 duplicates) containing known 
Samples 
concentrations of unlabelled pure ligandin 
prepared as follows: the protein concentration 
estimated to be 1.5mg/ml, a 3000ng/ml stock 
solution was prepared (600ng/ 200ul) and diluted 
accordingly to provide standards of 600, 300, 
75, 37.5, 18.75, 9.38, 4.69, 2.34, 1.17 and 
0.59ng/200ul. 
Up to 200 tubes containing unknown samples, 
in differing dilutions 
Internal 
Standards 
1: 5000 and 1: 1000 dilutions of known 
concentrations of ligandin, used in every assay 
for inter-assay comparisons. 
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(iii) Extraction of Sera for Testosterone Radioimmunoassay (Millar 
and Kewley 1976) 
Extraction of sera was carried out as follows; serum aliquots 
(lOOul) were pipetted into 10ml glass stoppered tubes. 3tt 
testosterone (approximately 2000cpm in lOOul) was added to each 
tube for internal recovery estimations, and left overnight to allow 
equilibrium binding of 3tt testosterone to serum proteins. After 
addition of lOOul of concentrated ammonium hydroxide, the serum 
samples were extracted by shaking for 5 min with 6ml diethyl ether. 
The aqueous phase was rapidly frozen in aq_etone / solid CO2 
mixture and the ether layer poured off and evaporated to dryness at 
45°C under nitrogen. 400ul of O.OlM sodium phosphate buffer pH 7.0 
/ 0.15M NaCl / 0.1% sodium azide / 1% methanol solution (PBS / 1% 
methanol) was added to the tubes and mixed. lOOul was taken for 
scintillation counting to estimate the recovery, and the remainder 
used for assay. 
(iv) Testosterone Radioimmunoassay Procedure 
Duplicate lOOul aliquots of standard testosterone (0.0156 0.03139 
0.625 0.125 0.25 0.50 and 1.0 p moles/lOOul) and serum extracts 
in the methanol phosphate buffer were pipetted into 12x75mm glass 
test tubes. lOOul of specific antiserum to testosterone (produced 
by immunising rabbits with testosterone-3-carboxymethyl oxime-
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bovine serum albumin conjugate intradermally) diluted in PBS / 0.1% 
gelatin was added, the tubes vortexed and left for 30 min at room 
temperature. After addition of lOOul of 3H testosterone (app-
roximately lOOOOcpm) the tubes were again vortexed and incubated 
overnight at 4°C. The tubes were then placed in an ice bath and 
500ul of dextran-coated charcoal, removed from a continuously 
stirring beaker, pipetted into the tubes. After standing for 
10 min the tubes were centrifuged at 2000 g for 10 min in a 
Sorval RC-3B centrifuge, and the supernatant poured into counting 
vials with scintillant and the radioactivity counted. 
All calculations were carried out using the computer data proces-
sing system for radioimmunoassays of Rodbard (1974). 
% B = sample mean x 100 
S=reading interpolated from standard curve. 
nanomoles/litre = (S)(cpm total recovery)(l03) 
(sample vol)(cpm sample recovery) 
(iv) Extraction of Sera and Procedure for Progesterone Radio-
immunoassay (Abraham et al 1971). 
A similar extraction procedure was followed to that previously 
described for the testosterone radioimmunoassay, excepting that 
lOOul of 3tt-progesterone (approximately lOOOcpm) was added to all 
tubes, and 6ml of petroleum ether (between 40°C-60°C) was added 
to each tube. The tubes were then stoppered and extracted by 

























supernatant organic phase was decanted off into clean 10ml tubes 
and evaporated to dryness at 40°C under nitrogen. 800ul of benzene 
was added to the tubes and thoroughly mixed. lOOul was taken for 
recovery estimation of the organic solvent extraction efficiency 
into scintillation vials and lOOul pipetted in duplicate into 
Wasserman tubes. The contents of the Wasserman tubes were 
evaporated to dryness at 40°C under nitrogen and lOOul of PBS / 1% 
methanol pipetted into each tube, and the tubes vortexed. 
Duplicate lOOul of progesterone standard (0.2, 0.5, 1, 2, 5, 10 
nanomoles I litre) in PBS / 1% methanol was pipetted out into 
Wasserman tubes. lOOul of progesterone antiserum (rabbit 
anti-progesterone, 11-alpha-bovine serum albumin) diluted in PBS, 
0 .1 % gelatin was added, and the tubes vortexed and incubated for 30 
min at room temperature. After addition of lOOul of 
3H-progesterone (approximately 10000 cpm) the tubes were again 
vortexed and incubated overnight at 4°C. The assay procedure then 
followed the same steps for charcoal treatment, centrifugation, 











RAT LIVER YaYa LIGANDIN RADIOIMMUNOASSAY 
Rat Liver Ligandin Iodination The elution profile of the iodina-
tion reaction mixture chromatographed on Sephadex G-25/TEAE-
cellulose is shown in Fig. 2. 23. Three peaks of radioactivity were 
apparent and an aliquot from each peak tube was assessed by TCA 
precipitation and chromatoelectrophoresis. Table 2.4 lists the 
results obtained from a typical iodination of rat liver ligandin. 
The first peak consists almost entirely of TCA precipitable protein 
and was shown by means of chromatoelectrophoresis to remain at the 
origin. These results suggest that peak 1 contains mainly intact 
protein. The percentage obtained of TCA precipitable protein as 
well as the results obtained from chromatoelectrophoresis suggests 
that peak 2 and 3 consists largely of damaged protein and free 
iodine respectively. 
Mean data obtained from chromatoelectrophoresis and TCA precipita-
tion (15 procedures) demonstrated incorporation of 1251 into 
liver ligandin to be 42%. The specific activity of 1251-
liver ligandin was estimated to be 35uCi/ug. 
FRACTION TCA% CHROMA TOELECTROPHORESIS% 
Intact Damaged Free 
Reaction mixture 32.8 25 38 37 
9 99.8 99.4 0.1 0.5 
19 8.2 5 80.4 14.6 
35 1.6 0.4 2.6 97 
Table 2.4 - Purification of Iodination Reaction Mixture by Gel-
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Fig. 2. 23 Purification of 1251 ligandin by Sephadex G-25/ 
TEAE cellulose chromatography. The iodination mixture was 
purified according to details described in Chapter 2, Section B, 
Methods. 
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Determination of First Antibody Titre for Radioimmunoassay Serial 
dilutions of rabbit anti-liver YaYa ligandin antiserum bound by a 
constant amount of 1251-liver ligandin are shown in Fig. 
2.24. Antiserum 1234/10/04 exhibited 50% of maximum binding at an 
initial dilution of 1:40000, while following a booster inoculation, 
antiserum 1234/ 29 / 04 exhibited 50% of maximum binding at a dilution 
of 1:80000, demonstrating a rise in titre (the "titre" of antiserum 
is that demonstrating binding of 50% of tracer). 
At an initial dilution of 1:800 antiserum 1817/10/04 bound 95% of 
freshly prepared 1251-liver YaYa ligandin, while antisera 
1234/10/04 and 1234/29/04 only bound 70% of label at this dilution. 
Thus antiserum 1817/10/04 was used for all subsequent assays. 50% 
of the tracer was bound at an initial dilution of 1: 12000. 
Parallelism of the Standard Curves The standard curve obtained by 
addition of increasing amounts of unlabelled liver YaYa ligandin to 
tubes containing constant amounts of anti-liver YaYa ligandin and 
1251-labelled liver Ya Ya ligandin, was shown to be identical 
to a curve obtained when unlabelled testis ligandin replaced liver 
ligandin (Fig. 2. 2 5). 
Characteristics of the Assay The characteristics of the assay 
were similar to those obtained by Bass et al (1977b). The 
percentage of total 125I-ligandin bound in the absence of 
anti-liver ligandin antiserum averaged 2. 8 ±_ 0. 2% (mean + SEM) in 
10 consecutive assays. Interassay variation over 10 consecutive 
assays for testis ligandin samples were 50.4 ±_ 2.3 ng/tube (1: 1000 
dilution) and 15.1 + 0.6 ng/tube (1:3000 dilution) both values, 
mean + SEM, with coefficients of variation 9.3% and 8.8% respec-
tively. The minimal detectable dose averaged 1.54 + 0.16 ng/ml 
(mean + SEM) and the slope of the standard curve averaged -0. 78 + 
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Fig. 2.24 Antiserum dilution curves of rabbit anti-YaYa ligandin 
antiserum. Serial dilutions of antisera harvested from rabbit 
1234 following the first and second booster inoculations, and 
antiserum from rabbit 1817 following second booster inoculations, 
were incubated with constant amounts of 1251-labelled liver 
ligandin. The standard radioimmunoassay procedure described in 
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Fig. 2. 25 Ligandin radioimmunoassay standard curves. These 
were obtained when liver YaYa ligandin and testis ligandin was 
added to the liver ligandin radioimmunoassay according to the 
procedure described in Chapter 2, Section B. On the ordinate is 
the percentage ratio of antibody-bound radioactivity to 
radioactivity bound in the absence of unlabelled ligandin (% B/Bo) 
and on the abscissa (log scale), · the amount of unlabelled 
ligandin. 
LIGANDIN AND SERUM HORMONE LEVELS IN RELATION TO 
DEVELOPMENT OF THE RAT 
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Ligandin levels were measured in rat tissue using the anti-liver 
YaYa ligandin radioimmunoassay in steroid-producing tissues of rats 
at 4, 9, 20, 31, 46 and 60 days postpartum. 
Testicular Ligandin Concentration During Development The develop-
mental pattern of testicular ligand in is shown in Fig. 2. 26. 
Relatively high concentrations of ligandin expressed as micrograms/ 
milligram of supernatant protein were present at 4 days. By 9 days 
the relative concentration of ligandin had decreased to low levels. 
These levels then rose sharply during puberty (30-40 days), and 
then increased gradually until 60 days of age. Serum testosterone 
levels (expressed as nanomoles/litre) paralleled those of ligandin 
(Fig. 2. 26) • 
Ligandin concentration expressed as micrograms per wet weight of 
tissue exhibited a similar pattern of change (Fig. 2.30). 
Adrenal Ligandin Concentration During Development Ligandin concen-
tration at 4 days was shown to be relatively high when expressed as 
micrograms/milligram of supernatant protein (Fig. 2.27). These 
values decreased by 9 days and thereafter increased sharply during 
puberty reaching a plateau between 46 and 60 days. 
Measurements of adrenal ligandin expressed per wet weight of tissue 
are shown in Fig. 2. 30. Ligandin levels decreased between day 4 
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Fig. 2.26 Postnatal development of rat testis ligandin and serum 
testosterone levels. Ligandin is expressed as micrograms-
/ milligram su~ernatant protein in 100000 g testis supernatant. For 
4-day-old animals 6 testes were pooled, for 9-day-old animals 9 
testes were poooled, for 20- and 31-day-old animals 6 testes were 
pooled and for 46- and 60-day-old 2 testes from the same animal 
were pooled. Each point represents the mean + SEM of six 
individual determinations at each time interval studiea. The serum 
testosterone is expressed in nanomoles/litre, and was taken from 
male animals at 4, 9, 21, 24, 37, 44, 49 and 75 days postpartum. 
Each point represents the mean + SEM of six individual 
determinations. 
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Fig. 2. 27 Postnatal development of rat adrenal ligandin. 
Ligandin is expressed as micrograms/milligram of supernatant 
protein, in 100000 g adrenal supernatant. For 4-, · 20- and 
30-day-old animals 6 adrenals were pooled, for 9-day-old animals 9 
adrenals were pooled and for 46- and 60-day-old animals 2 adrenals 
from the same animal were pooled. Each point represents the mean + 
SEM of six individual determinations at each time interval studied'7 
Only adrenals from male animals were used. 
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Ovarian Ligandin Concentration During Development There was an 
initial decline of ovarian ligandin (ug/mg protein) between 4 and 9 
days of age, followed by a rapid increase between 20 and 40 days 
which gradually levelled off at about 50 days (Fig. 2. 28). This 
pubertal rise, was closely paralleled by an increase in serum 
progesterone levels (Fig. 2.28). Once again, when the ligandin 
levels were expressed as micrograms per wet weight of tissue (Fig. 
2.30) the pattern was similar to that shown in Fig. 2.28. 
Liver and Kidney Ligandin Concentration During Development In 
order to compare the developmental pattern of ligandin in steroido-
genic and non-steroidogenic tissues measurements were made using 
the same system in liver and kidney. Hepatic and renal ligandin 
development differed from that of testis, ovary and adrenal. At 
birth hepatic ligandin was low, increasing to approximately 50% of 
adult values by 20 days, and thereafter showing a progressive rise 
to 60 days (Fig. 2.29, ug hepatic ligandin/mg protein; Fig. 2.30, 
ug hepatic ligandin/wet weight of tissue). 
Renal ligandin levels were also low at birth, but increased rapidly 
at 21 days and levelled off at 31 days, after which they increased 
gradually to 60 days of age (Fig. 2. 29). 
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Fig. 2. 28 Postnatal development of rat ovary ligandin an~ serum 
progesterone levels. Ligandin is expressed as micrograms/ 
milligram supernatant protein, in 100000 g ovary supernatant. 
Four-day-old values are from a single pool of ovaries from 10 rats. 
For 9-day-old animals 8 ovaries were pooled, for 20- and 31-day-old 
animals 6 ovaries were pooled, and for 46- and 60-day-old animals 2 
ovaries from the same animal were pooled. Each point represents 
the mean + SEM of six individual determinations at each time 
interval studied. "l'he serum progesterone is expressed in 
nanomoles/litre and was taken from female animals at 4, 9, 21, 24, 
37, 49, 57 and 75 days postpartum. Each point represents the mean 
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Fig. 2. 29 Postnatal development of rat liver and kidney ligandin. 
Ligandin is expressed as micrograms/milligram supernatant protein. 
For 4- and 9-day-old animals 2 livers were pooled. Livers of older 
animals were assayed individually. Values are means of six individ-
ual determinations + SEM. Renal ligandin values were determined in 
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POSTNATAL DEVELOPMENT OF RAT BODY AND TISSUE WEIGHT 
Other parameters of maturation, including total body weight and the 
weight of the various tissues studied, are all summarised in Figs 
2.31 to 2.32. 
OVARIAN LIGANDIN CONCENTRATION AND ENZYMATIC ACTIVITY 
DURING PREGNANCY 
Table 2. 5 shows the results of assays performed on pregnant ovaries 
at different stages of gestation. Ligandin levels in the early 
stages of pregnancy showed no significant changes compared to 
non-pregnant controls. By 16 and 21 days ligandin concentration 
had decreased. This was contrasted by a significant rise in GSH 
S-transferase specific activity (approximately 70%) towards CDNB by 
mid-pregnancy (12 days), relative to non-pregnant rats. GSH 
peroxidase specific activity (cumene hydroperoxide as substrate) 
showed a 91% increase at 12 days compared to controls with enzyme 
specific activity declining by 21 days gestation. Serum proges-
terone levels doubled by 4 days gestation, increased during the 
course of pregnancy and decreased sli.ghtly just before birth. 
EFFECT OF PHENOBARBITAL ON LIGANDIN CONCENTRATION 
DURING DEVELOPMENT 
The effect of phenobarbital treatment on liver, testis, ovary and 
~drenal ligandin concentration in developing rats is shown in Table 
2. 6. A significant increase in hepatic ligandin for each time 
interval studied was associated with phenobarbital treatment, while 
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Fig. 2. 31 Postnatal development of male and female rat body 
weight. For day O and 4, 14 animals were used. Thereafter 6 
animals were used for each tested age. 
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Fig. 2. 32 Postnatal development of male rat liver weight and male 
rat body weight (A) (details of male rat liver weight data were 
as in Fig. 2. 31). Postnatal development of rat testes weight and 
male rat body weight (B). Testes from 14 animals at 4 days 
were used. Thereafter testes from 6 individual animals were used 
at each time point studied. Postnatal development of rat ovary 

























































































































































































































































































































































































































































































































































































































TISSUE DAY CONTROL* PHENOBARBITAL-* 
TREATED 
Liver 4 12.29+0.41 20.03+1. 78 
20 12.62+0.64 26.68+2.37 
60 24. 66+1.3 33.96+3.35 
Testis 4 0.2 +0.03 0.2l+o.04 
20 0.06+0.0l 0.07+0.00 
60 0.18+0.0l 0.16+0.0l 
Ovary 4 0.17+0.0l 0.17+0.0l 
20 0.15+0.0l O.ll+o.02 -
60 0.45+0.03 0.44+0.05 
Adrenal 4 0.36+0. ll 0.36+0.09 
20 0.19+0.03 0.2o+0.04 
60 0.38+0.04 0.38+0.05 
Table 2.6 Effect of phenobarbital on immunoreactive ligandin 
concentration during development. Tissues from 3 animals were 
pooled for each 4-day-old and 20-day-old determination and tissue 
from the same animal were pooled for the 60-day-old animals. 
*Ligandin expressed as micrograms/milligram supernatant 
protein, all values represent the mean + SEM of six individual 
determinations at each time interval studied. 
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EFFECT OF VARIOUS HORMONES ON LIGANDIN CONCENTRATION 
AND ENZYME ACTIVITY OF IMMATURE RAT TESTIS. 
The effect of the gonadotrophins, HCG, HMG and dexamethasone on 
testis ligandin concentration and GSH S-transferase activity in 26 
day-old rats, 36 hours after hormonal injection is shown in Table 
2. 7. GSH S-transferase activity with CDNB as substrate was 
significantly increased by administration of H CG and HMG at a dose 
of lOOIU and lOIU per testis respectively, although ligandin 
concentration when expressed per mg of supernatant protein was not 
significantly increased. 
TREATMENT CDNB LIGANDIN 
umol/min/mg ug/mg 
protein protein 
CONTROL o. 56 + 0.05 1.54 + o. 084 
DEXAMETHASONE 0.67 + 0.04 1.31 + 0.21 
HMG 0.89 + 0.04** 1.60 + 0.14 
HCG 1.01 + 0.17* 1.70 + 0.12 
Table 2. 7 Effect of various hormones on ligandin concentration, 
and GSH S-transferase activity in immature rat testis. The 
values represent mean + SEM of 5 individual determinations. 
Significant differences from controls shown by *P < O. 005 and 
**P < O. 01. Testes from 2 rats were used for each determination. 
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Discussion 
Developmental studies, using radioimmunoassay, provided data which 
may elucidate the role of ligandin in steroidogenically active 
tissue. Previous ontogenetic studies of ligandin in these tissues 
are limited to qualitative immunocytochemistry (Bannikov et al 
1979) using immunofluorescent techniques and to studies of enzyme 
activity with substrates known to react with several species of GSH 
S-transferases (Mukhtar et al 1979a, b). Consequently, prev-
iously available information regarding ligandin maturation in the 
steroid-producing tissues of the rat is insufficient to allow for 
any conclusions. 
The characteristics of the rat ligandin radioimmunoassay used here 
were similar to those obtained by Bass et al (1977b). Non-
specific binding of 1251-ligandin was minimal, as was cross-
reactivity with other intracellular proteins. The sensitivity of 
the binding assay (minimal detectable concentration) was capable of 
measuring less than 1 ng/tube. The anti-liver YaYa ligandin 
antiserum used in the assay (1817/10/04) had the highest affinity 
of all the antisera tested. Thus the assay was considered to be 
sufficiently sensitive and specific for the studies undertaken. 
Several points of interest were noted with development of adrenal 
and gonadal ligandin in the rat. Firstly, relatively high levels 
of ligandin (ug ligandin per mg soluble protein) were present soon 
after birth, dropped during early life and rose with the onset of 
puberty. This pattern of development was similar when values 
obtained were expressed per wet weight of tissue. Secondly, a 
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close relationship was shown to exist between testicular ligandin 
and serum testosterone concentration and between ovarian ligandin 
and serum progesterone concentration during the developmental 
period. 
A different pattern was observed when liver and kidney ligandin 
maturation was compared to that of the steroidogenic tissues, ie 
concentrations were low soon after birth, rose to 50% of adult 
values by approximately 25 days and then increased progressively to 
reach adult values by 60 days. These results for liver and kidney 
ligandin agree with the findings of Bass ( 1977). Baars et al 
(1980) demonstrated that rat liver GSH S-transferase activities 
towards CDNB and SO are low at birth and develop regularly during 
the first 5 postnatal weeks, thus exhibiting a pattern similar to 
that of rat liver ligandin maturation. The development of hepatic 
and renal ligandin has been claimed to be related to the maturation 
of organic anion transport mechanisms (Kirsch et al 1975). 
Phenobarbital pre-treatment of neonatal, prepubertal and adult rats 
showed an increase in hepatic ligandin concentrations at each stage 
of development, while adrenal and gonadal ligandin concentrations 
were not affected. 
Ligandin in the testis is present mainly in the interstitial cells 
(Chapter 2, Section C), which is the principal site of steroido-
genic activity and also considered to be the major source of 
androgen production. The possibility exists that testicular 
interstitial or Leydig cell development may bear a relationship to 
the maturation of ligandin in this tissue. Two distinct phases of 
Leydig cell activity have been described during development. The 
first consists of foetal cells which peak in number shortly after 
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birth and then regress and disappear. The second phase is seen 
during puberty and persists into adult life (Christensen 1975). 
Histological and physiological studies have confirmed the existence 
of a quiescent interval between the neonatal and pubertal period 
during which Leydig cell activity is markedly diminished (Niemi and 
Ikonen 1963, Knorr et al 1970). These phases of Leydig cell 
activity parallel the changes in ligandin concentration and testos-
terone secretion during development. 
In humans serum testosterone levels parallel the decline of foetal 
Leydig cells (Forest et al 1973). Similarly in rats, serum 
testosterone levels are high at the end of foetal life and for the 
first few days of neonatal life. Thereafter testosterone levels 
drop and remain low until puberty (approximately 4 weeks) at which 
stage they increase abruptly to reach adult levels (Moger and 
Murphy 1977, Steinberger et al 1979). The results presented in 
this chapter are in accordance with these observations. The loss 
of foetal Leydig cells mirrors the loss of the foetal zone of human 
adrenal cortex. Recently Paz et al (1980) have shown that, 
although there is a quiescent period of steroidogenic activity in 
the rat testis during the 3rd to 5th week of life, the Leydig cells 
are still capable of responding to HCG from foetal life through to 
adulthood. The cells of the seminiferous tubules may also be 
capable of significant steroid synthesis, although the products and 
their functions may differ from those of Leydig cells (Lacy 1973). 
In the data presented here, the effect of the gonadotrophins, HCG, 
and HMG (FSH and LH) on immature rat testis, showed that these 
hormones are able to significantly increase GSH S-transferase 
activity with CDNB as substrate. LH and HCG act on the Leydig 
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cells of the testis causing an increase in steroidogenesis and 
intratesticular injection of HCG has been shown to stimulate mRNA 
synthesis in the Leydig cells (Reddy and Villee 1975). FSH and 
pregnant mare serum gonadotrophin (PMSG) which mimics the actions 
of FSH, act on the seminiferous tubules causing an increase in 
general protein synthesis (Means and Hall 1968). Activity of the 
enzyme glucosamine 6-phosphate synthase in immature rat testis was 
increased following intratesticular injection of PMSG, while HCG 
and LH had no effect, suggesting that this enzyme is present only 
in the seminiferous tubules (Rukmini and Reddy 1981). As ligandin 
has been localised immunohistochemically to the interstitial cells 
of the testis (Chapter 2, Section C), stimulation of enzyme 
specific activity by HCG provides additional evidence regarding the 
distribution of this protein. 
The results of the pregnant rat ovary study indicated that the GSH 
S-transferase and GSH peroxidase specific activities increase until 
mid-pregnancy (9-12 days) was reached. GSH S-transferase activity 
towards CDNB remained high until the 16 day measurement, decreasing 
by 21 days, while GSH peroxidase activity decreased earlier. This 
increase in ovarian enzyme activity during pregnancy did not 
correlate with relative ligandin concentration measured in the same 
specimens. Another GSH S-transferase form may be responsible for 
the increased enzyme activity. lmmunocytochemical studies present-
ed in Chapter 2, Section C, although not quantitative, suggest that 
GSH S-transferase AA may be induced during pregnancy and be 
responsible at least in part for the increase in enzyme activity 
with both CDNB and cumene hydroperoxide. 
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GSH S-transferase activities towards CDNB in the placenta at 
mid-pregnancy is found to be much higher (0.09 umoles/min/mg 
protein) than in the full-term placenta (0.047 umoles/min/mg 
protein) (Polidoro et al 1981b). The decline in GSH 
S-transferase and GSH peroxidase activity in the later stages of 
gestation suggest a progressive decrease in importance of this 
enzyme system in the placenta (Polidoro et al 1981b) and, as 
was shown in these studies, in the ovary. 
The present findings show a close association between steroid 
activity and ligandin concentration in testis, ovary and adrenal 
during development. Although the specific role of ligandin and the 
GSH S-transferases in steroidogenically active tissue is not known, 
this correlation indicates that these proteins may be involved in 




IMMUNOCYTOCHEMICAL STUDIES LOCALISING LIGANDIN IN THE 
STEROID-PRODUCING TISSUES OF THE DEVELOPING RAT 
(a) Introduction 
The presence of ligandin in appreciable amounts in testes, ovaries 
and adrenals at different stages of development has been 
demonstrated by means of radioimmunoassay (Chapter 2, Section B). 
Although several workers using the immunofluorescent technique have 
confirmed the presence of ligandin in the liver, kidney, small 
intestinal mucosa (Fleischner et al 1977), and more recently in 
the rat gonad cells (Bannikov and Tchipyseva 1979), others working 
in the field have failed to demonstrate the presence of ligandin in 
the rat steroid-producing tissues (Arias 1981). Localisation of 
ligandin in the rat adrenal or placenta has not been achieved. 
The purpose of this immunocytochemical study was to localise 
ligandin in the cells of the endocrine tissues of the maturing rat 
using an indirect immunoperoxidase sandwich method, a technique 
which has the potential for avoiding some of the shortcomings of 
the immunofluorescence method (Taylor 1978). This method which can 
be used on formalin fixed, paraffin-embedded tissues has a 
sensitivity estimated to be 100 to 1000 times that of immunofluore-
scence. The antibody selectively localises the tissue antigen 
under investigation (Fig. 2.33 - Stage (1)). Instead of visual-
ising this reaction by labelling the antibody directly (as in the 
immunofluorescence technique), visualisation is achieved by 
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using a second specific antibody (swine, antirabbit IgG) (Fig. 2.33 
- Stage ( 2)), and utilising the bivalence of I gG which can then 
bind to the rabbit IgG of the PAP-immune complex (consisting of 
rabbit antibody to horseradish peroxidase and horseradish peroxi-
dase antigen) (Fig. 2. 3 3 - Stage ( 3)). Thereafter bound peroxidase 
is reacted with its substrates, hydrogen peroxide and diaminoben-
zidine. Enzyme action forms the insoluble polymeric oxidation 






tissue antigen X 
Y,abbit anti-X 
y excess swine 
antirabbit lgG 
peroxidase-rabbit 
anti peroxidase complex ( PAP) 
Fig. 2.33 Peroxidase antiperoxidase (PAP) immune complex method. 
Stage 1: diluted antiserum from rabbit species specific to tissue 
constituent X. Stage 2: excess of antiserum to IgG of rabbit, 
produced in swine species. Stage 3: PAP-complex. Stage 4 (not 
shown): Localisation of peroxidase site demonstrated by means of 
chromogenic substrate, diaminobenzidine tetrahydrochloride-hydrogen 
peroxide. Adapted from Sternberger 1974. 
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(b) Materials 
Normal swine serum, swine anti-rabbit IgG and PAP-complex were 
purchased from Dako Immunoglobulins Ltd., 22, Guldborgvej, 2000 
Copenhagen F, Denmark. H202 and 3,4',3', tetraminobiphenyl-
hydrochloride (3-3 diaminobenzidine) were obtained from BDH. 
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(c) Methods 
The indirect peroxidase-antiperoxidase (PAP) method was used to 
locate ligandin in buffered formalin fixed, paraffin-embedded rat 
tissues. The method (Fig. 2.33), described in detail by Taylor 
(1978), consists of the following steps. Sections were dewaxed and 
taken into absolute alcohol, followed by blocking in both 0, 3% 
H202 in methanol for 30 minutes, and exposure to 1: 20 dilution 
of normal swine serum for 15 minutes. Sections were then incubated 
for 30 minutes at room temperature (24°C) with antiligandin at a 
1:200 dilution which gave no background staining. Various dilution 
and incubation times were tested, the above giving the most consis-
tent and comparable results. This was followed by incubation in 
1: 20 swine antirabbit IgG for 30 minutes at room temperature and 
then PAP complex for 30 minutes at room temperature. Sections were 
washed for 30 minutes in buffer A between each step on a magnetic 
stirrer. 
Buffer A (0,05M phosphate/ 0.14M NaCl pH 7.4), was used for all 
dilutions and washes. The colour reaction was developed for 5 
minutes in a solution of 5mg 3-3 di-aminobenzidine in 10ml Buffer A 
to which 0, 1ml of 1% H202 was added. After washing for 15 
minutes, sections were counter-stained with Mayers haematoxylin, 
dehydrated in alcohol, cleared in Xylol and mounted with Canada 
Balsam. 
Uninoculated rabbits from the colony provided non-immune control 
sera which were diluted in the same way. 
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Besides using a non-immune control serum, certain agents were 
omitted eg antisera or PAP from the staining schedule to see if a 
non-specific reaction occurred between any of the reagents and the 
tissue. All proved to be negative. As a final control the anti-
ligandin was absorbed with purified ligandin. The absorbed serum 
showed no specific staining. 
Two antisera, anti-liver ligandin (YaYa) antiserum (rabbit 1234) 
and anti-testis "ligandin" antiserum (rabbit 255) were used at 
similar dilutions (1: 2 00) • 
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(d) Results 
PAP - STAINING WITH ANTI-LIVER LIGANDIN ANTISERUM 
Immunocytochemical preparations using a specific antiserum to liver 
ligandin and the peroxidase-anti peroxidase (PAP) technique (Fig. 
2. 34) showed sparse staining of hepatocytes from 4-day-old rat 
livers, the rest of the tissue remaining negative. By 20 days 
postpartum a stronger, more diffuse staining was evident, partic-
ularly at the edge of the portal tract. At 60 days the adult liver 
tissue showed a strongly positive, brown reaction product, the 
intensity of staining for ligandin increasing from the central vein 
to the portal tract. 
All the tissue sections in which the anti-liver ligandin antiserum 
was replaced by non-immune control serum showed no brown colour at 
all (Fig. 2.36). 
The seminiferous tubules of neonatal testis appeared solid with the 
epithelium composed principally of Sertoli cells, while the 
surrounding interstitium was more cellular than that seen in adult 
sections (Fig. 2. 34, lB) • Specific staining was not evident at 
this stage of development. Sections of early pubertal testis (20 
days) contained larger seminiferous tubules, separated by a slight 
amount of interstitial, connective tissue containing groups of 
Leydig cells (Fig. 2.34, 2B). No reaction product was seen. By 60 
days positive staining was present, but was limited to the 
interstitial cells (3B). 
Early neonatal adrenal tissue did not show any specific staining in 
the glomerula r, fascicular and reticular zones of the adrenal 
Fig. 2.34 PAP-staining with anti-liver (YaYa) ligandin 
antiserum, of liver (A) . testis (B) . adrenal (C) 
and ovary (D) in neonatal (1) . pubertal (2) . and 
adult (3) rats. Magnifications of lA and lB x 600; lC, 
2A. 2B. 2c. 2D, 3C and 3D x 60; 3A and 3B x 150. See Chapter 
2, Section C for details. 
.. 
1 2 3 
D 
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cortex or in the medulla (lC). Pubertal and adult adrenal cortex 
show equivocal staining only (2C and 3C). 
No staining was evident in the prepubertal ovary (lD). Weakly 
positive staining of the stromal cells surrounding the follicles 
and corpus luteum was present in mature adult ovaries (3D). Preg-
nant ovary showed a similar response with this antibody, while 
placental tissue (not shown) was negative. 
PAP - STAINING WITH ANTI-TESTIS LIGANDIN ANTISERUM 
Antiserum raised against standard preparations of testis 
"ligandin", described in Chapter 2, Section A, was also used for 
imm unocytochemical studies. 
The intensity of staining was studied in various tissues using the 
PAP technique and the anti-testis ligandin antiserum (Fig. 2. 35). 
The liver showed faint non-specific staining at 4 days of age ( lA). 
By 20 days, however, a uniform light-brown stain of the hepatocytes 
was noted, with slightly darker staining at the portal tract edge 
(2A). At 60 days of age, the liver showed a strongly positive 
stain which was slightly darker in the cells surrounding the 
central vein (3A). 
4-day-old testis showed slight staining of the interstitial cells 
(lB). At 20 days scattered staining of these cells could be seen 
(2B), and by 60 days very dense staining of the interstitial cells 
was observed ( 3B). The seminiferous tubules remained negative. 
Fig. 2.35 PAP-staining with anti-testis ligandin antiserum, 
of liver (A), testis (B); adrenal (C) and ovary 
(D) in neonatal (1), pubertal (2) and adult 
(3) rats. (E), placenta and (F), ovary of a 
pregnant rat at 12 days gestation. Magnifications of lA, lB 
and Ex 600; lC, 10, 2A, 2B, 2C, 20, 30 and F x 60; 3A, 3B, 
and 3C x 150. 
F 
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4-day-old adrenal glands showed specific staining of the capsule 
and diffuse staining of the reticular zone of the cortex (lC). By 
30 days distinct staining was seen extending from an area immedi-
ately beneath the glomerular zone, through the fascicular zone to 
the reticular cells of the cortex (2C). The medulla did not stain. 
In the adult adrenal gland there was dense staining of the cortex 
but not of the medulla (3C). 
Staining of the stromal cells of the ovary was just discernable by 
9 days. The immature follicles were negative (lD). At 20 days, 
reaction product was present in the stromal cells surrounding the 
developing follicles (2D). A similar pattern with increased 
intensity was found in the adult ovary (3D). In the pregnant ovary 
the stromal cells stained with an even greater intensity, and for 
the first time a faint, diffuse staining was seen in the corpus 
luteum (F). 
·The clear trophoblast cells of the placenta showed slight staining 
with the anti-testis ligandin antiserum (E). 
Fig. 2. 36 PAP-staining with non-immune control serum of 
neonatal liver (A) (x 600), adult testis (B) (x 60), 
adrenal (C) and ovary (D). 

FOOTNOTE TO FIGS 2.34 AND 2.35 
Note: The histology slides were filed and stored in the dark. 
After storage for one year, it was noted that the brown reaction 
product had faded considerably. The mounting solution, Canada 
Balsam, which is an acidic, natural product, may have contributed 
to this occurrence. Use of a synthetic, neutral mounting medium 
would be more advisable. 
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(e) Discussion 
Karavanova et al (1980), using immunofluorescent techniques 
found ligandin to be uniformly distributed in the liver of foetal 
and newborn rats. By 4 days postpartum the number of ligandin 
positive cells had decreased sharply. Their data suggests adult 
liver lobule formation is complete by the 14th day postpartum, at 
which stage synthesis of ligandin abruptly increases. Campbell 
et al (1980) showed positive staining of isolated hepatocytes 
in a 16mm-long human foetus, while heavier staining of numerous 
hepatocytes was observed in a larger 50 mm foetus. 
Livers of 1-day-old rats were examined (results not shown) using 
anti-liver YaYa ligandin and the PAP technique. Staining for 
ligandin was similar to that seen in 4-day-old livers. The 
immunocytochemical studies of ligandin in rat liver at different 
stages of development (Figs 2. 34 and 2. 3 5), correlates with the 
radioimmunoassay measurements of liver ligandin (Chapter 2, Section 
A) during maturation. These findings support the studies done by 
Fleischner et al (1976), Hales et al (1976a) and Bass et 
al (1977b), which show ligandin concentration to be considerably 
lower in the neonatal rat than in the adult animal. This may be 
related to the functional capacity of the liver to handle organic 
anions which only develops after the first week of life. A 
gradient of ligandin-positive cells increasing from the periportal 
to the centrilobular areas of the liver is seen in Fig. 2.34, 2A, 
a finding similar to that of Karavanova et al (1980). 
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It is not intended here to compare the PAP reaction product of 
anti-liver ligandin antiserum with that of anti-testis ligandin 
antiserum, but rather to compare the reaction which takes place in 
the different tissues with the individual antiserum. The two 
antisera, although used at the same dilution and antibody titre, 
have different affinities and specificities. Even antisera raised 
against the same antigen, in different rabbits, may have different 
properties. Therefore the only comparisons which are valid are 
those in pattern and intensity of staining of different tissues 
with the same antiserum. The reaction of anti-liver ligandin 
antiserum in adult hepatic tissue is strongly positive, while its 
reaction in the steroid-producing tissues is weak. Normal adult 
kidney and intestine show strong staining with this antiserum (not 
shown). Thus antiserum raised against liver ligandin appears to 
react strongly with tissues involved in storage and transport 
(liver, kidney and gut) while steroid-producing tissues evoke a 
weak response. 
A different pattern is observed when antiserum raised against 
testis "ligandin" is used. The substance which reacts with this 
antiserum is distributed diffusely in the hepatic tissue, while a 
selective, intense reaction is observed in the steroid-producing 
tissues of testis, ovary, adrenal and placenta. The reaction 
is seen in developing tissues soon after birth, increasing 
progressively in intensity during maturation. Examination of the 
reactions of this antiserum with kidney and gut sections revealed 
relatively little staining (not shown). Therefore, the anti-testis 
"ligandin" antiserum behaves differently to the anti-liver ligandin 
antiserum in that the steroid-producing tissues are strongly 
positive, while a weaker response is seen in the liver, kidney and 
gut. 
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These immunocytochemical studies were carried out before it was 
established that standard preparations of testis ligandin contain 
another GS H S-transf erase (Chapter 2, Section A). It can, there-
fore, be assumed that anti-testis ligandin antiserum has been 
raised against both ligandin (YaYc) and GSH S-transferase AA 
(YcYc), and this must be considered when attempts are made to 
interpret these findings. 
A radioimmunoassay for GSH S-transferase AA has not yet been 
established. No published studies are available which describe the 
tissue distribution of this protein. Results obtained in Chapter 
2, Section B show that GSH S-transferase AA is a major basic 
transf erase of testis and and ovary, and may thus account for the 
intense staining seen in the testis, ovary, pregnant ovary and 
perhaps adrenal sections. 
Immunocytochemical studies do not provide quantitative results and 
can only show the distribution of the protein in question and its 
concentration relative to other tissues, provided sections were 
prepared under identical conditions. This technique is probably 
not as sensitive as radioimmunoassay which is able to detect very 
low concentrations of protein. It is therefore not surprising that 
the radioimmunoassay using anti-liver ligandin antiserum was able 
to detect ligandin in neonatal steroidogenic tissues (Chapter 2, 
Section B) while immunocytochemical techniques using this antiserum 
were probably not sensitive enough to detect the low concentrations 
found in these tissues. These immunocytochemical studies did 
demonstrate that the increased concentration of ligandin, measured 
by radioimmunoassay, in cytosol prepared from whole-organ homoge-
nates at different stages of development, is due to increased 
amounts of ligandin in specific cell types. 
Chapter 3 
CONCLUDING DISCUSSION 
AND DIRECTION FOR FUTURE STUDIES 
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CONCLUDING DISCUSSION 
The use of the term Ligandin to describe several, distinct proteins 
has resulted in considerable confusion. It would appear that 
different tissues and different methods of isolation do not 
neccessarily give rise to the same protein with the same subunit 
composition. This study attempted to provide insight into these 
anomalies by making use of various purification techniques and by 
studying other tissues where ligandin is present in appreciable 
quantities. Initially, comparisons between liver preparations and 
those obtained from steroidogenic tissue (testis, ovary and 
adrenal) isolated by the standard procedure, indicated that there 
were differences in subunit composition. Further studies however, 
showed that identity betweeen liver ligandin and testis ligandin 
existed, indicating that previously described differences (Bhargava 
et al 1980a) were not valid since an extra chromatographic step 
produced a protein with equal amounts of Ya and Ye which reacted 
with anti-liver ligandin YaYa. 
In the course of this study the different enzyme forms of the GSH 
S-transferases were investigated by affinity chromatographic 
techniques including S-hexylglutathione bound to epoxy-activated 
Sepharose. In addition the GSH S-transferases were separated using 
a chromatofocusing technique which, when refined, may reveal the 
presence of additional, previously undescribed forms of these 
enzymes. 
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Different combinations of the Ya, Yb and Y c subunits give rise to 
the multiple forms of the GSH S-transferases which differ in 
isoelectric point and substrate specificity. The overlapping 
specificities displayed by the different transferases may be 
accounted for by the presence of certain of the subunits in several 
peaks. Structural characterisation of these proteins has contri-
buted to the understanding of the many catalytic and binding 
functions attributed to them. 
All organs and tissues are potential targets for environmental 
toxins. Such exposure could be particularly critical in the testis 
and ovary since it may result in increased frequency of germ cell 
mutations and result in genetically-linked disease. Rat testis 
contains high levels of ligandin and the GSH S-transferases. 
Although there is no reported evidence linking these proteins to 
androgen metabolism or activity, there are several possible roles 
for ligandin in the steroidogenic tissues. Firstly it may act as a 
low affinity, high capacity binding protein for steroids. Purified 
rat liver ligandin has been shown to bind non-covalently to a wide 
variety of steroids and their metabolites in vitro, including 
estrone, estradiol, cortisol, testosterone, pregnenolone sulphate 
and dihydroepiandrosterone sulphate with association constants 
ranging from 105 to 6 x 105 M-1 (Ketterer et al 1976). 
Ligandin may be capable of binding more steroids in vivo than 
these results indicate. As such, the high levels of ligandin 
contained in the testis may be involved in the transport of 
steroids or the intermediates formed during steroidogenesis. 
Although it would seem plausible that hormone receptors with much 
higher affinities and capacities would be responsible for the 
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binding of steroids, the interstitial tissue of the testis does not 
appear to have specific receptors for these products, unlike target 
tissue of the body. The presence of high affinity binders in the 
steroid-synthesising tissue would retard the passage of hormones 
from their site of production to their site of action. Ligandin 
may be also be involved in the uptake of steroids from the plasma 
to the cell interior. Steroids have affinity constants for human 
serum albumin in the range 104 105 M-1 which is lower 
than that reported for ligandin. This may be a passive process 
where ligandin influences the efflux of steroids from the cell. 
Secondly, ligandin and the GSH S-transferases may be involved in 
either synthesis or metabolism of steroids and other compounds. 
Ligandin has been shown to have delta5-3-ketosteroid isomerase 
activity (Benson et al 1977). In the liver ligandin also has 
been shown to effect the catalysis of prostaglandin endoperoxides 
to prostaglandins F 2 and E2 (Christ-Hazelhof et al 1976). 
A third role for these enzymes in the steroid-producing tissue may 
be to detoxify xenobiotics. The GSH S-transferases are able to 
detoxify reactive electrophiles, thus allowing for excretion of 
these foreign compounds. Another possible enzymatic function woulcl 
be to inhibit lipid peroxidative damage which can be initiated by 
the reactive products of metabolism and oxidation (see Chapter 1, 
Section C). Lipid hydroperoxides can be described as the 
endogenous substrates for the GSH S-transferases which exhibit GSH 
peroxidase II activity. The data presented here have shown that 
gonadal tissue of the rat displays this activity. These proteins 
could therefore play a vitally important protective role in the 
steroidogenically active tissues of the rat. 
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AREAS FOR FUTURE RESEARCH 
It is hoped that the results of this study will stimulate further 
investigations of the function(s) of ligandin in the steroid-
producing tissues. The correlation between steroid hormone 
synthesis and gonadal and adrenal ligandin development could be 
studied further by means of modifying physiological occurences, eg 
by delaying or inducing puberty. The former may be achieved by 
means of hypophysectomy in prepubertal animals, while the latter 
could result from the administration of prolactin or other 
hormones. H ypophysectomies are difficult to perform and 
non-specific changes may complicate interpretation of results. 
Another approach would be to examine the ontogeny of other GSH 
S-transferases in the steroidogenically active tissues and their 
relationship with the development of ligandin. Measurements using 
specific radioimmunoassays for these proteins would provide much 
information. This would require production of monospecific 
antibodies to the individual GSH S-transferases. However, immuno-
logical cross-reactivity which occurs between GSH S-transferases A 
and C and possibly between B and AA, would prevent specific 
quantitation of these transferases in the different tissues. The 
exact nature and distribution of the other GSH S-transferases in 
steroid-synthesising tissues requires further study and will depend 
on their purification and successful antisera production. 
In terms of enzyme function, the relative importance of GSH 
S-transferases B and AA as GSH peroxidases requires further study. 
This additional information may elucidate their role in the 
prevention of lipid peroxidation which could have serious effects 
in reproductive organs. 
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I. One of the main problems in the field of multifunctional proteins such as ligandin is 
the possibility that multiple forms and isoproteins may exist. Because liver ligandin 
[GSH (reduced glutathione) S-transferase 8] consists of equal amounts of Ya 
(22 000 Da) and Y c (25 000 Da) subunits, and testis ligandin, prepared by the standard 
technique of anion-exchange and molecular-exclusion chromatography, contains more 
Ye subunit than Ya, it has been claimed that testis and liver ligandin are different 
entities. 2. We purified testis ligandin by immunoaffinity chromatography and have 
obtained a product identical with liver ligandin (Y c = Ya). This suggests that the 
differences previously described may be due to contamination of testis ligandin by a 
closely related species. In fact sodium dodecyl sulphate/polyacrylamide-gel-electro-
phoretic analysis of testis GSH S-transferases separated by CM-cellulose chromato-
graphy showed that GSH S-transferase AA, present in large amounts, migrated in the 
same region as Ye subunit. 3. Testis ligandin prepared by the standard technique was 
similar to that reported [Bhargava, Ohmi, Listowsky & Arias (1980) J. Biol. Chem. 255, 
724-7271 and contained more Ye subunit than Ya. CM-cellulose chromatography of 
this 'pure' preparation revealed significant amounts of GSH S-transferase AA migrating 
as Y c subunit, in addition to ligandin consisting of equal amounts of Ya and Y c 
subunits. 4. Our studies show that testis ligandin is identical with liver ligandin. 
Previously described differences are due to a contaminant identified as GSH 
S-transferase AA. 
193 
Ligandin is a basic protein (pl 8.9-9.3) present in 
abundance in the livers of all air-breathing verte-
brates studied (Litwack et al. , 19 71 ; Arias et al., 
1976). It has also been described in intestinal 
mucosa, proximal renal tubules and steroid-
producing tissues of the rat (Fleischner et al. , 1972; 
Kirsch et al., 1975; Bass et al. , 1977a). Rat liver 
ligandin has the chemical structure, enzymic ac-
tivity, ability to bind non-substrate ligands and 
immunological properties of GSH S-transferase B 
(EC 2.5.1.18) (Habig et al. , 1974). SDS/ poly-
acrylamide-gel electrophoresis of rat liver ligandin in 
a discontinuous system revealed two non-identical 
subunits, Ya (22000Da) and Ye (25000Da) (Bass 
et al. , 1977a). By using non-denaturing systems 
YaYa and YaYc dimers have been purified (Bass et 
al. , 1977 a; Hayes et al., 1979). It has been suggested 
that ligandin exists as a YaYc heterodimer (Listow-
sky et al. , 1976; Bhargava et al. , 1978) or as a 
mixture of a YaYa homodimer and a YaYc 
heterodimer (Carne et al., 1979). Indeed, Hayes et 
al. ( 1979) distinguish between ligandin (Ya Ya) and 
GSH S-transferase B (YaYc). However, this does 
not explain the finding by Bass et al. (I 977a) and by 
Bhargava et al. ( 1980) that testis ligandin consists 
predominantly of a Ye fraction. We have investi-
gated the possibility that a substance other than 
ligandin may contribute to this electrophoretic 
finding and to the differences in function attributed 
to testis ligandin. Our data suggest that GSH 
S-transferase AA accounts for part of the predomi-
nant Ye band seen on SDS/polyacrylamide-gel 
electrophoresis of testis preparations, that this 
protein is a major contaminant of testis ligandin 
purified by standard techniques, and that testis 
ligandin is made up of equal amounts of Ya and Ye 
subunits and is not different from liver ligandin. 
Abbreviations used: GSH, reduced glutathione ; SDS, 
sodium dodecyl sulphate. 
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Materials and methods 
Chemicals 
NADPH and bovine serum albumin were 
purchased from Miles Laboratories (Pty.) Ltd., 























Goodwood, South Africa. Glutathione reductase 
(Type IV) prepared from yeast was obtained from 
Sigma Chemical Co., St. Louis, MO, U.S.A. 
Cumene hydroperoxide {70% in cumene) was from 
Fluka A.G., Buchs, Switzerland. Complete Freund's 
Adjuvant and Agar Noble were from Difeo Labora-
tories, Detroit, MI, U.S.A. Acrylamide, NN'-methyl-
enebisacrylamide and SDS were from BDH 
Chemicals, Poole, Dorset, U.K. CNBr-activated 
Sepharose 4B was from Pharmacia, Uppsala, 
Sweden. Donkey anti-rabbit globulin was from Well-
come Reagents, Beckenham, Kent, U.K. 125I was 
from The Radiochemical Centre, Amersham, Bucks., 
U.K. Dimethyl suberimidate, 2HCI was from Pierce 
Chemical Co. , Rockford, IL, U.S.A. All reagents 
used were of analytical grade. 
Purification of ligandin 
Ligandin was purified from the liver and testis of 
Long-Evans rats (250-300 g) as described by 
Kirsch et al. {1975) and Bhargava et al. (1980). In 
brief, cytosol prepared by centrifugation at I 00 000 g 
for 120min was obtained from 100g of rat tissue, 
was dialysed against 0.01 M-Tris/HCI, pH 8.8 (buffer 
A), and chromatographed on a column of TEAE-
cellulose (triethylaminoethyl-cellulose) in buffer A. 
The single protein peak eluted was pooled, concen-
trated (Amicon cell, PM-10 membrane) and 
chromatographed on a column of Sephadex G-100 
in 0.01 M-sodium phosphate buffer (pH 7.4)/0. J M-
NaCI. Fraction~ exhibiting enzyme activity with 
J-chloro-2,4-dinitrobenzene were pooled, concen-
trated, dialysed against buffer A and chromato-
graphed on a column of QAE-Sephadex (quaternary 
aminoethyl-Sephadex) A-50 in buffer A. The single 
protein peak eluted was pooled and stored at 4°C. 
Polyacrylamide-gel electrophoresis 
Polyacrylamide-gel electrophoresis in 0.1 % SDS 
was performed on vertical slab gels (Laemmli, 
1970). The system comprised a 3% (w/v) stacking 
gel {3cm x 14cm x 0.2cm) in 0.14M-Tris/ HCI buf-
fer , pH6.8 , and a 5- 25% (w/v) gradient gel 
(20cm x 14cm x 0.2cm) in 0.56M-Tris/ HC1 buffer, 
pH 8.8. Samples were prepared as described by 
Maize! {1971). Gels were fixed and stained for 2.5h 
in 10% (v/v) trichloroacetic acid/ 1.0% Coomassie 
Brilliant Blue R in methanol/water ( 1: 2, v /v) and 
destained in 5% methanol/7% acetic acid {both v/v). 
Molecular weights were determined by com-
parison with standards of known molecular size. 
Immunological studies 
Antisera to liver and testis ligandin were raised by 
injecting 50µg of purified proteins in Freund's 
complete adjuvant into popliteal lymph nodes of 
male albino rabbits. Thereafter, 50µg of ligandin in 
adjuvant was injected into multiple subcutaneous 
K. A. Eidne and R. E. Kirsch 
sites at 3-week intervals. Animals were bled IO days 
after booster inoculations. The separated sera were 
tested for specific antibody production by immuno-
diffusion and immunoelectrophoresis (Bass et al. , 
1977a). Radial immunodiffusion used 1.2% agar 
gels (Ouchterlony, 1958) and immunoelectrophore-
sis used I% agar gels (Bass et al. , 1977 a). Gels were 
thoroughly washed with iso-osmotic saline (0.9% 
NaCl) before staining with Amido Black. Affinity 
reagents, consisting of the globulin fraction ei ther of 
anti-{rat liver ligandin) serum or anti-(rat testis 
ligandin) serum prepared by (NH4) 2S04 precipitation 
(Hebert et al. , 1973), were coupled overnight at 4 °C 
to CNBr-activated Sepharose 4B. The remaining 
active groups were treated with I M-ethanolamine at 
pH 8 for 2 h, after which several washing cycles 
(0.1 M-acetate buffer/ IM-NaCl, pH 8.0, and 0.1 M-
borate buffer/ IM-NaCl , pH 4.0) were carried out to 
remove non-covalently adsorbed protein. Thus 98.4% 
of liver antibody and 94.2% of testis antibody were 
coupled. Partially purified rat tissue ligandin (TEAE-
cellulose eluate, Fig. 3) was applied to a column 
{10cm x 0.9cm) of affinity material. After unbound 
protein had been washed from the column immuno-
reactive material was eluted with 0.1 M-glycine, 
pH 3.0. The pH of all fractions was immediately 
adjusted to 7.4 with 1 M-Tris buffer. 
Radioimmunoassay of ligandin from rat tissues 
was performed by the double antibody method of 
Morgan & Lazarow {1963), with anti-(rat liver 
ligandin) serum as the first antibody. The assay 
procedure and the antisera used in this study have 
been described in detail (Bass et al., 1977b). 
Separation of glutathione S -transf erases 
Rat liver and testis supernatants were chromato-
graphed on a DEAE-cellulose column (2.6cm x 
35 cm) in 0.01 M-Tris/HCl buffer, pH 8.0. Fractions 
exhibiting absorbance at 280 nm were pooled and 
concentrated to a volume of 10ml (Amicon cell, 
PM- IO membrane). After dialysis into 0.0 I M-potas-
sium phosphate buffer, pH 6. 7 (buffer C), the 
preparation was applied to a CM-cellulose column 
(2.6 cm x 30 cm) previously equilibrated with buffer 
C (Habig et al. , 1974). A 600 ml linear gradient of 
0-120mM-HCl in buffer C was applied to the 
column, and 3 ml fractions were collected and stored 
at 4°C before assay. 
In a separate experiment, testis ligandin prepared 
as described by Bhargava et al. (1980) was 
chromatographed on a CM-cellulose column 
( 1.6 cm x 10 cm) as described above. 
Assays 
Glutathione S-transferase activity was measured 
by following the conjugation of GSH with either 
1-chloro-2,4-dinitrobenzene at 340 nm or 1,2-
dichloro-4-nitrobenzene at 345 nm (Habig et al., 
1982 
Subunit composition of rat testis ligandin 
1974). Glutathione peroxidase activity was assayed, 
as described by Prohaska & Ganther ( 1977), with 
0.1 mM-cumene hydroperoxide dissolved in 10% 
(v/v) ethanol. One enzyme unit is defined as lµmol 
of NADPH oxidized/ min. Protein concentrations 
were determined by the method of Lowry et al. 
(19 51 ), with bovine serum albumin as standard. 
Covalent cross-linking of ligand in 
Ligandin in 0.05 M-triethanolamine buffer 
(pH 8.0)/0.05 M-KCl/0.4M-NaCl was mixed with 
dimethyl suberimidate at 4°C to give final con-
centrations of 0.3mg of protein/ ml and 30mg of 
cross-linking reagent/ ml. The reaction was termi-
nated by addition of an equal volume of 0.3 M-
ethanolamine, before electrophoresis in S DS on 
polyacrylamide gradient gels (Davies & Stark, 
1970). 
Results 
Purification of testis ligand in 
Specific act1v1ty, with l-chloro-2,4-dinitro-
benzene and GSH as substrates, was determined at 
each stage of testis ligandin purification by the 
method of Kirsch et al. (1975) and Bhargava et al. 
(1980). The mean specific activity of the final 
product of four separate testis preparations was 
15.6µmol/min per mg of protein . SDS/ polyacryl-
amide-gel electrophoresis of each stage of purifi-
cation is shown in Fig. 1. The final preparation of 
testis ligandin has more Ye subunit than Ya. These 
findings and those of difference spectroscopy (results 
not shown) are identical with those obtained by 
Bhargava et al. ( 1980), and suggest that we are 
dealing with the same preparation. 
Antisera 
Radial immunodiffusion and immunoelectro-
phoresis of anti-(liver YaYa ligandin) or anti-(liver 
Ya Y c ligandin) against liver and testis cytosol 
revealed single lines of identity. Antisera raised 
against testis 'ligandin' revealed a single line of 
identity when immunoelectrophoresed against testis 
cytosol. However, a faint second line was noticed on 
immunoelectrophoresis against liver cytosol (Fig. 2). 
Affinity chromatography 
The profile obtained when the testis protein peak 
(TEAE-cellulose eluate) was applied to an anti-(liver 
ligandin) affinity column is shown in Fig. 3. 
Fractions were analysed by SDS/ polyacrylamide-gel 
electrophoresis (Fig. 4). The TEAE-cellulose eluate 
had more Ye subunit than Ya. In contrast, the 
material recognized by the matrix-coupled liver 
ligandin antibody (elution volume 85 ml) had equal 
quantities of the two subunits. Unbound fractions 
(elution volume 15 ml) contained no Ya subunit, but 
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Fig. I. SDS/polyacrylamide (5-25%, w/v)-gradient-gel 
electrophoresis at each stage of testis ligandin purifi-
cation 
(I) Molecular-weight markers (94000, 67000, 
43000, 30000, 20100, 14400 daltons). (2) Testis 
cytosol (100000g supernatant). (3) Protein peak 
after TEAE-cellulose chromatography. (4) Peak 
exhibiting GSH-chlorodinitrobenzene-conjugating 
activity after Sephadex G-100 chromatography. (5) 
Pooled fractions from QAE-Sephadex A-50 eluate. 
Between 10 and 30µg of protein was loaded per 
sample. Samples were prepared as described by 
Maize! ( 1971 ). 
1+1 TESTIS AB - 1- 1 
Fig. 2. lmmunoelectrophoresis of testis ligandin antibody 
against liver and testis cytosols in 1% agar gel 
The peripheral wells contain liver cytosol and testis 
cytosol (CYT; 1 µg in IO µI). The central trough 
contains 10µ1 of rabbit antiserum (AB) to testis 
ligandin . Electrophoresis was performed in 0.07 M-
veronal buffer, pH8.7, at 12mA for 2h. The 











Elution volume (ml) 
Fig. 3. Chromatography of partially purified (TEAE-
cel/ulose eluate) rat testis ligandin on anti-ligandin-
Sepharose 4B affinity columns 
The elution profiles for anti -(liver ligandin) and 
anti-(testis ligandin) affinity columns are identical. 
Unbound material was eluted in the first peak 
(elution volume I0-40ml). Bound material was 
eluted with 0.1 M-glycine, pH 3.0 (elution volume 
80-95ml). 
Ill 12) 131 14) 
---Ye 
-Ya 
Fig. 4. SDS/polyacrylamide-gel electrophoresis of peaks 
eluted after anti-(/iver ligandin)-Sepharose 4B affinity 
chromatography 
(I) Testis TEAE-cellulose eluate (starting material); 
(2) material at elution volume 15 ml; (3) material at 
elution volume 30 ml; (4) material after elution with 
0.1 M-glycine, pH 3.0. See Fig. 3 for details. 
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Fig. 5. SDS/polyacrylamide-gel electrophoresis of eluate 
from anti-(testis ligandin)-Sepharose 4B affinity column 
(I) Testis TEAE-cellulose eluate (starting material), 
(2) material eluted at 15 ml, (3) materi al eluted at 
25 ml, (4) material eluted after application of 
0.1 M-glycine buffer, pH 3.0 (elution volume 80-
95 ml). See Fig. 3 for details. 
later fractions (elution volume 30 ml) contained trace 
amounts of this species. 
When the same testis starting preparation was 
applied to a column of anti-(testis ligandin) affinity 
material, SDS/ polyacrylamide-gel electrophoresis 
(Fig. 5) revealed more Y c subunit than Ya in the 
immunoreactive peak (elution volume 85 ml). 
Elution of testis GSH S -transferases from CM-
cellulose 
CM-cellulose chromatography resolved liver 
DEAE-cellulose eluate into five peaks of GSH 
S-transferase activity (GSH-chloronitrobenzene 
conjugating activity) similar to those described by 
Habig et al. (1976). Fig. 6 shows the results of 
a similar experiment with testis DEAE-cellulose 
1982 
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Fig. 6. Elution pattern from CM-cellulose of testis DEAE-cel/ulose eluate at pH6.7 
GSH S-transferase activity was assayed with l-chloro-2,4-dinitrobenzene (CDNB, O) and l,2-dichloro-4-
nitrobenzene (DCNB, e ). Enzyme activity is expressed as µmol/min per ml. GSH peroxidase II activity was assayed 
with cumene hydroperoxide (cumene HOOH) as substrate (II). Results were expressed as µmol of cumene 
hydroperoxide/ min, by using the absorption coefficient (e) for NADPH of 6 x 103 litre· mot- 1 • cm- 1• Ligandin as 
measured by anti-(liver ligandin) radioimmunoassay is expressed as ng of ligandin/tube (6). The KCI gradient was 
























Fig. 7. CM-cellulose chromatography of 'pure' testis ligandin at pH 6. 7 
The KCI gradient (--, 0-120 mM) was started at the beginning of the column run. GSH S-transferase activity was 
assayed with chlorodinitrobenzene (CDNB, O) and expressed as µmol/min per ml. GSH peroxidase II activity was 
assayed with cumene hydroperoxide (cumene HOOH) and expressed as µmol /min C• ). Radioimmunoassay with 
anti-(liver ligandin) measured ng of ligandin per tube (6 ). Comparisons of the standard preparation of testis ligandin 
( I) with fractions from each peak (2 and 3) by SDS/polyacrylamide-gel electrophoresis are shown. 
eluate. Peak I (elution volme 40-70ml) represents 
material that did not bind to the column at pH6.7. 
After initiation of the salt gradient, a further four 
peaks were obtained, peak 2 (elution volume 
460-530ml), peak 3 (530-600ml) peak 4 (600-
660ml) and peak 5 (690-780ml). Dichloronitro-
benzene-conjugating activity was limited to peaks 2 
and 4. GSH peroxidase II activity with cumene 
hydroperoxide as substrate was present in peak 5 
and to a lesser extent in peaks 2 and 4 . GSH 
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peroxidase I act1v1ty was not measured in this 
experiment. Immunoreactivity determined by radio-
immunoassay with antibody raised against liver 
ligandin was present in fractions eluted between 480 
and 600ml. No immunoreactive material was found 
in peak 5. SDS/ polyacrylamide-gel electrophoresis 
of the immunoreactive peak revealed equal amounts 
of Ya and Ye subunits, but for peak 5 it revealed a 
major band in the Ye region but no Ya subunit. 
Chromatography of ' purified' testis ligandin 
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Fig. 8. SDS/polyacrylamide-gel electrophoresis of 'pure' 
testis ligandin cross-linked with dimethyl suberimidate 
(I) Testis ligandin, purified by standard procedures, 
no dimethyl suberimidate added. (2) Testis ligandin, 
after addition of dimethyl suberimidate and cross-
linking reaction allowed to proceed for 1.2 h under 
conditions described in the Materials and methods 
section, (3) after cross-linking for 2.5 h, and (4) after 
cross-linking for 3.5 h. 
yielded two peaks of GSH-chlorodinitrobenzene-
conjugating activity. Both peaks had GSH peroxi-
dase II activity. Only peak 1 contained immuno-
reactive material as determined by radioimmuno-
assay by using antiserum raised against liver 
ligandin. SDS/ polyacrylamide-gel electrophoresis of 
peak- I material revealed equal amounts of Ya and 
Ye subunits; peak 2 consisted entirely of Ye subunit 
(Fig. 7). 
Covalent cross-linking of testis ligandin 
SDS/ polyacrylamide-gel-electrophoretic analysis 
of covalently cross-linked testis ligandin resulted in 
two bands in the region of approx. 50000 mol.wt. 
after cross-linking had been allowed to proceed for 
2.5 h under the conditions described in the Materials 
and methods section (Fig. 8). 
Discussion 
Liver ligandin, as defined by Bass et al. (1977a), 
consists of equal amounts of Ya and Y c subunits. In 
contrast, the Ye subunit accounts for as much as 
90% of testis ligandin (Bhargava et al. , 1980; Bass 
et al., 1977a). By the standard purification pro-
cedure we were able to purify a protein with subunit 
structure, amino acid composition, binding charac-
teristics (results not shown) and GSH S-transferase 
activity similar to that described by Bhargava et al. 
(1980). They found testis ligandin to have a lower 
affinity than liver ligandin for bilirubin and for 
sulphobromophthalein. Circular-dichroism spectra 
K . A. Eidne and R. E. Kirsch 
revealed the absence of the primary binding site for 
bilirubin (Bhargava et al. , 1980). 
When testis ligandin was prepared by affinity 
chromatography, with antibody raised against liver 
ligandin, it consisted of equal amounts of Ya and Y c 
subunits. This was clearly different from testis 
ligandin preparations obtained by the standard 
purification procedure. The testis starting material 
contained more Y c than Ya subunit (Fig. 5, lane I). 
However, a considerable amount of Ye subunit was 
eluted in the wash (Fig. 5, lanes 2 and 3), suggesting 
that this may not have been recognized by the 
antibody. The immunoreactive material eluted with 
glycine buffer, pH 3.0, consisted of equal amounts of 
Ye and Ya subunits (Fig. 5, lane 4), resembling the 
proportions of these subunits found in liver ligandin. 
In addition, antibodies raised against testis ligandin 
prepared by standard methods consistently failed to 
meet immunoduffusion and immunoelectrophoretic 
criteria for purity when tested against liver cyto-
sol. Furthermore, SDS/ polyacrylamide-gel electro-
phoresis of covalently cross-linked testis ligandin 
revealed more than one band in the 50 000 Da 
region. This finding differed from that reported by 
Bhargava et al. ( 1978) for liver ligand in and thus 
may suggest the presence of another protein in our 
testis preparations. Our suspicion that standard 
preparations of testis ligandin could be conta-
minated by a closely related protein were 
strengthened by the findings of Hayes et al. ( 1980) 
and Scully & Mantle (1980), who studied the 
subunit composition of liver GSH S-transferases. 
The GSH S -transferases of rat liver (AA, A, B, C, D 
and E) have been classified according to their reverse 
order of elution from CM-cellulose (Habig et al. , 
1976). Transferases D and E are eluted before the 
salt gradient is applied, after which transferases C , 
B, A and AA are eluted sequentially. Although there 
is overlap of substrate specificity, the various 
transferases may be identified by their order of 
elution from CM-cellulose and their ability to 
conjugate GSH to various substrates. All conjugate 
chlorodinitrobenzene. Only transferases A and C 
conjugate GSH to dichloronitrobenzene (Habig et 
al., 1974), and transferases B, A and AA have GSH 
peroxidase activity (Prohaska & Ganther, 1977 ; 
Lawrence et al. , 1978; Irwin et al., 1980). On 
S DS/ polyacrylamide-gel electrophoresis, liver trans-
ferase AA migrates as subunit Ye, liver transferase B 
migrated as YaYc dimer, and transferases A and C 
[which show immunological identity (Habig et al., 
1974)) migrate as Yb subunit. This finding led 
Hayes et al. (1979) to differentiate between GSH 
S-transferase B (YaYc) and ligandin (YaYa). Since 
our study has been aimed at determining the subunit 
composition of a protein in testis which reacts 
immunologically with anti-(liver ligandin), the term 







Subunit composition of rat testis ligandin 
light of our findings the term GSH S-transferase B 
may be more appropriate. 
To determine whether testis transferase AA 
migrated as Ye subunit, we separated the testis GSH 
S-transferases by CM-cellulose chromatography 
and used order of elution, SDS/ polyacrylamide-gel 
electrophoresis, radioimmunoassay and catalytic 
activity with different substrates to characterize the 
various fractions. Activity with chlorodinitro-
benzene and dichloronitrobenzene resembled that 
seen in liver. We found GSH peroxidase activity in 
peaks corresponding to liver GSH S-transferases B, 
A and AA. Of interest is the fact that transferase 
AA accounts for most of the GSH peroxidase II 
activity in testis cytosol. SDS/ polyacrylamide-gel 
electrophoresis of the CM-cellulose peak with the 
elution characteristics of transferase AA revealed a 
major band in the Ye-subunit region , similar to 
findings reported by Scully & Mantle ( 1981). This 
peak was not recognized by antibody raised against 
liver ligandin. Immunoreactivity was confined to 
fractions eluted in the transferase-B region of the 
CM-cellulose profile. On SDS/ polyacrylamide-gel 
electrophoresis, this peak consisted of equal amounts 
of Ya and Ye subunits. 
It was apparent that if GSH S-transferase AA 
was present in standard preparations of ligandin it 
would not be detected on SDS/ polyacrylamide-gel 
electrophoresis. We thus used CM-cellulose 
chromatography to study 'pure' testis ligandin and 
found it to consist of GSH S-transferase B (consist-
ing of equal amounts of Ya and Ye subunits and 
recognized by antibody raised against the liver Ya 
subunit) and GSH S-transferase AA (which resem-
bles Ye subunit on SDS/ polyacrylamide-gel electro-
phoresis). Our finding that standard preparations of 
testis ligandin are contaminated by GSH S-trans-
ferase AA offers a new explanation for studies 
previously reported and interpreted differently. 
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CN, ,.'"Ill 1'.nll I'/, 1','TJ. m ~11u:ruJ. ~nn:;r,,i s,::,u:. 1n; n: '!Hr HY1".>-
Nfl':,•1.,u-11zl: • OH".i'A'::r.n B.n. AJ l,cnw,n , w.c. lt"i'9CY,. a:-><l r. . s. 
rut }Pr , JI. l~·v..Join..·,..lal f:ldx:111Y-;i(X1)~Brand,; rrnx' f,, •Ut<' S< la, 
1'1: >. ·2020:,-; a ,id Pr1rnatt- Rc·~c>drch CPntt·r (w:,.t } , Nt"'w' ,..,_ . ,.lex> State 
Univ., ~-,Jlordn hf1l, N-1 ~8330 , 
71¥· chl"T'l'n7"" und<> rgo<:5 an adrer.al r.eturation (a.1n:nardie ) 
tha t 1s gual1utively ard guanuu tively si..n,i lar to U-.at in ma n. 
We have used the chi..npanze<> to le~t the hypoU,esis lhat adrenal 
ardrogen production' is suprort.ed by a pitu i tary factor distinct 
fron ,t,eni. Six adult mal e chi..npanzees who had CXJn4Jlet.ed both 
gonadal and a drenal m.1turation were castrat.ed and either hyj:qJhy-
s ecto ni zed (hypox) or s hari--hyp:,physect.omized. Carpleteness of 
hypophyseCtaTI)', evaluated by provocative tests one _.,k after 
surgery, was 60, 80, and 91 percent in the 3 hypox anirrals. 
lly;x)x chinµ; received a daily J.M. injection of s ynU.etic AC'rn 
l-24 and o.-al tt,yroxine to prevent adrenal· insuff 1ciency and 
hypothyroidism. lldrenal function was evaluated wl th a 3--h ACnl 
infusion before and at 7, 21, 40, 120, and 180 days after hypo-
physectcr.,y. Plasma cortisol (F), dehydruepiandrosternne (CW\),· 
DHA sulfate (IJ!l\S), and androslenedione (t.4A) wen, 11Easured at 
6 tine points cluring the A...."Ill infusions. 'l'he mean ratios of IJiA/ 
F, J:»lAS/F, and t.4A/f during ACffl infusion were calculated as in-
di~ of ..t.hP r.elatl~ acthd ty of t..~ a~:-~~ ~~r .. '.!".i c.xpar-c..:! 
to the oortisol pathway. 'l'he I:JlA/F and DHAS/F rati~ dE>creased 
to 30 percent of pre-treatnent levels a t 40 days after hypopt,y-
sectany (p<. 01), to 50 percent of pre-treatnent levels at 120 
days after hypophysect.Cl'l)' (p<. 05 for I:llA.5/F), and to 60 percent 
at 180 days after hypcphysect~ (p, "5). The e4-A/F ratio 
did not chan<je after hypophysectany. None of the rati06 changed 
in the sham-hypox CX)Otrols. Met.abol ic clearance rates for oorti-
sol and !llA were meas ured bEfore and a t 180 days after hypophy-
sectomy or sham-hypophysect~ to assess the possible CX)Otribu-
tion of clearance changes to the changes in plas ma I:llA/F ratio. 
None of the clearance rates changed significantly, but cortisol 
cl earance a t 180 days was 57 • 12 (mean • SE) percent of the 
mean pre-treatrrent level. We conclude: (1)-ACffl alone r..aintained 
a normal 64-A/f ratio bot failed to maintain normal OOA/F and 
DHAS/F rati06 after hypophysec~ in the chirrpi!OZee, (2) 'Jhe 
data are cx:nsistent wi th the hypothesis that e5 adrenal andr~ 
gen production is regulated by a non-1\Cnl pituitary factor, but 
we cannot exclude the possibility that a decrease in cortisol 
clearance ""'Y explain the fall in [Ji>,/F and DHAS/F ratios. 
- 13j9 
ONTOGENY OF LIGAl,'Dlll AND STEROID BOIOIOl!ES IN iAT TESTIS, OVARY 
AND ADRENAL: EVIDENCE FOR A llLATIONSHIP. 
K. A. EIDNE•, R. MlLLAI!•, N. M. BASS• and R. E. KIRSCH• 
(SPO!i : B. SIIAPIRO) Medical Research Council-Liver Reoearch Group, 
Uni vend ty of Cape Town, Cape Town, South Africa. 
Ligand1n is present in high conc entrations in steroid 
synthesising tissues and has been claimed to inf] uence iotra-
cel lu)ar accumulation and efflux of steroid l-.ormones and their 
aetabolites. Using radioimmW'loassays, we have studied the 
ontogeny of li gandin in various tissues ·or the rat in relation 
to serum testosterone and progesterone levels. Ligand.in levels 
1o te15tis, ovary and adrenal tissue are relatively high after 
birth (table), decrease by day 9 and increase during puberty to 
reach adult levels. These changes are closely para] leled with 
changes in circulating levels of testosterone and progesterone. 
In contrast, ligand in in non-endocrine tissues is lo~ at birth 
and di splays a progress! ve r1 se which is not correlated •'i th 
changes in steroid-producing tissues. 
DA)' ADRENAL• TESTIS• TESTOST.~ OVARY• PROGEST.Q 
4 0. 3&+-0.1 I 0.2o+-0.03 3.6~.68 0.17-+-0.0l 2.6~.57 
9 0. I 7+o.OJ o.oa+o.01 I. 4o+0.2S 0.07+o.OJ I. 67+o. 40 
20 0.19+<>.03 O.Ob+o .01 1.08J.24 0. 15+0.0I 11. 49+o. 72 
31 0.2~.os O.JD+0.01 0.37~.13 
37 5.0'.>+1.64 24. 3'>!f>. 80 
46 0. 39:!-0. 02 0.14_:tO. 01 0.4:J::0.02 
49 7. 71+1.43 31. 04-+J.. 01 
60 0. 36_!().04 0.18-+-0.0l 7.12~.76 0.4>_!0.03 2S. 52_!). 2S 
*ligand in expressed as ug/mg soluble protein. 
~testosterone and9proge&terone expressed as nH/1, all val ues!,SD1 
The correlation between ligandin and se.x hon»one levels in 
developing rat steroid-producing tissue& strongly suggest6 a 
functional relationship. Our immW'lohistoc hemical studies 
localise ligandin to the 6teroidogenic cells of testis, ovary, 
and adrenal cortex. Ligand in is immunologically indisti"!lul sh-
able from glutathione S-tranferase B and ha s delta-5, 3--keto-
&teroid isomerase and $lutathione peroxidase activity. It Uy 
thus be involved in steroid hormone biosynthesis and also play 
an important role in protecting steroid-producing ti&sues from 
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